{
  "workers": [
    {
      "name": "Renat",
      "surname": "Kovalov",
      "fathers_name": "",
      "age": 20,
      "address": "Lviv",
      "phone": "+380971978445",
      "email": "worker@gmail.com",
      "salary": 500,
      "can_receive_appointments": true,
      "registration_date": null,
      "schedule": {
        "start_time": "10:00:00",
        "end_time": "19:00:00",
        "start_day": "Monday",
        "end_day": "Friday",
        "hours_for_rest": 0
      }
    },
    {
      "name": "Alex",
      "surname": "Worker",
      "fathers_name": "",
      "age": 69,
      "address": "Lviv",
      "phone": "+123444555666",
      "email": "",
      "salary": 100,
      "can_receive_appointments": true,
      "registration_date": null,
      "schedule": {
        "start_time": "00:00:00",
        "end_time": "23:00:00",
        "start_day": "Monday",
        "end_day": "Tuesday",
        "hours_for_rest": 10
      }
    },
    {
      "name": "Nova",
      "surname": "Ukrainiv",
      "fathers_name": "Tato",
      "age": 40,
      "address": "Poland",
      "phone": "+67812367328",
      "email": "abc@gmail.com",
      "salary": 400,
      "can_receive_appointments": true,
      "registration_date": null,
      "schedule": {
        "start_time": "12:00:00",
        "end_time": "15:00:00",
        "start_day": "Friday",
        "end_day": "Saturday",
        "hours_for_rest": 0
      }
    },
    {
      "name": "Oldova",
      "surname": "Cooler",
      "fathers_name": "",
      "age": 15,
      "address": "Ukraine",
      "phone": "+12313444444",
      "email": "genius@gmail.com",
      "salary": 0,
      "can_receive_appointments": true,
      "registration_date": null,
      "schedule": {
        "start_time": "14:00:00",
        "end_time": "22:00:00",
        "start_day": "bruh",
        "end_day": "lol",
        "hours_for_rest": 4
      }
    }
  ],
  "patients": [
    {
      "name": "Renat",
      "surname": "Kovalov",
      "fathers_name": "",
      "age": 20,
      "address": "Lviv",
      "phone": "+380971978445",
      "email": "some@gmail.com",
      "registration_date": "2024-04-08T16:22:29"
    },
    {
      "name": "Renato",
      "surname": "Kovalovo",
      "fathers_name": "Batkovich",
      "age": 19,
      "address": "Not Lviv ",
      "phone": "+380971978445",
      "email": "kaka@gmail.com",
      "registration_date": "2024-04-08T16:39:10"
    },
    {
      "name": "Test1",
      "surname": "Testova",
      "fathers_name": "Tato",
      "age": 50,
      "address": "Kyiv",
      "phone": "+123123123123",
      "email": "mail@gmail.com",
      "registration_date": "2024-04-09T18:37:23"
    }
  ],
  "drugs": [
    {
      "id": 1705,
      "name": "New medicament",
      "appliances": "None",
      "notes": "",
      "amount": 1000
    },
    {
      "id": 1,
      "name": "asenapine",
      "appliances": "",
      "notes": "",
      "amount": 426
    },
    {
      "id": 2,
      "name": "apomorphine",
      "appliances": "",
      "notes": "",
      "amount": 187
    },
    {
      "id": 3,
      "name": "aripiprazole",
      "appliances": "",
      "notes": "",
      "amount": 591
    },
    {
      "id": 4,
      "name": "bromocriptine",
      "appliances": "",
      "notes": "",
      "amount": 272
    },
    {
      "id": 5,
      "name": "buspirone",
      "appliances": "",
      "notes": "",
      "amount": 273
    },
    {
      "id": 6,
      "name": "cabergoline",
      "appliances": "",
      "notes": "",
      "amount": 103
    },
    {
      "id": 7,
      "name": "clozapine",
      "appliances": "",
      "notes": "",
      "amount": 337
    },
    {
      "id": 8,
      "name": "eletriptan",
      "appliances": "",
      "notes": "",
      "amount": 513
    },
    {
      "id": 9,
      "name": "lisuride",
      "appliances": "",
      "notes": "",
      "amount": 541
    },
    {
      "id": 10,
      "name": "naratriptan",
      "appliances": "",
      "notes": "",
      "amount": 999
    },
    {
      "id": 11,
      "name": "olanzapine",
      "appliances": "<i>In vivo</i> and <i>in vitro</i> studies in rats have indicated that antagonism of &alpha;<sub>1A</sub>-AR by olanzapine is responsible for the side effect of orthostatic hypotension associated with this drug <Reference id=19966/>.",
      "notes": "",
      "amount": 622
    },
    {
      "id": 12,
      "name": "pergolide",
      "appliances": "Pergolide has activity across all of the monoamine receptor families: dopamine receptors, serotonin receptors and adrenoceptors.",
      "notes": "",
      "amount": 439
    },
    {
      "id": 13,
      "name": "quetiapine",
      "appliances": "",
      "notes": "",
      "amount": 763
    },
    {
      "id": 14,
      "name": "rizatriptan",
      "appliances": "",
      "notes": "",
      "amount": 985
    },
    {
      "id": 15,
      "name": "sumatriptan",
      "appliances": "",
      "notes": "",
      "amount": 397
    },
    {
      "id": 16,
      "name": "terguride",
      "appliances": "",
      "notes": "",
      "amount": 359
    },
    {
      "id": 17,
      "name": "ziprasidone",
      "appliances": "",
      "notes": "",
      "amount": 228
    },
    {
      "id": 18,
      "name": "zolmitriptan",
      "appliances": "",
      "notes": "",
      "amount": 267
    },
    {
      "id": 19,
      "name": "fluspirilene",
      "appliances": "We have been unable to find affinity data for this drug at its proposed human target to substantiate its MMOA.",
      "notes": "",
      "amount": 451
    },
    {
      "id": 20,
      "name": "ketanserin",
      "appliances": "",
      "notes": "",
      "amount": 252
    },
    {
      "id": 21,
      "name": "pimozide",
      "appliances": "",
      "notes": "",
      "amount": 685
    },
    {
      "id": 22,
      "name": "pindolol",
      "appliances": "",
      "notes": "",
      "amount": 276
    },
    {
      "id": 23,
      "name": "pizotifen",
      "appliances": "",
      "notes": "",
      "amount": 879
    },
    {
      "id": 24,
      "name": "risperidone",
      "appliances": "",
      "notes": "",
      "amount": 738
    },
    {
      "id": 25,
      "name": "sertindole",
      "appliances": "",
      "notes": "",
      "amount": 189
    },
    {
      "id": 26,
      "name": "yohimbine",
      "appliances": "",
      "notes": "",
      "amount": 857
    },
    {
      "id": 269,
      "name": "eldecalcitol",
      "appliances": "",
      "notes": "",
      "amount": 498
    },
    {
      "id": 270,
      "name": "doxercalciferol",
      "appliances": "",
      "notes": "",
      "amount": 637
    },
    {
      "id": 27,
      "name": "zotepine",
      "appliances": "A major active metabolite of zotepine, <Ligand id=7537/>, acts as a norepinephrine reuptake inhibitor <Reference id=24665/>, adding to the drug's antipsychotic-like and antidepressant-like actions.",
      "notes": "",
      "amount": 152
    },
    {
      "id": 28,
      "name": "dihydroergotamine",
      "appliances": "",
      "notes": "",
      "amount": 763
    },
    {
      "id": 29,
      "name": "oxymetazoline",
      "appliances": "",
      "notes": "",
      "amount": 988
    },
    {
      "id": 30,
      "name": "methysergide",
      "appliances": "",
      "notes": "",
      "amount": 711
    },
    {
      "id": 31,
      "name": "mianserin",
      "appliances": "",
      "notes": "",
      "amount": 484
    },
    {
      "id": 32,
      "name": "ergometrine",
      "appliances": "",
      "notes": "",
      "amount": 682
    },
    {
      "id": 33,
      "name": "ergotamine",
      "appliances": "",
      "notes": "",
      "amount": 864
    },
    {
      "id": 34,
      "name": "methylergonovine",
      "appliances": "",
      "notes": "",
      "amount": 784
    },
    {
      "id": 35,
      "name": "agomelatine",
      "appliances": "",
      "notes": "",
      "amount": 931
    },
    {
      "id": 36,
      "name": "amitriptyline",
      "appliances": "",
      "notes": "",
      "amount": 266
    },
    {
      "id": 37,
      "name": "amoxapine",
      "appliances": "",
      "notes": "",
      "amount": 790
    },
    {
      "id": 38,
      "name": "duloxetine",
      "appliances": "",
      "notes": "",
      "amount": 575
    },
    {
      "id": 39,
      "name": "loxapine",
      "appliances": "",
      "notes": "",
      "amount": 157
    },
    {
      "id": 40,
      "name": "molindone",
      "appliances": "",
      "notes": "",
      "amount": 313
    },
    {
      "id": 41,
      "name": "perphenazine",
      "appliances": "",
      "notes": "",
      "amount": 484
    },
    {
      "id": 42,
      "name": "sarpogrelate",
      "appliances": "",
      "notes": "",
      "amount": 255
    },
    {
      "id": 43,
      "name": "thiothixene",
      "appliances": "",
      "notes": "",
      "amount": 779
    },
    {
      "id": 44,
      "name": "trazodone",
      "appliances": "",
      "notes": "",
      "amount": 905
    },
    {
      "id": 45,
      "name": "melatonin",
      "appliances": "",
      "notes": "",
      "amount": 487
    },
    {
      "id": 46,
      "name": "tegaserod",
      "appliances": "",
      "notes": "",
      "amount": 906
    },
    {
      "id": 47,
      "name": "cisapride",
      "appliances": "",
      "notes": "",
      "amount": 619
    },
    {
      "id": 48,
      "name": "metoclopramide",
      "appliances": "",
      "notes": "",
      "amount": 512
    },
    {
      "id": 49,
      "name": "mosapride",
      "appliances": "",
      "notes": "",
      "amount": 975
    },
    {
      "id": 50,
      "name": "prucalopride",
      "appliances": "",
      "notes": "",
      "amount": 387
    },
    {
      "id": 51,
      "name": "tropisetron",
      "appliances": "",
      "notes": "",
      "amount": 610
    },
    {
      "id": 52,
      "name": "cyproheptadine",
      "appliances": "",
      "notes": "",
      "amount": 570
    },
    {
      "id": 53,
      "name": "bethanechol",
      "appliances": "No bioactivity mappings available.",
      "notes": "",
      "amount": 270
    },
    {
      "id": 54,
      "name": "carbachol",
      "appliances": "",
      "notes": "",
      "amount": 730
    },
    {
      "id": 55,
      "name": "pilocarpine",
      "appliances": "",
      "notes": "",
      "amount": 842
    },
    {
      "id": 56,
      "name": "N-methyl scopolamine",
      "appliances": "",
      "notes": "",
      "amount": 764
    },
    {
      "id": 57,
      "name": "atropine",
      "appliances": "",
      "notes": "",
      "amount": 434
    },
    {
      "id": 58,
      "name": "darifenacin",
      "appliances": "",
      "notes": "",
      "amount": 790
    },
    {
      "id": 59,
      "name": "ipratropium",
      "appliances": "",
      "notes": "",
      "amount": 834
    },
    {
      "id": 60,
      "name": "pirenzepine",
      "appliances": "",
      "notes": "",
      "amount": 172
    },
    {
      "id": 61,
      "name": "propantheline",
      "appliances": "",
      "notes": "",
      "amount": 304
    },
    {
      "id": 62,
      "name": "scopolamine",
      "appliances": "",
      "notes": "",
      "amount": 150
    },
    {
      "id": 63,
      "name": "dexetimide",
      "appliances": "",
      "notes": "",
      "amount": 468
    },
    {
      "id": 64,
      "name": "dicyclomine",
      "appliances": "",
      "notes": "",
      "amount": 437
    },
    {
      "id": 65,
      "name": "gallamine",
      "appliances": "Gallamine is a negative allosteric modulator of the M<sub>2</sub> muscarinic acetylcholine receptor.",
      "notes": "",
      "amount": 324
    },
    {
      "id": 66,
      "name": "imipramine",
      "appliances": "",
      "notes": "",
      "amount": 743
    },
    {
      "id": 67,
      "name": "oxybutynin",
      "appliances": "",
      "notes": "",
      "amount": 145
    },
    {
      "id": 68,
      "name": "tolterodine",
      "appliances": "",
      "notes": "",
      "amount": 551
    },
    {
      "id": 69,
      "name": "clidinium",
      "appliances": "",
      "notes": "",
      "amount": 104
    },
    {
      "id": 70,
      "name": "tiotropium",
      "appliances": "",
      "notes": "",
      "amount": 799
    },
    {
      "id": 71,
      "name": "caffeine",
      "appliances": "",
      "notes": "",
      "amount": 900
    },
    {
      "id": 72,
      "name": "theophylline",
      "appliances": "",
      "notes": "",
      "amount": 281
    },
    {
      "id": 74,
      "name": "methoxamine",
      "appliances": "",
      "notes": "",
      "amount": 532
    },
    {
      "id": 75,
      "name": "phenylephrine",
      "appliances": "",
      "notes": "",
      "amount": 509
    },
    {
      "id": 76,
      "name": "tamsulosin",
      "appliances": "",
      "notes": "",
      "amount": 217
    },
    {
      "id": 77,
      "name": "silodosin",
      "appliances": "",
      "notes": "",
      "amount": 738
    },
    {
      "id": 78,
      "name": "indoramin",
      "appliances": "",
      "notes": "",
      "amount": 978
    },
    {
      "id": 79,
      "name": "phentolamine",
      "appliances": "",
      "notes": "",
      "amount": 595
    },
    {
      "id": 80,
      "name": "prazosin",
      "appliances": "",
      "notes": "",
      "amount": 117
    },
    {
      "id": 82,
      "name": "corbadrine",
      "appliances": "",
      "notes": "",
      "amount": 702
    },
    {
      "id": 83,
      "name": "clonidine",
      "appliances": "",
      "notes": "",
      "amount": 160
    },
    {
      "id": 84,
      "name": "xylometazoline",
      "appliances": "As we have been unable to find publicly available affinity data for this drug (at the human target) to substantiate its MMOA, we have not mapped a primary drug target.",
      "notes": "",
      "amount": 484
    },
    {
      "id": 85,
      "name": "brimonidine (UK14304)",
      "appliances": "",
      "notes": "",
      "amount": 303
    },
    {
      "id": 86,
      "name": "dexmedetomidine",
      "appliances": "",
      "notes": "",
      "amount": 657
    },
    {
      "id": 87,
      "name": "guanfacine",
      "appliances": "",
      "notes": "",
      "amount": 226
    },
    {
      "id": 88,
      "name": "dobutamine",
      "appliances": "",
      "notes": "",
      "amount": 234
    },
    {
      "id": 89,
      "name": "isoprenaline",
      "appliances": "",
      "notes": "",
      "amount": 935
    },
    {
      "id": 90,
      "name": "atenolol",
      "appliances": "",
      "notes": "",
      "amount": 827
    },
    {
      "id": 91,
      "name": "betaxolol",
      "appliances": "Note that &beta;<sub>1</sub> selectivity is not absolute, and some inhibitory effects on &beta;<sub>2</sub>-adrenoceptors (mainly in the bronchial and vascular musculature) is exhibited at higher doses.",
      "notes": "",
      "amount": 463
    },
    {
      "id": 92,
      "name": "bupranolol",
      "appliances": "",
      "notes": "",
      "amount": 714
    },
    {
      "id": 93,
      "name": "carvedilol",
      "appliances": "",
      "notes": "",
      "amount": 999
    },
    {
      "id": 94,
      "name": "metoprolol",
      "appliances": "",
      "notes": "",
      "amount": 143
    },
    {
      "id": 95,
      "name": "nadolol",
      "appliances": "",
      "notes": "",
      "amount": 536
    },
    {
      "id": 96,
      "name": "practolol",
      "appliances": "",
      "notes": "",
      "amount": 141
    },
    {
      "id": 97,
      "name": "ephedrine",
      "appliances": "",
      "notes": "",
      "amount": 397
    },
    {
      "id": 98,
      "name": "fenoterol",
      "appliances": "",
      "notes": "",
      "amount": 575
    },
    {
      "id": 99,
      "name": "salbutamol",
      "appliances": "",
      "notes": "",
      "amount": 126
    },
    {
      "id": 100,
      "name": "salmeterol",
      "appliances": "",
      "notes": "",
      "amount": 151
    },
    {
      "id": 101,
      "name": "terbutaline",
      "appliances": "",
      "notes": "",
      "amount": 935
    },
    {
      "id": 102,
      "name": "alprenolol",
      "appliances": "",
      "notes": "",
      "amount": 140
    },
    {
      "id": 103,
      "name": "propranolol",
      "appliances": "",
      "notes": "",
      "amount": 133
    },
    {
      "id": 104,
      "name": "timolol",
      "appliances": "",
      "notes": "",
      "amount": 350
    },
    {
      "id": 105,
      "name": "carazolol",
      "appliances": "",
      "notes": "",
      "amount": 573
    },
    {
      "id": 106,
      "name": "bunolol",
      "appliances": "",
      "notes": "",
      "amount": 248
    },
    {
      "id": 107,
      "name": "candesartan",
      "appliances": "",
      "notes": "",
      "amount": 138
    },
    {
      "id": 108,
      "name": "eprosartan",
      "appliances": "",
      "notes": "",
      "amount": 720
    },
    {
      "id": 109,
      "name": "irbesartan",
      "appliances": "",
      "notes": "",
      "amount": 435
    },
    {
      "id": 110,
      "name": "losartan",
      "appliances": "",
      "notes": "",
      "amount": 187
    },
    {
      "id": 111,
      "name": "olmesartan",
      "appliances": "",
      "notes": "",
      "amount": 344
    },
    {
      "id": 112,
      "name": "telmisartan",
      "appliances": "",
      "notes": "",
      "amount": 927
    },
    {
      "id": 113,
      "name": "chenodeoxycholic acid",
      "appliances": "",
      "notes": "",
      "amount": 373
    },
    {
      "id": 114,
      "name": "cholic acid",
      "appliances": "",
      "notes": "",
      "amount": 164
    },
    {
      "id": 115,
      "name": "deoxycholic acid",
      "appliances": "",
      "notes": "",
      "amount": 129
    },
    {
      "id": 116,
      "name": "icatibant",
      "appliances": "",
      "notes": "",
      "amount": 107
    },
    {
      "id": 117,
      "name": "calcitonin",
      "appliances": "",
      "notes": "",
      "amount": 281
    },
    {
      "id": 118,
      "name": "neomycin",
      "appliances": "",
      "notes": "",
      "amount": 582
    },
    {
      "id": 119,
      "name": "rimonabant",
      "appliances": "",
      "notes": "",
      "amount": 821
    },
    {
      "id": 120,
      "name": "maraviroc",
      "appliances": "Maraviroc has been described as a negative allosteric modulator of CCR5 <Reference id=26068/>.",
      "notes": "",
      "amount": 982
    },
    {
      "id": 121,
      "name": "plerixafor",
      "appliances": "",
      "notes": "",
      "amount": 800
    },
    {
      "id": 122,
      "name": "pentagastrin",
      "appliances": "",
      "notes": "",
      "amount": 177
    },
    {
      "id": 123,
      "name": "rebamipide",
      "appliances": "",
      "notes": "",
      "amount": 619
    },
    {
      "id": 124,
      "name": "fenoldopam",
      "appliances": "",
      "notes": "",
      "amount": 580
    },
    {
      "id": 125,
      "name": "dopamine",
      "appliances": "",
      "notes": "",
      "amount": 843
    },
    {
      "id": 126,
      "name": "rotigotine",
      "appliances": "",
      "notes": "",
      "amount": 609
    },
    {
      "id": 127,
      "name": "pramipexole",
      "appliances": "",
      "notes": "",
      "amount": 842
    },
    {
      "id": 129,
      "name": "amisulpride",
      "appliances": "",
      "notes": "",
      "amount": 777
    },
    {
      "id": 130,
      "name": "domperidone",
      "appliances": "",
      "notes": "",
      "amount": 262
    },
    {
      "id": 132,
      "name": "fulvestrant",
      "appliances": "",
      "notes": "",
      "amount": 678
    },
    {
      "id": 133,
      "name": "cyclosporin A",
      "appliances": "",
      "notes": "",
      "amount": 833
    },
    {
      "id": 134,
      "name": "rosiglitazone",
      "appliances": "",
      "notes": "",
      "amount": 925
    },
    {
      "id": 135,
      "name": "baclofen",
      "appliances": "",
      "notes": "",
      "amount": 114
    },
    {
      "id": 136,
      "name": "pralmorelin",
      "appliances": "",
      "notes": "",
      "amount": 485
    },
    {
      "id": 137,
      "name": "liraglutide",
      "appliances": "",
      "notes": "",
      "amount": 202
    },
    {
      "id": 138,
      "name": "exendin-4",
      "appliances": "Binds to the GLP-1 receptor.",
      "notes": "",
      "amount": 678
    },
    {
      "id": 139,
      "name": "glucagon",
      "appliances": "",
      "notes": "",
      "amount": 768
    },
    {
      "id": 140,
      "name": "FSH",
      "appliances": "",
      "notes": "",
      "amount": 263
    },
    {
      "id": 141,
      "name": "LH",
      "appliances": "",
      "notes": "",
      "amount": 860
    },
    {
      "id": 142,
      "name": "leuprolide",
      "appliances": "",
      "notes": "",
      "amount": 945
    },
    {
      "id": 143,
      "name": "triptorelin",
      "appliances": "",
      "notes": "",
      "amount": 283
    },
    {
      "id": 144,
      "name": "abarelix",
      "appliances": "",
      "notes": "",
      "amount": 161
    },
    {
      "id": 145,
      "name": "cetrorelix",
      "appliances": "",
      "notes": "",
      "amount": 677
    },
    {
      "id": 147,
      "name": "cetirizine",
      "appliances": "In rodent studies, systemically administered cetirizine shows negligible brain penetration or binding to cerebral H<sub>1</sub> receptors.",
      "notes": "",
      "amount": 997
    },
    {
      "id": 148,
      "name": "diphenhydramine",
      "appliances": "",
      "notes": "",
      "amount": 648
    },
    {
      "id": 149,
      "name": "doxepin",
      "appliances": "Doxepin inhibits <Ligand id=318/> binding to muscarinic acetylcholine receptors in bovine brain preparations with a K<sub>i</sub> of 40nM <Reference id=32864/>.",
      "notes": "",
      "amount": 619
    },
    {
      "id": 150,
      "name": "mepyramine",
      "appliances": "The drug is administered as the maleate salt which has PubChem <a href=\"https://pubchem.ncbi.nlm.nih.gov/compound/5284451\" target=\"_blank\">CID 5284451</a>.",
      "notes": "",
      "amount": 738
    },
    {
      "id": 151,
      "name": "triprolidine",
      "appliances": "",
      "notes": "",
      "amount": 244
    },
    {
      "id": 152,
      "name": "cimetidine",
      "appliances": "",
      "notes": "",
      "amount": 747
    },
    {
      "id": 153,
      "name": "ranitidine",
      "appliances": "",
      "notes": "",
      "amount": 619
    },
    {
      "id": 154,
      "name": "afamelanotide",
      "appliances": "",
      "notes": "",
      "amount": 642
    },
    {
      "id": 155,
      "name": "ramelteon",
      "appliances": "",
      "notes": "",
      "amount": 851
    },
    {
      "id": 156,
      "name": "erythromycin",
      "appliances": "",
      "notes": "",
      "amount": 119
    },
    {
      "id": 157,
      "name": "levocabastine",
      "appliances": "We have been unable to find affinity data for this drug (at the human target) to substantiate this MMOA.",
      "notes": "",
      "amount": 896
    },
    {
      "id": 158,
      "name": "acipimox",
      "appliances": "",
      "notes": "",
      "amount": 203
    },
    {
      "id": 160,
      "name": "fentanyl",
      "appliances": "",
      "notes": "",
      "amount": 456
    },
    {
      "id": 161,
      "name": "morphine",
      "appliances": "",
      "notes": "",
      "amount": 459
    },
    {
      "id": 162,
      "name": "nalmefene",
      "appliances": "",
      "notes": "",
      "amount": 939
    },
    {
      "id": 163,
      "name": "nalorphine",
      "appliances": "",
      "notes": "",
      "amount": 341
    },
    {
      "id": 164,
      "name": "naloxone",
      "appliances": "",
      "notes": "",
      "amount": 822
    },
    {
      "id": 165,
      "name": "naltrexone",
      "appliances": "",
      "notes": "",
      "amount": 218
    },
    {
      "id": 166,
      "name": "nalbuphine",
      "appliances": "",
      "notes": "",
      "amount": 551
    },
    {
      "id": 167,
      "name": "buprenorphine",
      "appliances": "",
      "notes": "",
      "amount": 843
    },
    {
      "id": 168,
      "name": "codeine",
      "appliances": "",
      "notes": "",
      "amount": 723
    },
    {
      "id": 169,
      "name": "suramin",
      "appliances": "",
      "notes": "",
      "amount": 445
    },
    {
      "id": 170,
      "name": "ticagrelor",
      "appliances": "",
      "notes": "",
      "amount": 758
    },
    {
      "id": 171,
      "name": "cangrelor",
      "appliances": "",
      "notes": "",
      "amount": 147
    },
    {
      "id": 172,
      "name": "PTH",
      "appliances": "",
      "notes": "",
      "amount": 727
    },
    {
      "id": 173,
      "name": "PGE<sub>2</sub>",
      "appliances": "Although PGE<sub>2</sub> has potent affinity across the EP receptor family we have tagged the EP<sub>1</sub> and EP<sub>2</sub> receptors as primary drug targets.",
      "notes": "",
      "amount": 720
    },
    {
      "id": 174,
      "name": "iloprost",
      "appliances": "",
      "notes": "",
      "amount": 688
    },
    {
      "id": 175,
      "name": "indomethacin",
      "appliances": "",
      "notes": "",
      "amount": 226
    },
    {
      "id": 176,
      "name": "PGI<sub>2</sub>",
      "appliances": "",
      "notes": "",
      "amount": 823
    },
    {
      "id": 177,
      "name": "misoprostol (methyl ester)",
      "appliances": "",
      "notes": "",
      "amount": 426
    },
    {
      "id": 178,
      "name": "bimatoprost",
      "appliances": "",
      "notes": "",
      "amount": 351
    },
    {
      "id": 179,
      "name": "latanoprost (free acid form)",
      "appliances": "",
      "notes": "",
      "amount": 954
    },
    {
      "id": 180,
      "name": "latanoprost (isopropyl ester)",
      "appliances": "",
      "notes": "",
      "amount": 879
    },
    {
      "id": 181,
      "name": "pasireotide",
      "appliances": "",
      "notes": "",
      "amount": 975
    },
    {
      "id": 182,
      "name": "lanreotide",
      "appliances": "",
      "notes": "",
      "amount": 763
    },
    {
      "id": 183,
      "name": "vapreotide",
      "appliances": "",
      "notes": "",
      "amount": 203
    },
    {
      "id": 184,
      "name": "octreotide",
      "appliances": "",
      "notes": "",
      "amount": 729
    },
    {
      "id": 185,
      "name": "TRH",
      "appliances": "",
      "notes": "",
      "amount": 874
    },
    {
      "id": 186,
      "name": "dexamfetamine",
      "appliances": "",
      "notes": "",
      "amount": 310
    },
    {
      "id": 187,
      "name": "vasopressin",
      "appliances": "",
      "notes": "",
      "amount": 624
    },
    {
      "id": 188,
      "name": "oxytocin",
      "appliances": "",
      "notes": "",
      "amount": 568
    },
    {
      "id": 189,
      "name": "desmopressin",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 190,
      "name": "conivaptan",
      "appliances": "",
      "notes": "",
      "amount": 964
    },
    {
      "id": 191,
      "name": "atosiban",
      "appliances": "",
      "notes": "",
      "amount": 580
    },
    {
      "id": 192,
      "name": "tolvaptan",
      "appliances": "",
      "notes": "",
      "amount": 903
    },
    {
      "id": 193,
      "name": "azasetron",
      "appliances": "",
      "notes": "",
      "amount": 924
    },
    {
      "id": 194,
      "name": "cocaine",
      "appliances": "",
      "notes": "",
      "amount": 376
    },
    {
      "id": 195,
      "name": "ondansetron",
      "appliances": "",
      "notes": "",
      "amount": 596
    },
    {
      "id": 196,
      "name": "tubocurarine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of nACh channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 655
    },
    {
      "id": 197,
      "name": "alosetron",
      "appliances": "",
      "notes": "",
      "amount": 333
    },
    {
      "id": 198,
      "name": "diltiazem",
      "appliances": "",
      "notes": "",
      "amount": 624
    },
    {
      "id": 199,
      "name": "granisetron",
      "appliances": "",
      "notes": "",
      "amount": 907
    },
    {
      "id": 200,
      "name": "chlorzoxazone",
      "appliances": "",
      "notes": "",
      "amount": 666
    },
    {
      "id": 201,
      "name": "clotrimazole",
      "appliances": "",
      "notes": "",
      "amount": 615
    },
    {
      "id": 202,
      "name": "nitrendipine",
      "appliances": "",
      "notes": "",
      "amount": 811
    },
    {
      "id": 203,
      "name": "bepridil",
      "appliances": "",
      "notes": "",
      "amount": 724
    },
    {
      "id": 204,
      "name": "ivabradine",
      "appliances": "",
      "notes": "",
      "amount": 395
    },
    {
      "id": 205,
      "name": "colchicine",
      "appliances": "",
      "notes": "",
      "amount": 594
    },
    {
      "id": 206,
      "name": "dehydroepiandrosterone",
      "appliances": "",
      "notes": "",
      "amount": 633
    },
    {
      "id": 207,
      "name": "ivermectin",
      "appliances": "",
      "notes": "",
      "amount": 184
    },
    {
      "id": 208,
      "name": "pregnenolone",
      "appliances": "",
      "notes": "",
      "amount": 198
    },
    {
      "id": 209,
      "name": "progesterone",
      "appliances": "",
      "notes": "",
      "amount": 793
    },
    {
      "id": 210,
      "name": "bupivacaine",
      "appliances": "We have been unable to find publicly available affinity data for this drug (at human sodium channels) to substantiate its MMOA.",
      "notes": "",
      "amount": 163
    },
    {
      "id": 211,
      "name": "desipramine",
      "appliances": "",
      "notes": "",
      "amount": 942
    },
    {
      "id": 212,
      "name": "halothane",
      "appliances": "Halothane potentiates human K<sub>2P</sub>9.1 (TASK-3) activity <i>in vitro</i> <Reference id=29653/>.<Reference id=29654/>.",
      "notes": "",
      "amount": 679
    },
    {
      "id": 213,
      "name": "diazoxide",
      "appliances": "Note that we have been unable to find affinity data for this drug (at the human target) to substantiate this MMOA.",
      "notes": "",
      "amount": 779
    },
    {
      "id": 214,
      "name": "nicorandil",
      "appliances": "",
      "notes": "",
      "amount": 499
    },
    {
      "id": 215,
      "name": "pinacidil",
      "appliances": "",
      "notes": "",
      "amount": 770
    },
    {
      "id": 216,
      "name": "glibenclamide",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 217,
      "name": "fampridine",
      "appliances": "This drug is non-selective in action and blocks many of the voltage-gated potassium channels. Where we have affinity data for human channels we have tagged these as the primary drug target.",
      "notes": "",
      "amount": 511
    },
    {
      "id": 218,
      "name": "amiloride",
      "appliances": "",
      "notes": "",
      "amount": 860
    },
    {
      "id": 220,
      "name": "gentamicin",
      "appliances": "",
      "notes": "",
      "amount": 462
    },
    {
      "id": 222,
      "name": "niflumic acid",
      "appliances": "We have been unable to find affinity data for this drug (at the human targets) to substantiate its MMOA.",
      "notes": "",
      "amount": 616
    },
    {
      "id": 223,
      "name": "econazole",
      "appliances": "",
      "notes": "",
      "amount": 583
    },
    {
      "id": 224,
      "name": "flufenamic acid",
      "appliances": "",
      "notes": "",
      "amount": 345
    },
    {
      "id": 225,
      "name": "miconazole",
      "appliances": "",
      "notes": "",
      "amount": 674
    },
    {
      "id": 226,
      "name": "capsaicin",
      "appliances": "",
      "notes": "",
      "amount": 159
    },
    {
      "id": 227,
      "name": "angiotensin II",
      "appliances": "",
      "notes": "",
      "amount": 899
    },
    {
      "id": 228,
      "name": "isoflurane",
      "appliances": "",
      "notes": "",
      "amount": 501
    },
    {
      "id": 229,
      "name": "NO",
      "appliances": "",
      "notes": "",
      "amount": 679
    },
    {
      "id": 230,
      "name": "quinine",
      "appliances": "",
      "notes": "",
      "amount": 167
    },
    {
      "id": 231,
      "name": "nifedipine",
      "appliances": "",
      "notes": "",
      "amount": 961
    },
    {
      "id": 232,
      "name": "mibefradil",
      "appliances": "",
      "notes": "",
      "amount": 471
    },
    {
      "id": 233,
      "name": "nimodipine",
      "appliances": "Nimodipine is widely described as a L-type calcium channel inhibitor, however it also blocks T-type calcium channel (Ca<sub>V</sub>3.1-3.3) currents. The pK<sub>i</sub> for Ca<sub>V</sub>3.2 is 5.25 (~5.6 &mu;M).",
      "notes": "",
      "amount": 690
    },
    {
      "id": 234,
      "name": "nisoldipine",
      "appliances": "",
      "notes": "",
      "amount": 607
    },
    {
      "id": 235,
      "name": "ziconotide",
      "appliances": "Bioactivity data may have been generated using either the mollusc-derived peptide or the synthetically manufactured version.",
      "notes": "",
      "amount": 853
    },
    {
      "id": 236,
      "name": "nicardipine",
      "appliances": "",
      "notes": "",
      "amount": 703
    },
    {
      "id": 237,
      "name": "flecainide",
      "appliances": "",
      "notes": "",
      "amount": 812
    },
    {
      "id": 238,
      "name": "ketoconazole",
      "appliances": "",
      "notes": "",
      "amount": 124
    },
    {
      "id": 239,
      "name": "thiopental",
      "appliances": "",
      "notes": "",
      "amount": 196
    },
    {
      "id": 240,
      "name": "sibutramine",
      "appliances": "",
      "notes": "",
      "amount": 307
    },
    {
      "id": 241,
      "name": "mefenamic acid",
      "appliances": "",
      "notes": "",
      "amount": 584
    },
    {
      "id": 242,
      "name": "retigabine",
      "appliances": "",
      "notes": "",
      "amount": 524
    },
    {
      "id": 243,
      "name": "dofetilide",
      "appliances": "",
      "notes": "",
      "amount": 985
    },
    {
      "id": 244,
      "name": "terfenadine",
      "appliances": "",
      "notes": "",
      "amount": 969
    },
    {
      "id": 245,
      "name": "lamotrigine",
      "appliances": "We have been unable to find publicly available affinity data for this drug (at its proposed human targets) to substantiate its MMOA. For this reason, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 854
    },
    {
      "id": 246,
      "name": "lidocaine",
      "appliances": "",
      "notes": "",
      "amount": 542
    },
    {
      "id": 247,
      "name": "phenytoin",
      "appliances": "",
      "notes": "",
      "amount": 376
    },
    {
      "id": 248,
      "name": "mexiletine",
      "appliances": "",
      "notes": "",
      "amount": 477
    },
    {
      "id": 249,
      "name": "triiodothyronine",
      "appliances": "",
      "notes": "",
      "amount": 220
    },
    {
      "id": 250,
      "name": "T<sub>4</sub>",
      "appliances": "",
      "notes": "",
      "amount": 532
    },
    {
      "id": 251,
      "name": "tretinoin",
      "appliances": "All-trans-retinoic acid appears to have highest affinity for retinioc acid receptor-&beta; <Reference id=23508/>.",
      "notes": "",
      "amount": 119
    },
    {
      "id": 252,
      "name": "alitretinoin",
      "appliances": "",
      "notes": "",
      "amount": 999
    },
    {
      "id": 253,
      "name": "clofibrate",
      "appliances": "",
      "notes": "",
      "amount": 813
    },
    {
      "id": 254,
      "name": "bezafibrate",
      "appliances": "",
      "notes": "",
      "amount": 968
    },
    {
      "id": 255,
      "name": "troglitazone",
      "appliances": "",
      "notes": "",
      "amount": 879
    },
    {
      "id": 256,
      "name": "pioglitazone",
      "appliances": "",
      "notes": "",
      "amount": 199
    },
    {
      "id": 257,
      "name": "mesalazine",
      "appliances": "",
      "notes": "",
      "amount": 652
    },
    {
      "id": 258,
      "name": "ibuprofen",
      "appliances": "",
      "notes": "",
      "amount": 496
    },
    {
      "id": 259,
      "name": "diclofenac",
      "appliances": "",
      "notes": "",
      "amount": 686
    },
    {
      "id": 260,
      "name": "lovastatin",
      "appliances": "",
      "notes": "",
      "amount": 861
    },
    {
      "id": 261,
      "name": "vitamin D3",
      "appliances": "",
      "notes": "",
      "amount": 485
    },
    {
      "id": 262,
      "name": "meclizine",
      "appliances": "",
      "notes": "",
      "amount": 304
    },
    {
      "id": 263,
      "name": "rifampicin",
      "appliances": "Rifampicin inhibits uptake of estrone-3-sulfate by bovine Oatp1a2 <i>in vitro</i> (by approximately 40%), by competing with estrone-3-sulfate for the high affinity substrate binding site <Reference id=29683/>.",
      "notes": "",
      "amount": 600
    },
    {
      "id": 264,
      "name": "dexamethasone",
      "appliances": "",
      "notes": "",
      "amount": 558
    },
    {
      "id": 265,
      "name": "paclitaxel",
      "appliances": "Paclitaxel (taxol) mimics the action of lipopolysaccharide (LPS) in mice but not in humans, by activating a TLR4.MD-2 complex <Reference id=17721/>.",
      "notes": "",
      "amount": 723
    },
    {
      "id": 266,
      "name": "trabectedin",
      "appliances": "",
      "notes": "",
      "amount": 913
    },
    {
      "id": 267,
      "name": "calcipotriol",
      "appliances": "",
      "notes": "",
      "amount": 238
    },
    {
      "id": 268,
      "name": "1,25-dihydroxyvitamin D3",
      "appliances": "Appliances to cure cancer lol",
      "notes": "This is notes ",
      "amount": 833
    },
    {
      "id": 271,
      "name": "paricalcitol",
      "appliances": "",
      "notes": "",
      "amount": 136
    },
    {
      "id": 272,
      "name": "colfosceril palmitate",
      "appliances": "We have no interaction data for this compound.",
      "notes": "",
      "amount": 660
    },
    {
      "id": 273,
      "name": "diethylstilbestrol",
      "appliances": "",
      "notes": "",
      "amount": 869
    },
    {
      "id": 274,
      "name": "phenobarbital",
      "appliances": "",
      "notes": "",
      "amount": 271
    },
    {
      "id": 275,
      "name": "mifepristone",
      "appliances": "",
      "notes": "",
      "amount": 663
    },
    {
      "id": 276,
      "name": "bexarotene",
      "appliances": "",
      "notes": "",
      "amount": 680
    },
    {
      "id": 277,
      "name": "estrone",
      "appliances": "",
      "notes": "",
      "amount": 692
    },
    {
      "id": 278,
      "name": "estriol",
      "appliances": "",
      "notes": "",
      "amount": 106
    },
    {
      "id": 279,
      "name": "adenosine",
      "appliances": "",
      "notes": "",
      "amount": 801
    },
    {
      "id": 280,
      "name": "testosterone",
      "appliances": "Despite testosterone being an endogenous ligand,  we have been unable to find molecular affinity data at the human androgen receptor.",
      "notes": "",
      "amount": 668
    },
    {
      "id": 281,
      "name": "fluoxymesterone",
      "appliances": "",
      "notes": "",
      "amount": 764
    },
    {
      "id": 282,
      "name": "bicalutamide",
      "appliances": "",
      "notes": "",
      "amount": 631
    },
    {
      "id": 283,
      "name": "nilutamide",
      "appliances": "",
      "notes": "",
      "amount": 111
    },
    {
      "id": 284,
      "name": "cyproterone acetate",
      "appliances": "",
      "notes": "",
      "amount": 334
    },
    {
      "id": 285,
      "name": "prednisolone",
      "appliances": "",
      "notes": "",
      "amount": 432
    },
    {
      "id": 286,
      "name": "triamcinolone acetonide",
      "appliances": "",
      "notes": "",
      "amount": 960
    },
    {
      "id": 287,
      "name": "cortisol",
      "appliances": "",
      "notes": "",
      "amount": 896
    },
    {
      "id": 288,
      "name": "triamcinolone",
      "appliances": "",
      "notes": "",
      "amount": 725
    },
    {
      "id": 289,
      "name": "fludrocortisone",
      "appliances": "The mineralocorticoid activity of fludrocortisone is so high that its anti-inflammatory activity is not clinically significant.",
      "notes": "",
      "amount": 492
    },
    {
      "id": 290,
      "name": "drospirenone",
      "appliances": "",
      "notes": "",
      "amount": 639
    },
    {
      "id": 291,
      "name": "spironolactone",
      "appliances": "",
      "notes": "",
      "amount": 659
    },
    {
      "id": 292,
      "name": "eplerenone",
      "appliances": "",
      "notes": "",
      "amount": 944
    },
    {
      "id": 293,
      "name": "dydrogesterone",
      "appliances": "",
      "notes": "",
      "amount": 389
    },
    {
      "id": 294,
      "name": "medroxyprogesterone",
      "appliances": "",
      "notes": "",
      "amount": 288
    },
    {
      "id": 295,
      "name": "norethisterone",
      "appliances": "",
      "notes": "",
      "amount": 100
    },
    {
      "id": 296,
      "name": "levonorgestrel",
      "appliances": "",
      "notes": "",
      "amount": 802
    },
    {
      "id": 297,
      "name": "suvorexant",
      "appliances": "",
      "notes": "",
      "amount": 885
    },
    {
      "id": 298,
      "name": "celecoxib",
      "appliances": "",
      "notes": "",
      "amount": 291
    },
    {
      "id": 299,
      "name": "rofecoxib",
      "appliances": "",
      "notes": "",
      "amount": 763
    },
    {
      "id": 300,
      "name": "valdecoxib",
      "appliances": "",
      "notes": "",
      "amount": 781
    },
    {
      "id": 301,
      "name": "parecoxib",
      "appliances": "As parecoxib is a prodrug it may not have significant inhibitory action. Please see the ligand page for <Ligand id=2894/> for biological activity data.",
      "notes": "",
      "amount": 181
    },
    {
      "id": 302,
      "name": "etoricoxib",
      "appliances": "",
      "notes": "",
      "amount": 854
    },
    {
      "id": 303,
      "name": "lumiracoxib",
      "appliances": "",
      "notes": "",
      "amount": 826
    },
    {
      "id": 304,
      "name": "lorcaserin",
      "appliances": "",
      "notes": "",
      "amount": 847
    },
    {
      "id": 305,
      "name": "atorvastatin",
      "appliances": "",
      "notes": "",
      "amount": 440
    },
    {
      "id": 306,
      "name": "cerivastatin",
      "appliances": "",
      "notes": "",
      "amount": 532
    },
    {
      "id": 307,
      "name": "fluvastatin",
      "appliances": "",
      "notes": "",
      "amount": 650
    },
    {
      "id": 308,
      "name": "pravastatin",
      "appliances": "",
      "notes": "",
      "amount": 926
    },
    {
      "id": 309,
      "name": "rosuvastatin",
      "appliances": "",
      "notes": "",
      "amount": 384
    },
    {
      "id": 310,
      "name": "simvastatin",
      "appliances": "",
      "notes": "",
      "amount": 916
    },
    {
      "id": 311,
      "name": "pitavastatin",
      "appliances": "We have been unable to find publicly available bioactivity for this drug at its proposed human target, therefore we have not tagged a primary drug target in this instance.",
      "notes": "",
      "amount": 310
    },
    {
      "id": 312,
      "name": "ibandronic acid",
      "appliances": "",
      "notes": "",
      "amount": 428
    },
    {
      "id": 313,
      "name": "alendronate",
      "appliances": "",
      "notes": "",
      "amount": 401
    },
    {
      "id": 314,
      "name": "risedronate",
      "appliances": "",
      "notes": "",
      "amount": 538
    },
    {
      "id": 315,
      "name": "zoledronic acid",
      "appliances": "",
      "notes": "",
      "amount": 569
    },
    {
      "id": 316,
      "name": "cinacalcet",
      "appliances": "",
      "notes": "",
      "amount": 669
    },
    {
      "id": 317,
      "name": "zafirlukast",
      "appliances": "Zafirlukast shows low potency off-target effects on PPAR&gamma; and soluble epoxide hydrolase (sEH) <Reference id=35293/>.",
      "notes": "",
      "amount": 224
    },
    {
      "id": 318,
      "name": "montelukast",
      "appliances": "",
      "notes": "",
      "amount": 158
    },
    {
      "id": 319,
      "name": "midazolam",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 224
    },
    {
      "id": 320,
      "name": "diazepam",
      "appliances": "",
      "notes": "",
      "amount": 657
    },
    {
      "id": 321,
      "name": "chlordiazepoxide",
      "appliances": "In relation to the use of this drug as an anxiolytic, we have been unable to find publicly available, well defined affinity data at the GABA<sub>A</sub> channel to support this MMOA. Therefore, we have not tagged a primary drug target in this instance.",
      "notes": "",
      "amount": 696
    },
    {
      "id": 322,
      "name": "obeticholic acid",
      "appliances": "",
      "notes": "",
      "amount": 480
    },
    {
      "id": 323,
      "name": "ciprofibrate",
      "appliances": "",
      "notes": "",
      "amount": 923
    },
    {
      "id": 324,
      "name": "gemfibrozil",
      "appliances": "",
      "notes": "",
      "amount": 791
    },
    {
      "id": 325,
      "name": "procaterol",
      "appliances": "",
      "notes": "",
      "amount": 978
    },
    {
      "id": 326,
      "name": "formoterol",
      "appliances": "",
      "notes": "",
      "amount": 821
    },
    {
      "id": 327,
      "name": "aprepitant",
      "appliances": "",
      "notes": "",
      "amount": 839
    },
    {
      "id": 328,
      "name": "bosentan",
      "appliances": "",
      "notes": "",
      "amount": 703
    },
    {
      "id": 329,
      "name": "sufentanil",
      "appliances": "",
      "notes": "",
      "amount": 472
    },
    {
      "id": 330,
      "name": "pranlukast",
      "appliances": "",
      "notes": "",
      "amount": 344
    },
    {
      "id": 331,
      "name": "levodopa",
      "appliances": "Levodopa is a dopamine precursor and has no intrinsic target interactions that convey its therapeutic actions. It acts indirectly by promoting increased dopamine biosynthesis.",
      "notes": "",
      "amount": 274
    },
    {
      "id": 332,
      "name": "secretin",
      "appliances": "",
      "notes": "",
      "amount": 207
    },
    {
      "id": 333,
      "name": "buserelin",
      "appliances": "",
      "notes": "",
      "amount": 143
    },
    {
      "id": 334,
      "name": "ganirelix",
      "appliances": "",
      "notes": "",
      "amount": 785
    },
    {
      "id": 335,
      "name": "goserelin",
      "appliances": "",
      "notes": "",
      "amount": 741
    },
    {
      "id": 336,
      "name": "histrelin",
      "appliances": "",
      "notes": "",
      "amount": 348
    },
    {
      "id": 337,
      "name": "sovateltide",
      "appliances": "",
      "notes": "",
      "amount": 432
    },
    {
      "id": 338,
      "name": "nafarelin",
      "appliances": "",
      "notes": "",
      "amount": 525
    },
    {
      "id": 339,
      "name": "TSH",
      "appliances": "",
      "notes": "",
      "amount": 226
    },
    {
      "id": 340,
      "name": "lasmiditan",
      "appliances": "",
      "notes": "",
      "amount": 167
    },
    {
      "id": 341,
      "name": "valsartan",
      "appliances": "",
      "notes": "",
      "amount": 532
    },
    {
      "id": 342,
      "name": "sitaxsentan",
      "appliances": "",
      "notes": "",
      "amount": 765
    },
    {
      "id": 343,
      "name": "ambrisentan",
      "appliances": "",
      "notes": "",
      "amount": 147
    },
    {
      "id": 344,
      "name": "mecamylamine",
      "appliances": "",
      "notes": "",
      "amount": 340
    },
    {
      "id": 345,
      "name": "pancuronium",
      "appliances": "",
      "notes": "",
      "amount": 124
    },
    {
      "id": 346,
      "name": "vecuronium",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of nACh channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 403
    },
    {
      "id": 347,
      "name": "rocuronium",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of nACh channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 362
    },
    {
      "id": 348,
      "name": "succinylcholine",
      "appliances": "",
      "notes": "",
      "amount": 645
    },
    {
      "id": 349,
      "name": "vorapaxar",
      "appliances": "",
      "notes": "",
      "amount": 822
    },
    {
      "id": 351,
      "name": "amantadine",
      "appliances": "",
      "notes": "",
      "amount": 929
    },
    {
      "id": 352,
      "name": "aniracetam",
      "appliances": "",
      "notes": "",
      "amount": 117
    },
    {
      "id": 353,
      "name": "aspirin",
      "appliances": "",
      "notes": "",
      "amount": 675
    },
    {
      "id": 354,
      "name": "cannabidiol",
      "appliances": "",
      "notes": "",
      "amount": 141
    },
    {
      "id": 355,
      "name": "cyclothiazide",
      "appliances": "We have been unable to find peer reviewed affinity data to quantify the interaction between this drug and any of its proposed human molecular targets.",
      "notes": "",
      "amount": 712
    },
    {
      "id": 356,
      "name": "dantrolene",
      "appliances": "",
      "notes": "",
      "amount": 476
    },
    {
      "id": 357,
      "name": "flumazenil",
      "appliances": "Flumazenil is non-selective in action, but is most potent at GABA<sub>A</sub> receptors containing the &alpha;1, &alpha;3 and &alpha;5 subunits <Reference id=29652/>.",
      "notes": "",
      "amount": 223
    },
    {
      "id": 358,
      "name": "flunitrazepam",
      "appliances": "",
      "notes": "",
      "amount": 276
    },
    {
      "id": 359,
      "name": "flurbiprofen",
      "appliances": "",
      "notes": "",
      "amount": 212
    },
    {
      "id": 360,
      "name": "heparin",
      "appliances": "Binding affinities to the Spike glycoproteins from SARS-CoV and MERS-CoV are lower than the affinity for SARS-CoV-2 Spike (500 nM, 1 nM and 0.073 nM respectively) <Reference id=39934/>.",
      "notes": "",
      "amount": 617
    },
    {
      "id": 361,
      "name": "ketamine",
      "appliances": "",
      "notes": "",
      "amount": 338
    },
    {
      "id": 362,
      "name": "lubiprostone",
      "appliances": "",
      "notes": "",
      "amount": 388
    },
    {
      "id": 363,
      "name": "memantine",
      "appliances": "Most bioactivity data for memantine has been determined using whole brain tissue or cells lines, which means that information about direct interactions with selected NMDA receptor subunits is limited.",
      "notes": "",
      "amount": 635
    },
    {
      "id": 364,
      "name": "minoxidil",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 870
    },
    {
      "id": 365,
      "name": "nafamostat",
      "appliances": "",
      "notes": "",
      "amount": 186
    },
    {
      "id": 366,
      "name": "nordihydroguiaretic acid",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 741
    },
    {
      "id": 444,
      "name": "growth hormone 1",
      "appliances": "",
      "notes": "",
      "amount": 776
    },
    {
      "id": 538,
      "name": "quinaprilat",
      "appliances": "",
      "notes": "",
      "amount": 693
    },
    {
      "id": 367,
      "name": "piracetam",
      "appliances": "Piracetam has garnered popularity as a cognitive enhancement drug based on reported effects on memory and cognition.",
      "notes": "",
      "amount": 683
    },
    {
      "id": 368,
      "name": "procaine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 358
    },
    {
      "id": 369,
      "name": "toremifene",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 848
    },
    {
      "id": 370,
      "name": "triamterene",
      "appliances": "",
      "notes": "",
      "amount": 854
    },
    {
      "id": 371,
      "name": "triflupromazine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 187
    },
    {
      "id": 372,
      "name": "ivacaftor",
      "appliances": "",
      "notes": "",
      "amount": 220
    },
    {
      "id": 373,
      "name": "zaleplon",
      "appliances": "We have not tagged a primary  target for this drug as we have been unable to find publicly available affinity data to substantiate its MMOA.",
      "notes": "",
      "amount": 881
    },
    {
      "id": 374,
      "name": "zolpidem",
      "appliances": "",
      "notes": "",
      "amount": 560
    },
    {
      "id": 375,
      "name": "teriparatide",
      "appliances": "",
      "notes": "",
      "amount": 905
    },
    {
      "id": 376,
      "name": "isradipine",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 429
    },
    {
      "id": 377,
      "name": "NaHCO<sub>3</sub>",
      "appliances": "Acting as a buffer in the blood, sodium bicarbonate does not exhibit classical drug-target interaction to achieve its clinical outcome.",
      "notes": "",
      "amount": 912
    },
    {
      "id": 378,
      "name": "rifamycin SV",
      "appliances": "",
      "notes": "",
      "amount": 243
    },
    {
      "id": 379,
      "name": "canagliflozin",
      "appliances": "",
      "notes": "",
      "amount": 254
    },
    {
      "id": 380,
      "name": "dapagliflozin",
      "appliances": "",
      "notes": "",
      "amount": 255
    },
    {
      "id": 381,
      "name": "fenfluramine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 621
    },
    {
      "id": 383,
      "name": "valganciclovir",
      "appliances": "",
      "notes": "",
      "amount": 797
    },
    {
      "id": 384,
      "name": "digoxin",
      "appliances": "",
      "notes": "",
      "amount": 476
    },
    {
      "id": 385,
      "name": "sildenafil",
      "appliances": "",
      "notes": "",
      "amount": 498
    },
    {
      "id": 386,
      "name": "tauroursodeoxycholic acid",
      "appliances": "",
      "notes": "",
      "amount": 981
    },
    {
      "id": 387,
      "name": "estrone-3-sulphate",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 380
    },
    {
      "id": 388,
      "name": "empagliflozin",
      "appliances": "",
      "notes": "",
      "amount": 627
    },
    {
      "id": 389,
      "name": "metformin",
      "appliances": "As the molecular mechanism of metformin is incompletely understood we have not tagged a primary drug target.",
      "notes": "",
      "amount": 502
    },
    {
      "id": 390,
      "name": "guanidine",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 840
    },
    {
      "id": 392,
      "name": "5-fluorouracil",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target (thymidylate synthase) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 687
    },
    {
      "id": 393,
      "name": "paroxetine",
      "appliances": "",
      "notes": "",
      "amount": 563
    },
    {
      "id": 394,
      "name": "nomifensine",
      "appliances": "",
      "notes": "",
      "amount": 736
    },
    {
      "id": 395,
      "name": "gemcitabine",
      "appliances": "",
      "notes": "",
      "amount": 957
    },
    {
      "id": 396,
      "name": "ketoprofen",
      "appliances": "",
      "notes": "",
      "amount": 782
    },
    {
      "id": 397,
      "name": "penicillin G",
      "appliances": "",
      "notes": "",
      "amount": 535
    },
    {
      "id": 398,
      "name": "mazindol",
      "appliances": "",
      "notes": "",
      "amount": 598
    },
    {
      "id": 399,
      "name": "cladribine",
      "appliances": "",
      "notes": "",
      "amount": 700
    },
    {
      "id": 400,
      "name": "floxuridine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target (thymidylate synthase) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 154
    },
    {
      "id": 401,
      "name": "fludarabine",
      "appliances": "",
      "notes": "",
      "amount": 112
    },
    {
      "id": 402,
      "name": "methamphetamine",
      "appliances": "Although this drug is known to be a monoamine transporter inhibitor, we have been unable to find publicly available affinity data to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 204
    },
    {
      "id": 403,
      "name": "amphetamine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 751
    },
    {
      "id": 404,
      "name": "pentostatin",
      "appliances": "",
      "notes": "",
      "amount": 941
    },
    {
      "id": 405,
      "name": "vidarabine",
      "appliances": "",
      "notes": "",
      "amount": 884
    },
    {
      "id": 406,
      "name": "dipyridamole",
      "appliances": "",
      "notes": "",
      "amount": 408
    },
    {
      "id": 407,
      "name": "reboxetine",
      "appliances": "",
      "notes": "",
      "amount": 776
    },
    {
      "id": 408,
      "name": "aminohippuric acid",
      "appliances": "As a diagnostic agent for renal function this drug does not exhibit classical drug-target interaction.",
      "notes": "",
      "amount": 935
    },
    {
      "id": 409,
      "name": "procainamide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 540
    },
    {
      "id": 410,
      "name": "aliskiren",
      "appliances": "",
      "notes": "",
      "amount": 505
    },
    {
      "id": 411,
      "name": "saquinavir",
      "appliances": "",
      "notes": "",
      "amount": 744
    },
    {
      "id": 412,
      "name": "methotrexate",
      "appliances": "",
      "notes": "",
      "amount": 844
    },
    {
      "id": 413,
      "name": "folinic acid",
      "appliances": "Dihydrofolate reductase is the first enzyme with which folinic acid interacts, and by which it is reduced to the active metabolites tetrahydrofolic acid and methyltetrahydrofolate.",
      "notes": "",
      "amount": 830
    },
    {
      "id": 414,
      "name": "cyclacillin",
      "appliances": "Cyclacillin has a similar antibacterial spectrum to that of <Ligand id=10896/> and demonstrates excellent therapeutic effectiveness against experimental infections produced by both Gram-positive and Gram-negative bacteria <Reference id=45049/>.",
      "notes": "",
      "amount": 466
    },
    {
      "id": 415,
      "name": "tiagabine",
      "appliances": "",
      "notes": "",
      "amount": 745
    },
    {
      "id": 416,
      "name": "fexofenadine",
      "appliances": "",
      "notes": "",
      "amount": 621
    },
    {
      "id": 417,
      "name": "fenoprofen",
      "appliances": "",
      "notes": "",
      "amount": 960
    },
    {
      "id": 418,
      "name": "vigabatrin",
      "appliances": "",
      "notes": "",
      "amount": 312
    },
    {
      "id": 419,
      "name": "reserpine",
      "appliances": "",
      "notes": "",
      "amount": 538
    },
    {
      "id": 420,
      "name": "valacyclovir",
      "appliances": "",
      "notes": "",
      "amount": 496
    },
    {
      "id": 421,
      "name": "zidovudine",
      "appliances": "",
      "notes": "",
      "amount": 742
    },
    {
      "id": 422,
      "name": "ouabain",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 301
    },
    {
      "id": 423,
      "name": "cytarabine",
      "appliances": "",
      "notes": "",
      "amount": 602
    },
    {
      "id": 424,
      "name": "zalcitabine",
      "appliances": "",
      "notes": "",
      "amount": 714
    },
    {
      "id": 425,
      "name": "aciclovir",
      "appliances": "",
      "notes": "",
      "amount": 538
    },
    {
      "id": 426,
      "name": "cephradine",
      "appliances": "",
      "notes": "",
      "amount": 768
    },
    {
      "id": 427,
      "name": "cefadroxil",
      "appliances": "",
      "notes": "",
      "amount": 856
    },
    {
      "id": 428,
      "name": "cephalexin",
      "appliances": "",
      "notes": "",
      "amount": 246
    },
    {
      "id": 429,
      "name": "didanosine",
      "appliances": "",
      "notes": "",
      "amount": 393
    },
    {
      "id": 430,
      "name": "tetrabenazine",
      "appliances": "",
      "notes": "",
      "amount": 338
    },
    {
      "id": 431,
      "name": "chlorothiazide",
      "appliances": "",
      "notes": "",
      "amount": 519
    },
    {
      "id": 432,
      "name": "hydrochlorothiazide",
      "appliances": "",
      "notes": "",
      "amount": 574
    },
    {
      "id": 433,
      "name": "bumetanide",
      "appliances": "",
      "notes": "",
      "amount": 479
    },
    {
      "id": 434,
      "name": "metolazone",
      "appliances": "",
      "notes": "",
      "amount": 615
    },
    {
      "id": 435,
      "name": "furosemide",
      "appliances": "",
      "notes": "",
      "amount": 761
    },
    {
      "id": 436,
      "name": "miglustat",
      "appliances": "",
      "notes": "",
      "amount": 933
    },
    {
      "id": 437,
      "name": "miglitol",
      "appliances": "",
      "notes": "",
      "amount": 492
    },
    {
      "id": 438,
      "name": "adalimumab",
      "appliances": "",
      "notes": "",
      "amount": 919
    },
    {
      "id": 439,
      "name": "brain natriuretic peptide",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular target.",
      "notes": "",
      "amount": 289
    },
    {
      "id": 440,
      "name": "erlotinib",
      "appliances": "",
      "notes": "",
      "amount": 690
    },
    {
      "id": 441,
      "name": "erythropoietin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 322
    },
    {
      "id": 442,
      "name": "G-CSF",
      "appliances": "",
      "notes": "",
      "amount": 833
    },
    {
      "id": 443,
      "name": "gefitinib",
      "appliances": "",
      "notes": "",
      "amount": 647
    },
    {
      "id": 391,
      "name": "5-aminolevulinic acid",
      "appliances": "TEST TEST TEST TEST TEST TEST TEST TEST TEST TEST TEST TEST TEST TEST ",
      "notes": "",
      "amount": 772
    },
    {
      "id": 445,
      "name": "IFN-&alpha;2",
      "appliances": "IFN-&alpha;2 binds the IFN-&alpha;/&beta; receptor (IFNAR), a dimeric receptor that consists of protein chains encoded by the <i>IFNAR1</i> and <i>IFNAR2</i> genes, and induces expression of proteins containing  ISRE or GAS transcription elements.",
      "notes": "",
      "amount": 693
    },
    {
      "id": 446,
      "name": "IFN-&gamma;",
      "appliances": "",
      "notes": "",
      "amount": 657
    },
    {
      "id": 447,
      "name": "insulin-like growth factor 1",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 891
    },
    {
      "id": 448,
      "name": "IL-2",
      "appliances": "",
      "notes": "",
      "amount": 867
    },
    {
      "id": 449,
      "name": "imiquimod",
      "appliances": "",
      "notes": "",
      "amount": 488
    },
    {
      "id": 450,
      "name": "insulin",
      "appliances": "",
      "notes": "",
      "amount": 403
    },
    {
      "id": 451,
      "name": "linaclotide",
      "appliances": "",
      "notes": "",
      "amount": 902
    },
    {
      "id": 452,
      "name": "NGF",
      "appliances": "",
      "notes": "",
      "amount": 252
    },
    {
      "id": 453,
      "name": "PDGF BB",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at PDGFR&beta; to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 351
    },
    {
      "id": 454,
      "name": "pertuzumab",
      "appliances": "",
      "notes": "",
      "amount": 152
    },
    {
      "id": 455,
      "name": "methyltyrosine",
      "appliances": "We have been unable to find a peer reviewed report quantifying the direct interaction of methyltyrosine with its proposed molecular target.",
      "notes": "",
      "amount": 904
    },
    {
      "id": 456,
      "name": "anastrozole",
      "appliances": "",
      "notes": "",
      "amount": 347
    },
    {
      "id": 457,
      "name": "benserazide",
      "appliances": "",
      "notes": "",
      "amount": 981
    },
    {
      "id": 458,
      "name": "captopril",
      "appliances": "",
      "notes": "",
      "amount": 521
    },
    {
      "id": 459,
      "name": "carbidopa",
      "appliances": "",
      "notes": "",
      "amount": 556
    },
    {
      "id": 460,
      "name": "cilastatin",
      "appliances": "",
      "notes": "",
      "amount": 855
    },
    {
      "id": 461,
      "name": "eflornithine",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 462,
      "name": "fasudil",
      "appliances": "",
      "notes": "",
      "amount": 497
    },
    {
      "id": 463,
      "name": "letrozole",
      "appliances": "",
      "notes": "",
      "amount": 572
    },
    {
      "id": 464,
      "name": "Li<sup>+</sup>",
      "appliances": "",
      "notes": "",
      "amount": 984
    },
    {
      "id": 465,
      "name": "L-&alpha;-methyldopa",
      "appliances": "",
      "notes": "",
      "amount": 796
    },
    {
      "id": 466,
      "name": "metyrapone",
      "appliances": "",
      "notes": "",
      "amount": 997
    },
    {
      "id": 467,
      "name": "milrinone",
      "appliances": "",
      "notes": "",
      "amount": 533
    },
    {
      "id": 468,
      "name": "naproxen",
      "appliances": "",
      "notes": "",
      "amount": 609
    },
    {
      "id": 469,
      "name": "paracetamol",
      "appliances": "",
      "notes": "",
      "amount": 354
    },
    {
      "id": 470,
      "name": "riociguat",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at and sGC subunit to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 806
    },
    {
      "id": 471,
      "name": "sapropterin",
      "appliances": "",
      "notes": "",
      "amount": 792
    },
    {
      "id": 472,
      "name": "tranylcypromine",
      "appliances": "",
      "notes": "",
      "amount": 606
    },
    {
      "id": 473,
      "name": "vinpocetine",
      "appliances": "",
      "notes": "",
      "amount": 362
    },
    {
      "id": 474,
      "name": "zileuton",
      "appliances": "",
      "notes": "",
      "amount": 706
    },
    {
      "id": 475,
      "name": "ceftriaxone",
      "appliances": "",
      "notes": "",
      "amount": 352
    },
    {
      "id": 476,
      "name": "primidone",
      "appliances": "",
      "notes": "",
      "amount": 530
    },
    {
      "id": 477,
      "name": "carbamazepine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 325
    },
    {
      "id": 478,
      "name": "cisplatin",
      "appliances": "",
      "notes": "",
      "amount": 833
    },
    {
      "id": 479,
      "name": "sulindac",
      "appliances": "",
      "notes": "",
      "amount": 995
    },
    {
      "id": 480,
      "name": "adapalene",
      "appliances": "Adapalene is selective for the &beta; and &gamma; RARs over the &alpha; isoform <Reference id=23117/>.",
      "notes": "",
      "amount": 269
    },
    {
      "id": 481,
      "name": "guanabenz",
      "appliances": "",
      "notes": "",
      "amount": 128
    },
    {
      "id": 482,
      "name": "methadone",
      "appliances": "",
      "notes": "",
      "amount": 422
    },
    {
      "id": 483,
      "name": "varenicline",
      "appliances": "",
      "notes": "",
      "amount": 511
    },
    {
      "id": 484,
      "name": "etomidate",
      "appliances": "",
      "notes": "",
      "amount": 260
    },
    {
      "id": 485,
      "name": "propofol",
      "appliances": "As the GABA<sub>A</sub> binding site was reported to exist on both &beta;3 homopentamers and &alpha;1&beta;3 heteropentamers <Reference id=24548/> we have not tagged a primary drug target for propofol.",
      "notes": "",
      "amount": 258
    },
    {
      "id": 486,
      "name": "stiripentol",
      "appliances": "",
      "notes": "",
      "amount": 625
    },
    {
      "id": 487,
      "name": "felbamate",
      "appliances": "",
      "notes": "",
      "amount": 773
    },
    {
      "id": 488,
      "name": "pentobarbitone",
      "appliances": "",
      "notes": "",
      "amount": 139
    },
    {
      "id": 489,
      "name": "dexlansoprazole",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 969
    },
    {
      "id": 490,
      "name": "esomeprazole",
      "appliances": "",
      "notes": "",
      "amount": 411
    },
    {
      "id": 491,
      "name": "foscarnet",
      "appliances": "",
      "notes": "",
      "amount": 852
    },
    {
      "id": 492,
      "name": "sulpiride",
      "appliances": "Sulpiride is selective for the D<sub>2</sub> and D<sub>3</sub> dopamine receptors. In comparison this drug has low affinity for the other D2-like receptor, D<sub>4</sub> dopamine receptor (K<sub>i</sub> 2100nM <Reference id=24341/>)",
      "notes": "",
      "amount": 579
    },
    {
      "id": 493,
      "name": "naphazoline",
      "appliances": "",
      "notes": "",
      "amount": 641
    },
    {
      "id": 494,
      "name": "degarelix",
      "appliances": "",
      "notes": "",
      "amount": 521
    },
    {
      "id": 495,
      "name": "relugolix",
      "appliances": "",
      "notes": "",
      "amount": 956
    },
    {
      "id": 496,
      "name": "regadenoson",
      "appliances": "",
      "notes": "",
      "amount": 391
    },
    {
      "id": 497,
      "name": "istradefylline",
      "appliances": "",
      "notes": "",
      "amount": 331
    },
    {
      "id": 498,
      "name": "edotreotide",
      "appliances": "",
      "notes": "",
      "amount": 333
    },
    {
      "id": 499,
      "name": "quizartinib",
      "appliances": "Known off-targets include KIT, PDGFR&alpha;, PDGFR&beta;, RET, and CSF1R <Reference id=26003/>.",
      "notes": "",
      "amount": 431
    },
    {
      "id": 500,
      "name": "axitinib",
      "appliances": "",
      "notes": "",
      "amount": 381
    },
    {
      "id": 501,
      "name": "selumetinib",
      "appliances": "",
      "notes": "",
      "amount": 109
    },
    {
      "id": 502,
      "name": "afatinib",
      "appliances": "",
      "notes": "",
      "amount": 901
    },
    {
      "id": 503,
      "name": "dasatinib",
      "appliances": "Src is a secondary target of this inhibitor <Reference id=22943/>.",
      "notes": "",
      "amount": 621
    },
    {
      "id": 504,
      "name": "neratinib",
      "appliances": "",
      "notes": "",
      "amount": 545
    },
    {
      "id": 505,
      "name": "imatinib",
      "appliances": "Off-targets include PDGFRA, PDGFRB and KIT.",
      "notes": "",
      "amount": 961
    },
    {
      "id": 506,
      "name": "ruxolitinib",
      "appliances": "",
      "notes": "",
      "amount": 266
    },
    {
      "id": 507,
      "name": "lapatinib",
      "appliances": "",
      "notes": "",
      "amount": 178
    },
    {
      "id": 508,
      "name": "nilotinib",
      "appliances": "Off-targets include KIT, PDGFRA and PDGFRB.",
      "notes": "",
      "amount": 505
    },
    {
      "id": 509,
      "name": "pazopanib",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 510,
      "name": "midostaurin",
      "appliances": "Midostaurin inhibits proliferation of cells carrying FLT3 translocations or single amino acid changes, and inhibits autophosphorylation of mutant FLT3 receptors <Reference id=26791/>.",
      "notes": "",
      "amount": 437
    },
    {
      "id": 511,
      "name": "sorafenib",
      "appliances": "Sorafenib significantly inhibits neovascularization in xenograft models of human colon, breast, and non-small-cell lung cancer <Reference id=26830/>.",
      "notes": "",
      "amount": 206
    },
    {
      "id": 512,
      "name": "sunitinib",
      "appliances": "",
      "notes": "",
      "amount": 821
    },
    {
      "id": 513,
      "name": "fedratinib",
      "appliances": "Fedratinib is active against wild type and mutationally activated JAK2 and FMS-like tyrosine kinase 3 (FLT3). It exhibits higher potency for JAK2 over the other Jamus kinase family members JAK1, JAK3 and TYK2.",
      "notes": "",
      "amount": 913
    },
    {
      "id": 514,
      "name": "vandetanib",
      "appliances": "",
      "notes": "",
      "amount": 812
    },
    {
      "id": 515,
      "name": "netupitant",
      "appliances": "",
      "notes": "",
      "amount": 919
    },
    {
      "id": 516,
      "name": "rolapitant",
      "appliances": "",
      "notes": "",
      "amount": 687
    },
    {
      "id": 517,
      "name": "treprostinil",
      "appliances": "",
      "notes": "",
      "amount": 465
    },
    {
      "id": 518,
      "name": "sufinpyrazone",
      "appliances": "",
      "notes": "",
      "amount": 175
    },
    {
      "id": 519,
      "name": "cabozantinib",
      "appliances": "",
      "notes": "",
      "amount": 104
    },
    {
      "id": 520,
      "name": "everolimus",
      "appliances": "",
      "notes": "",
      "amount": 956
    },
    {
      "id": 521,
      "name": "regorafenib",
      "appliances": "",
      "notes": "",
      "amount": 865
    },
    {
      "id": 522,
      "name": "temsirolimus",
      "appliances": "",
      "notes": "",
      "amount": 335
    },
    {
      "id": 523,
      "name": "vemurafenib",
      "appliances": "",
      "notes": "",
      "amount": 540
    },
    {
      "id": 524,
      "name": "beclometasone dipropionate",
      "appliances": "As this drug is a prodrug it is unlikely to have signifivcant affinity for the <a href=\"FamilyDisplayForward?familyId=98#show_object_625\">glucocorticoid receptor</a>. Therefore we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 874
    },
    {
      "id": 525,
      "name": "sirolimus",
      "appliances": "<i>In vitro</i> studies have been performed and these show that sirolimus inhibits MERS-CoV infection of Huh7 cells <Reference id=38946/><Reference id=38945/>. This mechanism could also be applied to SAR-CoV-2 infection.",
      "notes": "",
      "amount": 129
    },
    {
      "id": 526,
      "name": "sitagliptin",
      "appliances": "",
      "notes": "",
      "amount": 660
    },
    {
      "id": 527,
      "name": "auranofin",
      "appliances": "Auranofin inhibits  thioredoxin reductase isolated from human placenta, with a K<sub>i</sub> of 4nM <Reference id=25148/>.",
      "notes": "",
      "amount": 606
    },
    {
      "id": 528,
      "name": "vildagliptin",
      "appliances": "",
      "notes": "",
      "amount": 325
    },
    {
      "id": 529,
      "name": "saxagliptin",
      "appliances": "",
      "notes": "",
      "amount": 695
    },
    {
      "id": 530,
      "name": "linagliptin",
      "appliances": "",
      "notes": "",
      "amount": 699
    },
    {
      "id": 531,
      "name": "alogliptin",
      "appliances": "",
      "notes": "",
      "amount": 961
    },
    {
      "id": 532,
      "name": "enalapril",
      "appliances": "",
      "notes": "",
      "amount": 790
    },
    {
      "id": 533,
      "name": "tranilast",
      "appliances": "",
      "notes": "",
      "amount": 427
    },
    {
      "id": 534,
      "name": "enalaprilat",
      "appliances": "",
      "notes": "",
      "amount": 332
    },
    {
      "id": 535,
      "name": "ramipril",
      "appliances": "",
      "notes": "",
      "amount": 658
    },
    {
      "id": 536,
      "name": "ramiprilat",
      "appliances": "",
      "notes": "",
      "amount": 886
    },
    {
      "id": 537,
      "name": "quinapril",
      "appliances": "",
      "notes": "",
      "amount": 989
    },
    {
      "id": 539,
      "name": "lisinopril",
      "appliances": "",
      "notes": "",
      "amount": 405
    },
    {
      "id": 540,
      "name": "perindopril",
      "appliances": "",
      "notes": "",
      "amount": 762
    },
    {
      "id": 541,
      "name": "perindoprilat",
      "appliances": "",
      "notes": "",
      "amount": 810
    },
    {
      "id": 542,
      "name": "benazepril",
      "appliances": "",
      "notes": "",
      "amount": 724
    },
    {
      "id": 543,
      "name": "benazeprilat",
      "appliances": "",
      "notes": "",
      "amount": 391
    },
    {
      "id": 544,
      "name": "imidapril",
      "appliances": "",
      "notes": "",
      "amount": 118
    },
    {
      "id": 545,
      "name": "imidaprilat",
      "appliances": "",
      "notes": "",
      "amount": 474
    },
    {
      "id": 546,
      "name": "dabigatran etexilate",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 630
    },
    {
      "id": 547,
      "name": "ximelagatran",
      "appliances": "Ximelagatran is inactive towards human &alpha;-thrombin <Reference id=25299/>.  Bioactivity is associated with the active metabolite, melagatran.",
      "notes": "",
      "amount": 298
    },
    {
      "id": 548,
      "name": "argatroban",
      "appliances": "",
      "notes": "",
      "amount": 825
    },
    {
      "id": 549,
      "name": "rivaroxaban",
      "appliances": "",
      "notes": "",
      "amount": 850
    },
    {
      "id": 550,
      "name": "apixaban",
      "appliances": "",
      "notes": "",
      "amount": 186
    },
    {
      "id": 551,
      "name": "sivelestat",
      "appliances": "",
      "notes": "",
      "amount": 298
    },
    {
      "id": 552,
      "name": "trandolapril",
      "appliances": "",
      "notes": "",
      "amount": 308
    },
    {
      "id": 553,
      "name": "trandolaprilat",
      "appliances": "",
      "notes": "",
      "amount": 960
    },
    {
      "id": 554,
      "name": "fosinopril",
      "appliances": "",
      "notes": "",
      "amount": 536
    },
    {
      "id": 555,
      "name": "fosinoprilat",
      "appliances": "",
      "notes": "",
      "amount": 706
    },
    {
      "id": 556,
      "name": "desirudin",
      "appliances": "",
      "notes": "",
      "amount": 166
    },
    {
      "id": 557,
      "name": "cilazapril",
      "appliances": "",
      "notes": "",
      "amount": 777
    },
    {
      "id": 558,
      "name": "cilazaprilat",
      "appliances": "",
      "notes": "",
      "amount": 184
    },
    {
      "id": 559,
      "name": "zofenopril",
      "appliances": "As bioactivity is associated with the active metabolite of this drug, we do mot map a primary drug target in this case.",
      "notes": "",
      "amount": 376
    },
    {
      "id": 560,
      "name": "zofenoprilat",
      "appliances": "",
      "notes": "",
      "amount": 703
    },
    {
      "id": 561,
      "name": "lepirudin",
      "appliances": "",
      "notes": "",
      "amount": 857
    },
    {
      "id": 562,
      "name": "bivalirudin",
      "appliances": "",
      "notes": "",
      "amount": 957
    },
    {
      "id": 563,
      "name": "dabrafenib",
      "appliances": "",
      "notes": "",
      "amount": 752
    },
    {
      "id": 564,
      "name": "trametinib",
      "appliances": "",
      "notes": "",
      "amount": 451
    },
    {
      "id": 565,
      "name": "aprotinin",
      "appliances": "",
      "notes": "",
      "amount": 336
    },
    {
      "id": 566,
      "name": "moexipril",
      "appliances": "",
      "notes": "",
      "amount": 744
    },
    {
      "id": 567,
      "name": "moexiprilat",
      "appliances": "",
      "notes": "",
      "amount": 423
    },
    {
      "id": 568,
      "name": "tranexamic acid",
      "appliances": "",
      "notes": "",
      "amount": 540
    },
    {
      "id": 569,
      "name": "6-aminocaproic acid",
      "appliances": "",
      "notes": "",
      "amount": 103
    },
    {
      "id": 570,
      "name": "spirapril",
      "appliances": "",
      "notes": "",
      "amount": 220
    },
    {
      "id": 571,
      "name": "spiraprilat",
      "appliances": "",
      "notes": "",
      "amount": 431
    },
    {
      "id": 572,
      "name": "eptifibatide",
      "appliances": "",
      "notes": "",
      "amount": 757
    },
    {
      "id": 573,
      "name": "tirofiban",
      "appliances": "",
      "notes": "",
      "amount": 796
    },
    {
      "id": 574,
      "name": "natalizumab",
      "appliances": "We have been unable to find affinity data for this antibody from an open access article.",
      "notes": "",
      "amount": 636
    },
    {
      "id": 575,
      "name": "efalizumab",
      "appliances": "A peptide BLAST search using the heavy chain peptide sequence of efalizumab identifies sequence ID 5 in patent US6703018 <Reference id=27113/> and data is presented from the monoclonal variant designated MHM24 F(ab)-8.",
      "notes": "",
      "amount": 137
    },
    {
      "id": 576,
      "name": "physostigmine",
      "appliances": "",
      "notes": "",
      "amount": 801
    },
    {
      "id": 577,
      "name": "donepezil",
      "appliances": "Reported as 188-fold selctive against  acetylcholinesterase (<a href=\"http://www.uniprot.org/uniprot/P22303\">P22303</a>) over butyrylcholinesterase  (<a href=\"http://www.uniprot.org/uniprot/P06276\">P06276</a>) <Reference id=22424/>.",
      "notes": "",
      "amount": 335
    },
    {
      "id": 578,
      "name": "bambuterol",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 545
    },
    {
      "id": 579,
      "name": "rivastigmine",
      "appliances": "",
      "notes": "",
      "amount": 695
    },
    {
      "id": 580,
      "name": "pirlindole",
      "appliances": "",
      "notes": "",
      "amount": 891
    },
    {
      "id": 581,
      "name": "selegiline",
      "appliances": "",
      "notes": "",
      "amount": 131
    },
    {
      "id": 582,
      "name": "rasagiline",
      "appliances": "",
      "notes": "",
      "amount": 994
    },
    {
      "id": 583,
      "name": "tolcapone",
      "appliances": "",
      "notes": "",
      "amount": 929
    },
    {
      "id": 584,
      "name": "entacapone",
      "appliances": "",
      "notes": "",
      "amount": 933
    },
    {
      "id": 585,
      "name": "methimazole",
      "appliances": "",
      "notes": "",
      "amount": 601
    },
    {
      "id": 586,
      "name": "propylthiouracil",
      "appliances": "",
      "notes": "",
      "amount": 886
    },
    {
      "id": 587,
      "name": "ketorolac",
      "appliances": "",
      "notes": "",
      "amount": 464
    },
    {
      "id": 588,
      "name": "tacrine",
      "appliances": "",
      "notes": "",
      "amount": 142
    },
    {
      "id": 589,
      "name": "fluticasone",
      "appliances": "",
      "notes": "",
      "amount": 486
    },
    {
      "id": 590,
      "name": "idelalisib",
      "appliances": "Idelalisib inhibits proliferation of mouse MLg2908 lung fibroblasts (IC<sub>50</sub> 6900 nM) <Reference id=38117/>.",
      "notes": "",
      "amount": 120
    },
    {
      "id": 591,
      "name": "alirocumab",
      "appliances": "",
      "notes": "",
      "amount": 368
    },
    {
      "id": 592,
      "name": "von Willebrand factor",
      "appliances": "",
      "notes": "",
      "amount": 102
    },
    {
      "id": 593,
      "name": "bevacizumab",
      "appliances": "",
      "notes": "",
      "amount": 853
    },
    {
      "id": 594,
      "name": "canakinumab",
      "appliances": "",
      "notes": "",
      "amount": 164
    },
    {
      "id": 595,
      "name": "gemtuzumab ozogamicin",
      "appliances": "We have been unable to find publicly available affinity data for the interaction between gemtuzumab and CD33 to substantiate its primary molecular target.",
      "notes": "",
      "amount": 343
    },
    {
      "id": 596,
      "name": "golimumab",
      "appliances": "",
      "notes": "",
      "amount": 637
    },
    {
      "id": 597,
      "name": "ibritumomab tiuxetan",
      "appliances": "The labelled antibody shows high affinity and selectivity for its target antigen <Reference id=26505/>. We have been unable to find affinity data for the interaction between this antibody and CD20 in any open access article.",
      "notes": "",
      "amount": 564
    },
    {
      "id": 598,
      "name": "ofatumumab",
      "appliances": "",
      "notes": "",
      "amount": 387
    },
    {
      "id": 599,
      "name": "ranibizumab",
      "appliances": "",
      "notes": "",
      "amount": 140
    },
    {
      "id": 600,
      "name": "rituximab",
      "appliances": "The patents covering rituximab do not contain any data regarding antibody-antigen affinity <Reference id=27070/><Reference id=27071/>, but a dissociation constant is provided by Stein <i>et al</i> (2004) <Reference id=27303/>.",
      "notes": "",
      "amount": 119
    },
    {
      "id": 601,
      "name": "digitoxin",
      "appliances": "",
      "notes": "",
      "amount": 647
    },
    {
      "id": 602,
      "name": "pimecrolimus",
      "appliances": "",
      "notes": "",
      "amount": 680
    },
    {
      "id": 603,
      "name": "tacrolimus",
      "appliances": "",
      "notes": "",
      "amount": 583
    },
    {
      "id": 604,
      "name": "vincristine",
      "appliances": "",
      "notes": "",
      "amount": 814
    },
    {
      "id": 605,
      "name": "aflibercept",
      "appliances": "",
      "notes": "",
      "amount": 228
    },
    {
      "id": 606,
      "name": "drotrecogin alfa",
      "appliances": "The molecular mechanism is complex and includes inhibition of coagulation factors Va and VIIIa, but we have been unable to find peer reviewed data to substantiate the molecular interaction.",
      "notes": "",
      "amount": 559
    },
    {
      "id": 607,
      "name": "etanercept",
      "appliances": "",
      "notes": "",
      "amount": 432
    },
    {
      "id": 608,
      "name": "rilonacept",
      "appliances": "",
      "notes": "",
      "amount": 718
    },
    {
      "id": 609,
      "name": "acarbose",
      "appliances": "",
      "notes": "",
      "amount": 227
    },
    {
      "id": 610,
      "name": "acetazolamide",
      "appliances": "",
      "notes": "",
      "amount": 570
    },
    {
      "id": 611,
      "name": "acetohexamide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 643
    },
    {
      "id": 612,
      "name": "acetyldigitoxin",
      "appliances": "",
      "notes": "",
      "amount": 732
    },
    {
      "id": 613,
      "name": "allopurinol",
      "appliances": "",
      "notes": "",
      "amount": 932
    },
    {
      "id": 614,
      "name": "azacitidine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 976
    },
    {
      "id": 615,
      "name": "brinzolamide",
      "appliances": "",
      "notes": "",
      "amount": 262
    },
    {
      "id": 616,
      "name": "cabazitaxel",
      "appliances": "",
      "notes": "",
      "amount": 345
    },
    {
      "id": 617,
      "name": "capecitabine",
      "appliances": "",
      "notes": "",
      "amount": 202
    },
    {
      "id": 618,
      "name": "carmustine",
      "appliances": "",
      "notes": "",
      "amount": 884
    },
    {
      "id": 619,
      "name": "clofarabine",
      "appliances": "",
      "notes": "",
      "amount": 552
    },
    {
      "id": 620,
      "name": "dalteparin",
      "appliances": "",
      "notes": "",
      "amount": 694
    },
    {
      "id": 621,
      "name": "danaparoid",
      "appliances": "",
      "notes": "",
      "amount": 808
    },
    {
      "id": 622,
      "name": "decitabine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 714
    },
    {
      "id": 623,
      "name": "deslanoside",
      "appliances": "",
      "notes": "",
      "amount": 968
    },
    {
      "id": 624,
      "name": "diclofenamide",
      "appliances": "",
      "notes": "",
      "amount": 450
    },
    {
      "id": 625,
      "name": "dicumarol",
      "appliances": "",
      "notes": "",
      "amount": 902
    },
    {
      "id": 626,
      "name": "docetaxel",
      "appliances": "",
      "notes": "",
      "amount": 314
    },
    {
      "id": 627,
      "name": "dorzolamide",
      "appliances": "",
      "notes": "",
      "amount": 197
    },
    {
      "id": 628,
      "name": "enoxaparin",
      "appliances": "",
      "notes": "",
      "amount": 800
    },
    {
      "id": 629,
      "name": "enzalutamide",
      "appliances": "",
      "notes": "",
      "amount": 912
    },
    {
      "id": 630,
      "name": "eribulin",
      "appliances": "",
      "notes": "",
      "amount": 184
    },
    {
      "id": 631,
      "name": "ethoxzolamide",
      "appliances": "",
      "notes": "",
      "amount": 103
    },
    {
      "id": 632,
      "name": "etoposide",
      "appliances": "",
      "notes": "",
      "amount": 334
    },
    {
      "id": 633,
      "name": "ezetimibe",
      "appliances": "",
      "notes": "",
      "amount": 198
    },
    {
      "id": 634,
      "name": "febuxostat",
      "appliances": "",
      "notes": "",
      "amount": 559
    },
    {
      "id": 635,
      "name": "finasteride",
      "appliances": "",
      "notes": "",
      "amount": 922
    },
    {
      "id": 636,
      "name": "fondaparinux",
      "appliances": "",
      "notes": "",
      "amount": 316
    },
    {
      "id": 637,
      "name": "glimepiride",
      "appliances": "As we are unable to identify which subunit of the sulfonylurea receptor/potassium channel the drug binds, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 872
    },
    {
      "id": 714,
      "name": "valproic acid",
      "appliances": "",
      "notes": "",
      "amount": 456
    },
    {
      "id": 638,
      "name": "glipizide",
      "appliances": "As we are unable to identify which subunit of the sulfonylurea receptor/potassium channel the drug binds, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 583
    },
    {
      "id": 639,
      "name": "hydroxyurea",
      "appliances": "",
      "notes": "",
      "amount": 495
    },
    {
      "id": 640,
      "name": "ixabepilone",
      "appliances": "",
      "notes": "",
      "amount": 630
    },
    {
      "id": 641,
      "name": "leflunomide",
      "appliances": "",
      "notes": "",
      "amount": 640
    },
    {
      "id": 642,
      "name": "levetiracetam",
      "appliances": "",
      "notes": "",
      "amount": 468
    },
    {
      "id": 643,
      "name": "mequinol",
      "appliances": "We have been unable to find peer reviewed data supporting the proposed inhibitory action of this drug.",
      "notes": "",
      "amount": 397
    },
    {
      "id": 644,
      "name": "methazolamide",
      "appliances": "",
      "notes": "",
      "amount": 486
    },
    {
      "id": 645,
      "name": "methocarbamol",
      "appliances": "",
      "notes": "",
      "amount": 853
    },
    {
      "id": 646,
      "name": "monobenzone",
      "appliances": "We have been unable to find peer reviewed data supporting the proposed inhibitory action of this drug.",
      "notes": "",
      "amount": 712
    },
    {
      "id": 647,
      "name": "mycophenolate mofetil",
      "appliances": "",
      "notes": "",
      "amount": 726
    },
    {
      "id": 648,
      "name": "mycophenolic acid",
      "appliances": "",
      "notes": "",
      "amount": 631
    },
    {
      "id": 649,
      "name": "nateglinide",
      "appliances": "As we are unable to identify which subunit of the sulfonylurea receptor/potassium channel the drug binds, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 797
    },
    {
      "id": 650,
      "name": "nitisinone",
      "appliances": "",
      "notes": "",
      "amount": 142
    },
    {
      "id": 651,
      "name": "oxiglutatione",
      "appliances": "",
      "notes": "",
      "amount": 738
    },
    {
      "id": 652,
      "name": "pegaptanib",
      "appliances": "",
      "notes": "",
      "amount": 703
    },
    {
      "id": 653,
      "name": "pemetrexed",
      "appliances": "",
      "notes": "",
      "amount": 384
    },
    {
      "id": 654,
      "name": "phenindione",
      "appliances": "",
      "notes": "",
      "amount": 683
    },
    {
      "id": 655,
      "name": "phenprocoumon",
      "appliances": "",
      "notes": "",
      "amount": 554
    },
    {
      "id": 656,
      "name": "pralatrexate",
      "appliances": "",
      "notes": "",
      "amount": 603
    },
    {
      "id": 657,
      "name": "repaglinide",
      "appliances": "As we are unable to identify which subunit of the sulfonylurea receptor/potassium channel the drug binds, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 477
    },
    {
      "id": 658,
      "name": "ribavirin",
      "appliances": "",
      "notes": "",
      "amount": 428
    },
    {
      "id": 659,
      "name": "teniposide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 490
    },
    {
      "id": 660,
      "name": "teriflunomide",
      "appliances": "",
      "notes": "",
      "amount": 875
    },
    {
      "id": 661,
      "name": "thioguanine",
      "appliances": "",
      "notes": "",
      "amount": 519
    },
    {
      "id": 662,
      "name": "tinzaparin",
      "appliances": "",
      "notes": "",
      "amount": 349
    },
    {
      "id": 663,
      "name": "tolazamide",
      "appliances": "As we are unable to identify which subunit of the sulfonylurea receptor/potassium channel the drug binds, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 615
    },
    {
      "id": 664,
      "name": "tolbutamide",
      "appliances": "",
      "notes": "",
      "amount": 658
    },
    {
      "id": 665,
      "name": "topiramate",
      "appliances": "Due to the polypharmacology of this drug we have not mapped it to a primary target.",
      "notes": "",
      "amount": 624
    },
    {
      "id": 666,
      "name": "trilostane",
      "appliances": "",
      "notes": "",
      "amount": 435
    },
    {
      "id": 667,
      "name": "vinblastine",
      "appliances": "",
      "notes": "",
      "amount": 795
    },
    {
      "id": 668,
      "name": "warfarin",
      "appliances": "<i>In vitro</i> potencies are low but the  MMOA is inhibition of vitamin K 2,3-epoxide reductase (VKOR) enzymes, specifically  VKORC1.",
      "notes": "",
      "amount": 561
    },
    {
      "id": 669,
      "name": "capromab",
      "appliances": "We have been unable to find affinity data for this antibody from any open access source.",
      "notes": "",
      "amount": 460
    },
    {
      "id": 670,
      "name": "daclizumab",
      "appliances": "Peptide sequence analysis of the heavy chain variable region of daclizumab provides a match with patented sequence from US5693761 <Reference id=27099/>.",
      "notes": "",
      "amount": 101
    },
    {
      "id": 671,
      "name": "tocilizumab",
      "appliances": "Unfortunately, we have been unable to find publicly available data providing a binding affinity for this antibody at its molecular target.",
      "notes": "",
      "amount": 627
    },
    {
      "id": 672,
      "name": "cetuximab",
      "appliances": "Peptide sequence analysis matches the light chain variable region of cetuximab to patent US7060808 <Reference id=27098/>. The K<sub>d</sub> value provided in the interaction table below is taken from this patent for the C225 monoclonal presented therein.",
      "notes": "",
      "amount": 223
    },
    {
      "id": 673,
      "name": "panitumumab",
      "appliances": "",
      "notes": "",
      "amount": 857
    },
    {
      "id": 674,
      "name": "eculizumab",
      "appliances": "Eculizumab binds to and blocks the cleavage of the complement protein C5, thereby preventing the formation of <Ligand id=573/>. The terminal half-life of eculizumab is 11.3 &plusmn; 3.4 days <Reference id=36626/>.",
      "notes": "",
      "amount": 202
    },
    {
      "id": 675,
      "name": "denosumab",
      "appliances": "",
      "notes": "",
      "amount": 615
    },
    {
      "id": 676,
      "name": "belimumab",
      "appliances": "",
      "notes": "",
      "amount": 693
    },
    {
      "id": 677,
      "name": "ipilimumab",
      "appliances": "",
      "notes": "",
      "amount": 756
    },
    {
      "id": 678,
      "name": "muromonab-CD3",
      "appliances": "We have been unable to find affinity data for this antibody from any open access source.",
      "notes": "",
      "amount": 703
    },
    {
      "id": 679,
      "name": "omalizumab",
      "appliances": "",
      "notes": "",
      "amount": 253
    },
    {
      "id": 680,
      "name": "abatacept",
      "appliances": "In a cell based CD80/86 inhibition assay abatacept inhibits IL-2 release with an IC<sub>50</sub> of 22.6 nM <Reference id=33411/>.",
      "notes": "",
      "amount": 194
    },
    {
      "id": 681,
      "name": "belatacept",
      "appliances": "Belatacept binds to human CD86 with an IC<sub>50</sub> of 0.102&micro;g/mL and to CD80 with an IC<sub>50</sub> of 0.009&micro;g/mL <Reference id=29669/>.",
      "notes": "",
      "amount": 955
    },
    {
      "id": 682,
      "name": "forasartan",
      "appliances": "Due to the polypharmacology of this drug we have not mapped it to a primary target.",
      "notes": "",
      "amount": 167
    },
    {
      "id": 683,
      "name": "azilsartan medoxomil",
      "appliances": "As a prodrug this compound is unlikely to have significant activity. Therefore we have not tagged a primary target for this compound.",
      "notes": "",
      "amount": 818
    },
    {
      "id": 684,
      "name": "ibrutinib",
      "appliances": "",
      "notes": "",
      "amount": 712
    },
    {
      "id": 685,
      "name": "calcifediol",
      "appliances": "",
      "notes": "",
      "amount": 735
    },
    {
      "id": 686,
      "name": "danazol",
      "appliances": "",
      "notes": "",
      "amount": 273
    },
    {
      "id": 687,
      "name": "flutamide",
      "appliances": "",
      "notes": "",
      "amount": 634
    },
    {
      "id": 688,
      "name": "dromostanolone propionate",
      "appliances": "",
      "notes": "",
      "amount": 736
    },
    {
      "id": 689,
      "name": "ethylestrenol",
      "appliances": "",
      "notes": "",
      "amount": 261
    },
    {
      "id": 690,
      "name": "nandrolone",
      "appliances": "",
      "notes": "",
      "amount": 636
    },
    {
      "id": 691,
      "name": "dextrothyroxine",
      "appliances": "",
      "notes": "",
      "amount": 740
    },
    {
      "id": 692,
      "name": "tazarotene",
      "appliances": "Tazarotene appears to have highest affinity for the retinoic acid receptor-&beta; <Reference id=23508/>.",
      "notes": "",
      "amount": 526
    },
    {
      "id": 693,
      "name": "dextromethorphan",
      "appliances": "We have identified binding affinity data for the sigma opioid receptor, SIGMAR1 <Reference id=24477/>, but have been unable to find publicly available data providing the same for the &sigma;2 receptor. We have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 180
    },
    {
      "id": 694,
      "name": "palifermin",
      "appliances": "",
      "notes": "",
      "amount": 308
    },
    {
      "id": 695,
      "name": "ecallantide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 735
    },
    {
      "id": 696,
      "name": "alpha-methyltyrosine",
      "appliances": "We have been unable to find a peer reviewed report quantifying the direct interaction of alpha-methyltyrosine with its proposed molecular target.",
      "notes": "",
      "amount": 342
    },
    {
      "id": 697,
      "name": "mitotane",
      "appliances": "",
      "notes": "",
      "amount": 871
    },
    {
      "id": 698,
      "name": "tesamorelin",
      "appliances": "",
      "notes": "",
      "amount": 258
    },
    {
      "id": 699,
      "name": "eltrombopag",
      "appliances": "",
      "notes": "",
      "amount": 590
    },
    {
      "id": 700,
      "name": "roflumilast",
      "appliances": "",
      "notes": "",
      "amount": 698
    },
    {
      "id": 701,
      "name": "clonazepam",
      "appliances": "Although we have tagged the &alpha;-subunit as the primary drug target, the benzodiazepine allosteric binding site is actually formed at the interface of the &alpha; and &gamma; subunits <Reference id=24430/>.",
      "notes": "",
      "amount": 969
    },
    {
      "id": 702,
      "name": "cosyntropin",
      "appliances": "",
      "notes": "",
      "amount": 343
    },
    {
      "id": 703,
      "name": "corticotropin zinc hydroxide",
      "appliances": "",
      "notes": "",
      "amount": 550
    },
    {
      "id": 704,
      "name": "filgrastim",
      "appliances": "",
      "notes": "",
      "amount": 110
    },
    {
      "id": 705,
      "name": "pegfilgrastim",
      "appliances": "",
      "notes": "",
      "amount": 140
    },
    {
      "id": 706,
      "name": "oprelvekin",
      "appliances": "Recombinant human IL-11 promotes cellular proliferation of Ba/F3 cells exogenously expressing IL-11 receptors, with an EC<sub>50</sub> value of 2.5ng/mL <Reference id=30056/>, so it would be expected that oprelvekin would have similar activity.",
      "notes": "",
      "amount": 107
    },
    {
      "id": 707,
      "name": "anakinra",
      "appliances": "",
      "notes": "",
      "amount": 934
    },
    {
      "id": 708,
      "name": "calcitonin (salmon)",
      "appliances": "",
      "notes": "",
      "amount": 487
    },
    {
      "id": 709,
      "name": "romiplostim",
      "appliances": "",
      "notes": "",
      "amount": 946
    },
    {
      "id": 710,
      "name": "vismodegib",
      "appliances": "",
      "notes": "",
      "amount": 598
    },
    {
      "id": 711,
      "name": "chlorpheniramine",
      "appliances": "",
      "notes": "",
      "amount": 208
    },
    {
      "id": 712,
      "name": "amlodipine",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.<br><br>Amlodipine has been described as a gating modifier of Ca<sub>v</sub> channels <Reference id=26068/>.",
      "notes": "",
      "amount": 539
    },
    {
      "id": 713,
      "name": "sermorelin",
      "appliances": "",
      "notes": "",
      "amount": 837
    },
    {
      "id": 715,
      "name": "tazemetostat",
      "appliances": "",
      "notes": "",
      "amount": 318
    },
    {
      "id": 716,
      "name": "denileukin diftitox",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target, in this case the IL-2R, to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 431
    },
    {
      "id": 717,
      "name": "dimethyl fumarate",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 278
    },
    {
      "id": 718,
      "name": "zonisamide",
      "appliances": "As the precise MMOA for this drug is unclear we have not tagged a primary drug target.",
      "notes": "",
      "amount": 661
    },
    {
      "id": 719,
      "name": "teduglutide",
      "appliances": "",
      "notes": "",
      "amount": 948
    },
    {
      "id": 720,
      "name": "perampanel",
      "appliances": "We have been unable to find interaction affinity data for this drug to substantiate its MMOA.",
      "notes": "",
      "amount": 411
    },
    {
      "id": 721,
      "name": "isosorbide dinitrate",
      "appliances": "",
      "notes": "",
      "amount": 438
    },
    {
      "id": 722,
      "name": "isosorbide mononitrate",
      "appliances": "",
      "notes": "",
      "amount": 949
    },
    {
      "id": 723,
      "name": "nitroglycerin",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 724,
      "name": "aminoglutethimide",
      "appliances": "Low doses of aminoglutethimide inhibit only CYP19A1 function, but at higher doses both enzymes are inhibited.",
      "notes": "",
      "amount": 273
    },
    {
      "id": 725,
      "name": "beclometasone",
      "appliances": "",
      "notes": "",
      "amount": 227
    },
    {
      "id": 726,
      "name": "amcinonide",
      "appliances": "",
      "notes": "",
      "amount": 239
    },
    {
      "id": 727,
      "name": "betamethasone",
      "appliances": "",
      "notes": "",
      "amount": 872
    },
    {
      "id": 728,
      "name": "clobetasol propionate",
      "appliances": "",
      "notes": "",
      "amount": 307
    },
    {
      "id": 729,
      "name": "daunorubicin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 494
    },
    {
      "id": 730,
      "name": "deserpidine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target (SLC18A2)  to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 356
    },
    {
      "id": 731,
      "name": "desogestrel",
      "appliances": "Although this drug is a known progesterone receptor agonist we have been unable to find publicly available bioactivity data to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 274
    },
    {
      "id": 732,
      "name": "desonide",
      "appliances": "We have been unable to find publicly available affinity data for this drug to substantiate its MMOA, so have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 605
    },
    {
      "id": 733,
      "name": "desoximetasone",
      "appliances": "",
      "notes": "",
      "amount": 392
    },
    {
      "id": 734,
      "name": "diflorasone diacetate",
      "appliances": "",
      "notes": "",
      "amount": 510
    },
    {
      "id": 735,
      "name": "doxorubicin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 735
    },
    {
      "id": 736,
      "name": "dyphylline",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 572
    },
    {
      "id": 737,
      "name": "ethinylestradiol",
      "appliances": "",
      "notes": "",
      "amount": 542
    },
    {
      "id": 738,
      "name": "ethynodiol diacetate",
      "appliances": "Although this drug is a known progesterone receptor agonist we have been unable to find publicly available bioactivity data to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 318
    },
    {
      "id": 739,
      "name": "exemestane",
      "appliances": "",
      "notes": "",
      "amount": 949
    },
    {
      "id": 740,
      "name": "famotidine",
      "appliances": "",
      "notes": "",
      "amount": 206
    },
    {
      "id": 741,
      "name": "flumethasone pivalate",
      "appliances": "",
      "notes": "",
      "amount": 334
    },
    {
      "id": 742,
      "name": "flunisolide",
      "appliances": "",
      "notes": "",
      "amount": 341
    },
    {
      "id": 743,
      "name": "fluocinolone acetonide",
      "appliances": "",
      "notes": "",
      "amount": 999
    },
    {
      "id": 744,
      "name": "fluocinonide",
      "appliances": "",
      "notes": "",
      "amount": 305
    },
    {
      "id": 745,
      "name": "fluorometholone",
      "appliances": "",
      "notes": "",
      "amount": 172
    },
    {
      "id": 746,
      "name": "fluticasone propionate",
      "appliances": "",
      "notes": "",
      "amount": 299
    },
    {
      "id": 747,
      "name": "hydrocodone",
      "appliances": "",
      "notes": "",
      "amount": 954
    },
    {
      "id": 748,
      "name": "hydromorphone",
      "appliances": "",
      "notes": "",
      "amount": 361
    },
    {
      "id": 749,
      "name": "idarubicin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 440
    },
    {
      "id": 750,
      "name": "loteprednol etabonate",
      "appliances": "",
      "notes": "",
      "amount": 285
    },
    {
      "id": 751,
      "name": "medrysone",
      "appliances": "",
      "notes": "",
      "amount": 224
    },
    {
      "id": 752,
      "name": "mestranol",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 113
    },
    {
      "id": 753,
      "name": "methylprednisolone",
      "appliances": "",
      "notes": "",
      "amount": 410
    },
    {
      "id": 754,
      "name": "mitomycin C",
      "appliances": "",
      "notes": "",
      "amount": 607
    },
    {
      "id": 755,
      "name": "nelarabine",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 416
    },
    {
      "id": 756,
      "name": "norgestimate",
      "appliances": "Although this drug is a known progesterone receptor agonist we have been unable to find publicly available bioactivity data to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 522
    },
    {
      "id": 757,
      "name": "oxandrolone",
      "appliances": "",
      "notes": "",
      "amount": 552
    },
    {
      "id": 758,
      "name": "oxycodone",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 572
    },
    {
      "id": 759,
      "name": "oxymorphone",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at any of the opioid receptors to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 395
    },
    {
      "id": 760,
      "name": "pentoxifylline",
      "appliances": "Although we have affinity data for this drug at the A<sub>2B</sub> receptor, we have been unable to find publicly available bioactivity data for this drug to substantiate its inhibition of PDEs. We have not tagged a primary drug target.",
      "notes": "",
      "amount": 529
    },
    {
      "id": 761,
      "name": "prednisone",
      "appliances": "",
      "notes": "",
      "amount": 111
    },
    {
      "id": 762,
      "name": "quinestrol",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 819
    },
    {
      "id": 763,
      "name": "rescinnamine",
      "appliances": "As we have been unable to find affinity data for this drug to substantiate its MMOA we have not tagged a primary drug target.",
      "notes": "",
      "amount": 111
    },
    {
      "id": 764,
      "name": "rimexolone",
      "appliances": "",
      "notes": "",
      "amount": 432
    },
    {
      "id": 765,
      "name": "testosterone propionate",
      "appliances": "",
      "notes": "",
      "amount": 580
    },
    {
      "id": 766,
      "name": "topotecan",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 778
    },
    {
      "id": 767,
      "name": "travoprost",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 949
    },
    {
      "id": 768,
      "name": "ursodeoxycholic acid",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 477
    },
    {
      "id": 769,
      "name": "vinorelbine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at any tubulin isoform to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 380
    },
    {
      "id": 770,
      "name": "acamprosate",
      "appliances": "Due to the complex nature of this drug's MMOA, and a paucity of well defined target affinity data, we do not map to a primary drug target in this instance.",
      "notes": "",
      "amount": 886
    },
    {
      "id": 771,
      "name": "acebutolol",
      "appliances": "",
      "notes": "",
      "amount": 322
    },
    {
      "id": 772,
      "name": "alfentanil",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 813
    },
    {
      "id": 773,
      "name": "alfuzosin",
      "appliances": "",
      "notes": "",
      "amount": 287
    },
    {
      "id": 774,
      "name": "almotriptan",
      "appliances": "",
      "notes": "",
      "amount": 662
    },
    {
      "id": 775,
      "name": "alprazolam",
      "appliances": "",
      "notes": "",
      "amount": 904
    },
    {
      "id": 776,
      "name": "altretamine",
      "appliances": "",
      "notes": "",
      "amount": 338
    },
    {
      "id": 777,
      "name": "amlexanox",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 634
    },
    {
      "id": 778,
      "name": "anagrelide",
      "appliances": "",
      "notes": "",
      "amount": 394
    },
    {
      "id": 779,
      "name": "anileridine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 913
    },
    {
      "id": 780,
      "name": "antazoline",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 869
    },
    {
      "id": 781,
      "name": "apraclonidine",
      "appliances": "",
      "notes": "",
      "amount": 262
    },
    {
      "id": 782,
      "name": "atomoxetine",
      "appliances": "",
      "notes": "",
      "amount": 296
    },
    {
      "id": 783,
      "name": "azatadine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 956
    },
    {
      "id": 784,
      "name": "azelastine",
      "appliances": "",
      "notes": "",
      "amount": 808
    },
    {
      "id": 785,
      "name": "bendroflumethiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target (SLC12A3) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 236
    },
    {
      "id": 786,
      "name": "oxybuprocaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 453
    },
    {
      "id": 787,
      "name": "benzquinamide",
      "appliances": "",
      "notes": "",
      "amount": 919
    },
    {
      "id": 788,
      "name": "benzthiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target (SLC12A3) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 116
    },
    {
      "id": 789,
      "name": "betazole",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 620
    },
    {
      "id": 790,
      "name": "biperiden",
      "appliances": "",
      "notes": "",
      "amount": 567
    },
    {
      "id": 791,
      "name": "bisoprolol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 300
    },
    {
      "id": 792,
      "name": "bretylium",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 164
    },
    {
      "id": 793,
      "name": "bromfenac",
      "appliances": "",
      "notes": "",
      "amount": 646
    },
    {
      "id": 794,
      "name": "bromodiphenhydramine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 370
    },
    {
      "id": 795,
      "name": "brompheniramine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 182
    },
    {
      "id": 796,
      "name": "buclizine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 616
    },
    {
      "id": 797,
      "name": "bupropion",
      "appliances": "",
      "notes": "",
      "amount": 594
    },
    {
      "id": 798,
      "name": "busulfan",
      "appliances": "",
      "notes": "",
      "amount": 735
    },
    {
      "id": 799,
      "name": "butabarbital",
      "appliances": "",
      "notes": "",
      "amount": 847
    },
    {
      "id": 800,
      "name": "butalbital",
      "appliances": "",
      "notes": "",
      "amount": 621
    },
    {
      "id": 801,
      "name": "carbinoxamine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 516
    },
    {
      "id": 802,
      "name": "carphenazine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 521
    },
    {
      "id": 803,
      "name": "carprofen",
      "appliances": "",
      "notes": "",
      "amount": 906
    },
    {
      "id": 804,
      "name": "carteolol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 463
    },
    {
      "id": 805,
      "name": "chlorambucil",
      "appliances": "",
      "notes": "",
      "amount": 249
    },
    {
      "id": 806,
      "name": "chloroprocaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 385
    },
    {
      "id": 807,
      "name": "chlorotrianisene",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 884
    },
    {
      "id": 808,
      "name": "chlorthalidone",
      "appliances": "",
      "notes": "",
      "amount": 552
    },
    {
      "id": 809,
      "name": "cilostazol",
      "appliances": "Cilostazol has also been reported to promote the clearance of fluorescent soluble amyloid &beta; tracers in cilostazol-treated cerebral amyloid angiopathy (CAA) model mice, by enhancing the perivascular drainage system <Reference id=27484/>.",
      "notes": "",
      "amount": 703
    },
    {
      "id": 810,
      "name": "clobazam",
      "appliances": "",
      "notes": "",
      "amount": 969
    },
    {
      "id": 811,
      "name": "clopidogrel",
      "appliances": "As this is an inactive prodrug, all bioactivity resides with <Ligand id=1772/> <Reference id=5917/>.",
      "notes": "",
      "amount": 683
    },
    {
      "id": 812,
      "name": "cyclizine",
      "appliances": "",
      "notes": "",
      "amount": 638
    },
    {
      "id": 813,
      "name": "cyclobenzaprine",
      "appliances": "We have been unable to find publicly available affinity data for this drug to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 617
    },
    {
      "id": 814,
      "name": "cyclopentolate",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 293
    },
    {
      "id": 815,
      "name": "cyclophosphamide",
      "appliances": "",
      "notes": "",
      "amount": 212
    },
    {
      "id": 816,
      "name": "dapiprazole",
      "appliances": "",
      "notes": "",
      "amount": 183
    },
    {
      "id": 817,
      "name": "desflurane",
      "appliances": "Due to the complex polypharmacology underlying this drug's MMOA, we do not tag a primary drug target.",
      "notes": "",
      "amount": 485
    },
    {
      "id": 818,
      "name": "desvenlafaxine",
      "appliances": "",
      "notes": "",
      "amount": 553
    },
    {
      "id": 819,
      "name": "dibucaine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 176
    },
    {
      "id": 820,
      "name": "dienestrol",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 350
    },
    {
      "id": 821,
      "name": "diethylpropion",
      "appliances": "This prodrug is reported to have no measurable bioactivity at the molecular target(s) of its active counterpart. Therefore, there is no tagged primary drug target.",
      "notes": "",
      "amount": 314
    },
    {
      "id": 822,
      "name": "diflunisal",
      "appliances": "We have been unable to find affinity data for this drug to substantiate its MMOA and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 634
    },
    {
      "id": 823,
      "name": "diphenidol",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 491
    },
    {
      "id": 824,
      "name": "diphenoxylate",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 272
    },
    {
      "id": 1347,
      "name": "polymyxin B",
      "appliances": "",
      "notes": "",
      "amount": 640
    },
    {
      "id": 1348,
      "name": "solriamfetol",
      "appliances": "",
      "notes": "",
      "amount": 760
    },
    {
      "id": 1349,
      "name": "ulinastatin",
      "appliances": "",
      "notes": "",
      "amount": 223
    },
    {
      "id": 825,
      "name": "diphenylpyraline",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 468
    },
    {
      "id": 826,
      "name": "dipivefrine",
      "appliances": "As this compound is a prodrug, it is likely to have limited or no affinity for its molecular target.",
      "notes": "",
      "amount": 610
    },
    {
      "id": 827,
      "name": "disopyramide",
      "appliances": "",
      "notes": "",
      "amount": 998
    },
    {
      "id": 828,
      "name": "doxapram",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 468
    },
    {
      "id": 829,
      "name": "doxazosin",
      "appliances": "",
      "notes": "",
      "amount": 831
    },
    {
      "id": 830,
      "name": "doxylamine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 284
    },
    {
      "id": 831,
      "name": "droperidol",
      "appliances": "",
      "notes": "",
      "amount": 292
    },
    {
      "id": 832,
      "name": "dyclonine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 672
    },
    {
      "id": 833,
      "name": "emedastine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 666
    },
    {
      "id": 834,
      "name": "enflurane",
      "appliances": "Due to the polypharmacology of this drug we have not mapped it to a primary target.",
      "notes": "",
      "amount": 965
    },
    {
      "id": 835,
      "name": "epinastine",
      "appliances": "",
      "notes": "",
      "amount": 598
    },
    {
      "id": 836,
      "name": "escitalopram",
      "appliances": "",
      "notes": "",
      "amount": 763
    },
    {
      "id": 837,
      "name": "esmolol",
      "appliances": "",
      "notes": "",
      "amount": 193
    },
    {
      "id": 838,
      "name": "ethacrynic acid",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 946
    },
    {
      "id": 839,
      "name": "ethchlorvynol",
      "appliances": "",
      "notes": "",
      "amount": 707
    },
    {
      "id": 840,
      "name": "ethopropazine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 138
    },
    {
      "id": 841,
      "name": "ethosuximide",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 220
    },
    {
      "id": 842,
      "name": "ethotoin",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 374
    },
    {
      "id": 843,
      "name": "etidronic acid",
      "appliances": "",
      "notes": "",
      "amount": 340
    },
    {
      "id": 844,
      "name": "etodolac",
      "appliances": "",
      "notes": "",
      "amount": 861
    },
    {
      "id": 845,
      "name": "fenofibrate",
      "appliances": "Bioactivity resides with the active metabolite.",
      "notes": "",
      "amount": 488
    },
    {
      "id": 846,
      "name": "flavoxate",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 717
    },
    {
      "id": 847,
      "name": "flurazepam",
      "appliances": "Due to the complex nature of this drug's MMOA, and a paucity of well defined target affinity data, we do not map to a primary drug target in this instance.",
      "notes": "",
      "amount": 717
    },
    {
      "id": 848,
      "name": "fluvoxamine",
      "appliances": "Fluvoxamine has high affinity for the &sigma;1 receptor and appears to act as a receptor agonist <Reference id=41008/><Reference id=41009/>.",
      "notes": "",
      "amount": 334
    },
    {
      "id": 849,
      "name": "fosphenytoin",
      "appliances": "If this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 505
    },
    {
      "id": 850,
      "name": "frovatriptan",
      "appliances": "",
      "notes": "",
      "amount": 838
    },
    {
      "id": 851,
      "name": "glutethimide",
      "appliances": "",
      "notes": "",
      "amount": 947
    },
    {
      "id": 852,
      "name": "guanadrel",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 924
    },
    {
      "id": 853,
      "name": "guanethidine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 978
    },
    {
      "id": 854,
      "name": "halazepam",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 486
    },
    {
      "id": 855,
      "name": "hexylcaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 154
    },
    {
      "id": 856,
      "name": "hydroflumethiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 847
    },
    {
      "id": 857,
      "name": "hydroxychloroquine",
      "appliances": "",
      "notes": "",
      "amount": 948
    },
    {
      "id": 858,
      "name": "hydroxyzine",
      "appliances": "",
      "notes": "",
      "amount": 423
    },
    {
      "id": 859,
      "name": "ibutilide",
      "appliances": "",
      "notes": "",
      "amount": 989
    },
    {
      "id": 860,
      "name": "ifosfamide",
      "appliances": "",
      "notes": "",
      "amount": 899
    },
    {
      "id": 861,
      "name": "inamrinone",
      "appliances": "",
      "notes": "",
      "amount": 264
    },
    {
      "id": 862,
      "name": "indapamide",
      "appliances": "Due to the polypharmacology of this drug, and the paucity of human affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 806
    },
    {
      "id": 863,
      "name": "isocarboxazid",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 827
    },
    {
      "id": 864,
      "name": "ketotifen",
      "appliances": "",
      "notes": "",
      "amount": 607
    },
    {
      "id": 865,
      "name": "labetalol",
      "appliances": "This drug is a non-selective adrenoceptor agonist.",
      "notes": "",
      "amount": 609
    },
    {
      "id": 866,
      "name": "lansoprazole",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 682
    },
    {
      "id": 867,
      "name": "levallorphan",
      "appliances": "",
      "notes": "",
      "amount": 746
    },
    {
      "id": 868,
      "name": "levamisole",
      "appliances": "As the target for this drug's action in humans has not been definitively resolved we do not tag a primary drug target.",
      "notes": "",
      "amount": 690
    },
    {
      "id": 869,
      "name": "levobupivacaine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 274
    },
    {
      "id": 870,
      "name": "levomethadyl acetate",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 767
    },
    {
      "id": 871,
      "name": "lisdexamfetamine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 838
    },
    {
      "id": 872,
      "name": "lomustine",
      "appliances": "",
      "notes": "",
      "amount": 326
    },
    {
      "id": 873,
      "name": "loratadine",
      "appliances": "",
      "notes": "",
      "amount": 531
    },
    {
      "id": 874,
      "name": "mechlorethamine",
      "appliances": "",
      "notes": "",
      "amount": 582
    },
    {
      "id": 875,
      "name": "meclofenamic acid",
      "appliances": "",
      "notes": "",
      "amount": 294
    },
    {
      "id": 876,
      "name": "meloxicam",
      "appliances": "",
      "notes": "",
      "amount": 147
    },
    {
      "id": 877,
      "name": "pethidine",
      "appliances": "",
      "notes": "",
      "amount": 703
    },
    {
      "id": 878,
      "name": "mephentermine",
      "appliances": "Unfortunately, we have been unable to find bioactivity data for this drug at its human target, to substantiate its MMOA.",
      "notes": "",
      "amount": 340
    },
    {
      "id": 879,
      "name": "mephenytoin",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 143
    },
    {
      "id": 880,
      "name": "mepivacaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 340
    },
    {
      "id": 881,
      "name": "meprobamate",
      "appliances": "",
      "notes": "",
      "amount": 750
    },
    {
      "id": 882,
      "name": "mercaptopurine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 693
    },
    {
      "id": 883,
      "name": "mesuximide",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of (human) affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 828
    },
    {
      "id": 884,
      "name": "metaraminol",
      "appliances": "",
      "notes": "",
      "amount": 571
    },
    {
      "id": 885,
      "name": "metharbital",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 630
    },
    {
      "id": 886,
      "name": "methdilazine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 178
    },
    {
      "id": 887,
      "name": "methixene",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 551
    },
    {
      "id": 888,
      "name": "methohexital",
      "appliances": "",
      "notes": "",
      "amount": 321
    },
    {
      "id": 889,
      "name": "methoxyflurane",
      "appliances": "",
      "notes": "",
      "amount": 360
    },
    {
      "id": 890,
      "name": "methyclothiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 871
    },
    {
      "id": 891,
      "name": "methylphenidate",
      "appliances": "",
      "notes": "",
      "amount": 504
    },
    {
      "id": 892,
      "name": "methyprylon",
      "appliances": "",
      "notes": "",
      "amount": 978
    },
    {
      "id": 893,
      "name": "metipranolol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 563
    },
    {
      "id": 894,
      "name": "midodrine",
      "appliances": "",
      "notes": "",
      "amount": 777
    },
    {
      "id": 895,
      "name": "mitoxantrone",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 981
    },
    {
      "id": 896,
      "name": "mivacurium",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of nACh channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 956
    },
    {
      "id": 897,
      "name": "moracizine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 868
    },
    {
      "id": 898,
      "name": "nabumetone",
      "appliances": "We have been unable to find publicly available affinity data for this drug to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 857
    },
    {
      "id": 899,
      "name": "nebivolol",
      "appliances": "",
      "notes": "",
      "amount": 885
    },
    {
      "id": 900,
      "name": "nefazodone",
      "appliances": "",
      "notes": "",
      "amount": 857
    },
    {
      "id": 901,
      "name": "nizatidine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 772
    },
    {
      "id": 902,
      "name": "olopatadine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 118
    },
    {
      "id": 903,
      "name": "orciprenaline",
      "appliances": "",
      "notes": "",
      "amount": 109
    },
    {
      "id": 904,
      "name": "orphenadrine",
      "appliances": "",
      "notes": "",
      "amount": 766
    },
    {
      "id": 905,
      "name": "oxaprozin",
      "appliances": "",
      "notes": "",
      "amount": 755
    },
    {
      "id": 906,
      "name": "oxazepam",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 267
    },
    {
      "id": 907,
      "name": "oxcarbazepine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 519
    },
    {
      "id": 908,
      "name": "oxprenolol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 979
    },
    {
      "id": 909,
      "name": "oxyphencyclimine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 164
    },
    {
      "id": 910,
      "name": "oxyphenonium",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 119
    },
    {
      "id": 911,
      "name": "paliperidone",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 902
    },
    {
      "id": 912,
      "name": "pamidronic acid",
      "appliances": "",
      "notes": "",
      "amount": 926
    },
    {
      "id": 913,
      "name": "pantoprazole",
      "appliances": "Much of the experimental work on proton pump inhibitors has been carried out in non-human animal models. There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 892
    },
    {
      "id": 914,
      "name": "paramethadione",
      "appliances": "Due to the complex nature of this drug's MMOA, and the paucity of human affinity data, we do not tag a primary drug target.",
      "notes": "",
      "amount": 192
    },
    {
      "id": 915,
      "name": "pargyline",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 945
    },
    {
      "id": 916,
      "name": "penbutolol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 710
    },
    {
      "id": 917,
      "name": "penicillamine",
      "appliances": "As the molecular target(s) of this drug are not definitively described, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 486
    },
    {
      "id": 918,
      "name": "phenacemide",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 817
    },
    {
      "id": 919,
      "name": "phenelzine",
      "appliances": "Prusevich <i>et al</i> (2014) report the inactivation efficiency (K<sub>inact</sub>) of phenelzine against human MAO-A and MAO-B as 820nM and 3900nM respectively <Reference id=24431/>.",
      "notes": "",
      "amount": 917
    },
    {
      "id": 920,
      "name": "pheniramine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 706
    },
    {
      "id": 921,
      "name": "phenoxybenzamine",
      "appliances": "We have curated affinity data for the human &alpha;<sub>2B</sub>-AR, but note that this is not a selective antagonist, so will have antagonist action at other &alpha;-adrenoceptors.",
      "notes": "",
      "amount": 495
    },
    {
      "id": 922,
      "name": "phentermine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 866
    },
    {
      "id": 923,
      "name": "phenylbutazone",
      "appliances": "",
      "notes": "",
      "amount": 746
    },
    {
      "id": 924,
      "name": "pipobroman",
      "appliances": "",
      "notes": "",
      "amount": 127
    },
    {
      "id": 925,
      "name": "pirbuterol",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets.",
      "notes": "",
      "amount": 428
    },
    {
      "id": 926,
      "name": "piroxicam",
      "appliances": "",
      "notes": "",
      "amount": 445
    },
    {
      "id": 927,
      "name": "polythiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 113
    },
    {
      "id": 928,
      "name": "prazepam",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 454
    },
    {
      "id": 929,
      "name": "prilocaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 700
    },
    {
      "id": 930,
      "name": "probucol",
      "appliances": "Favari <i>et al.</i> (2005) report that probucol inhibits ABCA1-mediated cholesterol efflux from <i>in vitro</i> cultured mouse J774 cells by 80%, and from human fibroblasts by &gt;50% <Reference id=24277/>.",
      "notes": "",
      "amount": 904
    },
    {
      "id": 931,
      "name": "procarbazine",
      "appliances": "",
      "notes": "",
      "amount": 478
    },
    {
      "id": 932,
      "name": "prochlorperazine",
      "appliances": "Prochlorperazine has selective affinity for the dopamine 2-like receptors, with highest affinity for the D<sub>2</sub> and D<sub>3</sub> receptors. The drug's affinity for the D<sub>4</sub> receptor is significantly lower.",
      "notes": "",
      "amount": 198
    },
    {
      "id": 933,
      "name": "procyclidine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 668
    },
    {
      "id": 934,
      "name": "proparacaine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 225
    },
    {
      "id": 935,
      "name": "propiomazine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 196
    },
    {
      "id": 936,
      "name": "protriptyline",
      "appliances": "",
      "notes": "",
      "amount": 450
    },
    {
      "id": 937,
      "name": "pseudoephedrine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 147
    },
    {
      "id": 938,
      "name": "pyrazinamide",
      "appliances": "",
      "notes": "",
      "amount": 295
    },
    {
      "id": 939,
      "name": "quazepam",
      "appliances": "We have been unable to find publicly available affinity data for this drug, at its proposed human target, to substantiate this MMOA. For this reason we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 607
    },
    {
      "id": 940,
      "name": "quinethazone",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 644
    },
    {
      "id": 941,
      "name": "rabeprazole",
      "appliances": "Much of the experimental work on proton pump inhibitors has been carried out in non-human animal models. There appears to be no publicly available bioactivity data for this drug at its human molecular targets",
      "notes": "",
      "amount": 745
    },
    {
      "id": 942,
      "name": "ranolazine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 250
    },
    {
      "id": 943,
      "name": "remifentanil",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 701
    },
    {
      "id": 944,
      "name": "ritodrine",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular targets, the &beta;<sub>2</sub>-ARs.",
      "notes": "",
      "amount": 869
    },
    {
      "id": 945,
      "name": "ropinirole",
      "appliances": "",
      "notes": "",
      "amount": 774
    },
    {
      "id": 946,
      "name": "sevoflurane",
      "appliances": "Due to the polypharmacology of this drug we have not mapped it to a primary target.",
      "notes": "",
      "amount": 640
    },
    {
      "id": 947,
      "name": "sotalol",
      "appliances": "",
      "notes": "",
      "amount": 177
    },
    {
      "id": 948,
      "name": "suprofen",
      "appliances": "",
      "notes": "",
      "amount": 832
    },
    {
      "id": 949,
      "name": "tadalafil",
      "appliances": "",
      "notes": "",
      "amount": 344
    },
    {
      "id": 950,
      "name": "temazepam",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 535
    },
    {
      "id": 951,
      "name": "temozolomide",
      "appliances": "",
      "notes": "",
      "amount": 301
    },
    {
      "id": 952,
      "name": "terazosin",
      "appliances": "",
      "notes": "",
      "amount": 990
    },
    {
      "id": 953,
      "name": "testolactone",
      "appliances": "",
      "notes": "",
      "amount": 524
    },
    {
      "id": 954,
      "name": "thiabendazole",
      "appliances": "As a chelating agent this drug does not have a biological, mechanistic target.",
      "notes": "",
      "amount": 583
    },
    {
      "id": 955,
      "name": "thiamylal",
      "appliances": "",
      "notes": "",
      "amount": 339
    },
    {
      "id": 956,
      "name": "thiethylperazine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 922
    },
    {
      "id": 957,
      "name": "tizanidine",
      "appliances": "As we have been unable to find publicly available affinity data for this drug (at the human target) to substantiate its MMOA, we have not mapped a primary drug target in this case.",
      "notes": "",
      "amount": 875
    },
    {
      "id": 958,
      "name": "tocainide",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 893
    },
    {
      "id": 959,
      "name": "tolazoline",
      "appliances": "<i>In vitro</i> experiments have shown that tolazoline inhibits noradrenaline-induced contraction of isolated radial arteries from human patients with a pEC<sub>50</sub> of  5.4 <Reference id=24289/>.",
      "notes": "",
      "amount": 350
    },
    {
      "id": 960,
      "name": "tolmetin",
      "appliances": "We have been unable to find publicly available affinity data for this drug to substantiate its MMOA and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 424
    },
    {
      "id": 961,
      "name": "torsemide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 644
    },
    {
      "id": 962,
      "name": "triazolam",
      "appliances": "",
      "notes": "",
      "amount": 102
    },
    {
      "id": 963,
      "name": "trichlormethiazide",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 508
    },
    {
      "id": 964,
      "name": "trihexyphenidyl",
      "appliances": "",
      "notes": "",
      "amount": 178
    },
    {
      "id": 965,
      "name": "trimethadione",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 894
    },
    {
      "id": 966,
      "name": "tripelennamine",
      "appliances": "",
      "notes": "",
      "amount": 650
    },
    {
      "id": 967,
      "name": "tropicamide",
      "appliances": "",
      "notes": "",
      "amount": 922
    },
    {
      "id": 968,
      "name": "vardenafil",
      "appliances": "",
      "notes": "",
      "amount": 634
    },
    {
      "id": 969,
      "name": "venlafaxine",
      "appliances": "",
      "notes": "",
      "amount": 594
    },
    {
      "id": 970,
      "name": "chlormezanone",
      "appliances": "This drug probably acts as a positive allosteric modulator of the GABA<sub>A</sub> receptor complex, but as we are unable to substantiate this MMOA we have not tagged a primary drug target.",
      "notes": "",
      "amount": 535
    },
    {
      "id": 971,
      "name": "chlophedianol",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 520
    },
    {
      "id": 972,
      "name": "ethinamate",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 109
    },
    {
      "id": 973,
      "name": "hydralazine",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 510
    },
    {
      "id": 974,
      "name": "thalidomide",
      "appliances": "",
      "notes": "",
      "amount": 606
    },
    {
      "id": 975,
      "name": "tromethamine",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 851
    },
    {
      "id": 976,
      "name": "pemirolast",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 228
    },
    {
      "id": 977,
      "name": "dexrazoxane",
      "appliances": "This drug appears to act as an iron chelating agent, and therefore has no biological protein target.",
      "notes": "",
      "amount": 842
    },
    {
      "id": 978,
      "name": "lenalidomide",
      "appliances": "",
      "notes": "",
      "amount": 803
    },
    {
      "id": 979,
      "name": "metreleptin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 966
    },
    {
      "id": 980,
      "name": "oliceridine",
      "appliances": "This compound is reported to provoke biased signalling of the &mu; opioid receptor towards G protein coupling, with reduced compound-induced &beta;-arrestin coupling and receptor internalisation observed, compared to morphine <Reference id=23936/>.",
      "notes": "",
      "amount": 532
    },
    {
      "id": 981,
      "name": "nivolumab",
      "appliances": "",
      "notes": "",
      "amount": 821
    },
    {
      "id": 982,
      "name": "ataluren",
      "appliances": "",
      "notes": "",
      "amount": 575
    },
    {
      "id": 983,
      "name": "flutemetamol",
      "appliances": "",
      "notes": "",
      "amount": 992
    },
    {
      "id": 984,
      "name": "evolocumab",
      "appliances": "Pending publication, affinity data for evolocumab is derived from patent <a href=\"https://www.google.com/search?tbm=pts&hl=en&q=US+8030457\">US8030457</a>.",
      "notes": "",
      "amount": 587
    },
    {
      "id": 985,
      "name": "florbetapir",
      "appliances": "",
      "notes": "",
      "amount": 521
    },
    {
      "id": 986,
      "name": "crisantaspase",
      "appliances": "The substrate for this enzyme is L-asparagine, which it converts to aspartic acid and ammonia. We have not tagged a primary target for this enzyme drug.",
      "notes": "",
      "amount": 746
    },
    {
      "id": 987,
      "name": "pomalidomide",
      "appliances": "",
      "notes": "",
      "amount": 372
    },
    {
      "id": 988,
      "name": "eslicarbazepine",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of sodium channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 842
    },
    {
      "id": 989,
      "name": "vortioxetine",
      "appliances": "Vortioxetine binds to 5-HT<sub>2C</sub> receptors with a K<sub>i</sub> of 180 nM <Reference id=24039/>.",
      "notes": "",
      "amount": 696
    },
    {
      "id": 990,
      "name": "macitentan",
      "appliances": "",
      "notes": "",
      "amount": 551
    },
    {
      "id": 991,
      "name": "vilanterol",
      "appliances": "",
      "notes": "",
      "amount": 581
    },
    {
      "id": 992,
      "name": "umeclidinium",
      "appliances": "This compound has low nanomolar K<sub>i</sub>s for the M<sub>1</sub> (0.16nM), M<sub>2</sub> (0.15nM) and M<sub>3</sub> (0.06nM) muscarinic acetylcholine receptor subtypes <Reference id=24042/>.",
      "notes": "",
      "amount": 948
    },
    {
      "id": 993,
      "name": "bazedoxifene",
      "appliances": "",
      "notes": "",
      "amount": 644
    },
    {
      "id": 994,
      "name": "mipomersen",
      "appliances": "We do not list RNA as a drug target, although the specificity of this compound is unquestionable, there is no classical affinity data for the interaction between the drug and it's mRNA target. Therefore we have not tagged a primary drug target.",
      "notes": "",
      "amount": 931
    },
    {
      "id": 995,
      "name": "dolutegravir",
      "appliances": "",
      "notes": "",
      "amount": 110
    },
    {
      "id": 996,
      "name": "luliconazole",
      "appliances": "",
      "notes": "",
      "amount": 186
    },
    {
      "id": 997,
      "name": "simeprevir",
      "appliances": "",
      "notes": "",
      "amount": 373
    },
    {
      "id": 998,
      "name": "sofosbuvir",
      "appliances": "",
      "notes": "",
      "amount": 403
    },
    {
      "id": 999,
      "name": "apremilast",
      "appliances": "Apremilast inhibits a crude extract of human PDE4 with an IC<sub>50</sub> of 74nM <Reference id=24124/> and has broad spectrum activity across isoforms from all four PDE4 sub-families (IC<sub>50</sub>s 10-100nM) <Reference id=32860/>.",
      "notes": "",
      "amount": 338
    },
    {
      "id": 1001,
      "name": "tebentafusp",
      "appliances": "Affinity of the antibody for the engagement of the TCR is reported to be in the picomolar range <Reference id=27152/>. We cannot find information regarding the affinity for the CD3e interaction.",
      "notes": "",
      "amount": 486
    },
    {
      "id": 1002,
      "name": "palbociclib",
      "appliances": "Palbociclib acts <i>via</i> inhibition of CDK4/6 to dose-dependently reduce phosphorylation of the retinoblastoma protein (Rb) with an IC<sub>50</sub> of 30nM <Reference id=24192/> in both MV4-11 and MOLM13 acute myelocytic leukemia (AML) cell lines.",
      "notes": "",
      "amount": 853
    },
    {
      "id": 1003,
      "name": "abemaciclib",
      "appliances": "<i>In vitro</i>, and in rodent models, abemaciclib is active against HER2-positive breast tumour cells that are resistant to standard treatments <Reference id=31225/>.",
      "notes": "",
      "amount": 552
    },
    {
      "id": 1004,
      "name": "ribociclib",
      "appliances": "Treatment with nanomolar concentrations of ribociclib reduces proliferation in human neuroblastoma-derived cell lines (mean IC<sub>50</sub> 307nM) and in mouse xenograft models <Reference id=24202/>.",
      "notes": "",
      "amount": 445
    },
    {
      "id": 1005,
      "name": "lixisenatide",
      "appliances": "",
      "notes": "",
      "amount": 378
    },
    {
      "id": 1006,
      "name": "ramucirumab",
      "appliances": "",
      "notes": "",
      "amount": 353
    },
    {
      "id": 1007,
      "name": "droxidopa",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart.",
      "notes": "",
      "amount": 266
    },
    {
      "id": 1008,
      "name": "elosulfase alfa",
      "appliances": "We have not tagged a primary drug target for this enzyme replacement therapeutic.",
      "notes": "",
      "amount": 622
    },
    {
      "id": 1009,
      "name": "tasimelteon",
      "appliances": "Tasimelteon is a non-selective MT<sub>1</sub>/MT<sub>2</sub> receptor ligand, with low nanomolar affinities for the human receptors.",
      "notes": "",
      "amount": 311
    },
    {
      "id": 1010,
      "name": "siltuximab",
      "appliances": "",
      "notes": "",
      "amount": 237
    },
    {
      "id": 1011,
      "name": "ceritinib",
      "appliances": "",
      "notes": "",
      "amount": 705
    },
    {
      "id": 1012,
      "name": "ibudilast",
      "appliances": "Ibudilast is predominantly a PDE4 inhibitor <Reference id=24358/>. Ibudilast has been identified as a negative allosteric modulator of <Ligand id=9981/> <Reference id=35222/>.",
      "notes": "",
      "amount": 778
    },
    {
      "id": 1013,
      "name": "iodipamide",
      "appliances": "As a contrast agent for organ visualisation this drug does not exhibit classical drug-target interaction.",
      "notes": "",
      "amount": 769
    },
    {
      "id": 1014,
      "name": "nimesulide",
      "appliances": "",
      "notes": "",
      "amount": 573
    },
    {
      "id": 1015,
      "name": "phenacetin",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 736
    },
    {
      "id": 1016,
      "name": "raltitrexed",
      "appliances": "",
      "notes": "",
      "amount": 995
    },
    {
      "id": 1017,
      "name": "tolrestat",
      "appliances": "",
      "notes": "",
      "amount": 748
    },
    {
      "id": 1018,
      "name": "dacomitinib",
      "appliances": "Inhibits infection by SARS-CoV-2 in cell assays with IC<sub>50</sub> 420-1430 nM depending on cell type <Reference id=41947/>.",
      "notes": "",
      "amount": 122
    },
    {
      "id": 1019,
      "name": "lenvatinib",
      "appliances": "",
      "notes": "",
      "amount": 895
    },
    {
      "id": 1020,
      "name": "vilazodone",
      "appliances": "",
      "notes": "",
      "amount": 469
    },
    {
      "id": 1021,
      "name": "moclobemide",
      "appliances": "",
      "notes": "",
      "amount": 402
    },
    {
      "id": 1022,
      "name": "eszopiclone",
      "appliances": "Due to the complex and varied nature of the precise subunit composition of GABA<sub>A</sub> channels, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.",
      "notes": "",
      "amount": 596
    },
    {
      "id": 1023,
      "name": "oxaliplatin",
      "appliances": "",
      "notes": "",
      "amount": 590
    },
    {
      "id": 1024,
      "name": "budesonide",
      "appliances": "",
      "notes": "",
      "amount": 249
    },
    {
      "id": 1025,
      "name": "levomilnacipran",
      "appliances": "",
      "notes": "",
      "amount": 690
    },
    {
      "id": 1026,
      "name": "milnacipran",
      "appliances": "",
      "notes": "",
      "amount": 403
    },
    {
      "id": 1027,
      "name": "methacholine",
      "appliances": "We have been able to find publicly available bioactivity data at human muscarinic receptors to substantiate this drug's MMOA. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 749
    },
    {
      "id": 1028,
      "name": "lomitapide",
      "appliances": "<i>In vitro</i>, lomitapide inhibits human MTTP with an IC<sub>50</sub> of 8nM in an assay measuring triglyceride transfer <Reference id=24490/>.",
      "notes": "",
      "amount": 723
    },
    {
      "id": 1029,
      "name": "mercaptamine",
      "appliances": "There is no classical primary biological target for this drug, therefore we have not tagged a primary drug target.",
      "notes": "",
      "amount": 770
    },
    {
      "id": 1030,
      "name": "icosapent",
      "appliances": "As we are unable to define the MMOA of this drug, and as it is likely to have multiple actions, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 807
    },
    {
      "id": 1031,
      "name": "taliglucerase alfa",
      "appliances": "",
      "notes": "",
      "amount": 948
    },
    {
      "id": 1032,
      "name": "mirabegron",
      "appliances": "Potential off-targets and any clinical relevance of off-target activity of mirabegron are discussed by Dehvari <i>et al.</i> (2017) <Reference id=34055/>.",
      "notes": "",
      "amount": 333
    },
    {
      "id": 1033,
      "name": "ocriplasmin",
      "appliances": "As we have been unable to find publicly available bioactivity data for this enzyme construct at any of its proposed substrates (collagen, fibronectin and laminin) we have not tagged a primary drug target.",
      "notes": "",
      "amount": 205
    },
    {
      "id": 1034,
      "name": "peginesatide",
      "appliances": "Initial studies in humans demonstrate that peginesatide increases haemoglobin (<i>ie</i> stimulates red blood cell production) in patients with chronic kidney disease <Reference id=24504/>.",
      "notes": "",
      "amount": 438
    },
    {
      "id": 1035,
      "name": "glucarpidase",
      "appliances": "As this drug metabolises an exogenously introduced compound (methotrexate) it does not act at a classic human primary target.",
      "notes": "",
      "amount": 509
    },
    {
      "id": 1036,
      "name": "tafluprost",
      "appliances": "Bioactivity is attributed to the active metabolite, <Ligand id=7452/>. EC<sub>50</sub> for tafluprost acid at the human <a href=\"FamilyDisplayForward?familyId=58#show_object_344\">prostanoid FP receptor</a> is 0.53nM <Reference id=24510/>.",
      "notes": "",
      "amount": 876
    },
    {
      "id": 1037,
      "name": "indacaterol",
      "appliances": "",
      "notes": "",
      "amount": 815
    },
    {
      "id": 1038,
      "name": "deferiprone",
      "appliances": "Iron is the target of this drug.",
      "notes": "",
      "amount": 521
    },
    {
      "id": 1039,
      "name": "dutasteride",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 355
    },
    {
      "id": 1040,
      "name": "carglumic acid",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 515
    },
    {
      "id": 1041,
      "name": "glycopyrrolate",
      "appliances": "Glycopyrrolate has high, equipotent affinity for all muscarinic acetylcholine receptor subtypes (M<sub>1-5</sub>) <Reference id=24527/>.",
      "notes": "",
      "amount": 851
    },
    {
      "id": 1042,
      "name": "ulipristal acetate",
      "appliances": "",
      "notes": "",
      "amount": 909
    },
    {
      "id": 1043,
      "name": "pegloticase",
      "appliances": "We have not tagged a primary drug target in this case, as the enzyme substrate is not a classical biological drug target.",
      "notes": "",
      "amount": 141
    },
    {
      "id": 1044,
      "name": "velaglucerase alfa",
      "appliances": "",
      "notes": "",
      "amount": 364
    },
    {
      "id": 1045,
      "name": "bepotastine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 999
    },
    {
      "id": 1046,
      "name": "rasburicase",
      "appliances": "",
      "notes": "",
      "amount": 779
    },
    {
      "id": 1047,
      "name": "clevidipine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 681
    },
    {
      "id": 1048,
      "name": "alvimopan",
      "appliances": "",
      "notes": "",
      "amount": 533
    },
    {
      "id": 1049,
      "name": "fesoterodine",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 535
    },
    {
      "id": 1050,
      "name": "fospropofol",
      "appliances": "As the GABA<sub>A</sub> binding site was reported to exist on both &beta;3 homopentamers and &alpha;1&beta;3 heteropentamers <Reference id=24548/> we have not tagged a primary drug target for propofol.",
      "notes": "",
      "amount": 105
    },
    {
      "id": 1051,
      "name": "lorlatinib",
      "appliances": "PF-06463922 shows activity in both crizotinib-naive and crizotinib-resistant cells <Reference id=24549/>, so has the potential to replace crizotinib in the clinic.",
      "notes": "",
      "amount": 135
    },
    {
      "id": 1052,
      "name": "tapentadol",
      "appliances": "ChEMBL bioassay data provides a K<sub>i </sub> value of 160nM and an EC<sub>50</sub> value of 670nM for the human &mu;-opioid receptor.",
      "notes": "",
      "amount": 227
    },
    {
      "id": 1053,
      "name": "bendamustine",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database, hence this drug has no tagged primary mechanistic target.",
      "notes": "",
      "amount": 884
    },
    {
      "id": 1054,
      "name": "arformoterol",
      "appliances": "",
      "notes": "",
      "amount": 555
    },
    {
      "id": 1055,
      "name": "trospium",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at any of the muscarinic receptor subtypes to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 201
    },
    {
      "id": 1056,
      "name": "lumacaftor",
      "appliances": "",
      "notes": "",
      "amount": 595
    },
    {
      "id": 1057,
      "name": "pramlintide",
      "appliances": "",
      "notes": "",
      "amount": 868
    },
    {
      "id": 1058,
      "name": "solifenacin",
      "appliances": "",
      "notes": "",
      "amount": 456
    },
    {
      "id": 1059,
      "name": "azelaic acid",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 596
    },
    {
      "id": 1060,
      "name": "pegvisomant",
      "appliances": "",
      "notes": "",
      "amount": 917
    },
    {
      "id": 1061,
      "name": "palonosetron",
      "appliances": "",
      "notes": "",
      "amount": 489
    },
    {
      "id": 1062,
      "name": "alpha1-proteinase inhibitor",
      "appliances": "",
      "notes": "",
      "amount": 314
    },
    {
      "id": 1063,
      "name": "panobinostat",
      "appliances": "In <i>Plasmodium</i>, panobinostat demonstrates <i>in vitro</i> activity against both the sexual and asexual blood stages of the parasite lifecycle.",
      "notes": "",
      "amount": 695
    },
    {
      "id": 1064,
      "name": "givinostat",
      "appliances": "",
      "notes": "",
      "amount": 725
    },
    {
      "id": 1065,
      "name": "bufexamac",
      "appliances": "",
      "notes": "",
      "amount": 848
    },
    {
      "id": 1066,
      "name": "pembrolizumab",
      "appliances": "",
      "notes": "",
      "amount": 429
    },
    {
      "id": 1067,
      "name": "olaparib",
      "appliances": "",
      "notes": "",
      "amount": 416
    },
    {
      "id": 1068,
      "name": "pirfenidone",
      "appliances": "As the precise MMOA of this drug is not fully understood, we are unable to define a primary drug target.",
      "notes": "",
      "amount": 340
    },
    {
      "id": 1069,
      "name": "eteplirsen",
      "appliances": "",
      "notes": "",
      "amount": 246
    },
    {
      "id": 1070,
      "name": "cobicistat",
      "appliances": "<i>In vitro</i>, cobicistat inactivates human hepatic microsomal CYP3A-dependent midazolam 1′-hydroxylase activity with a K<sub>i</sub> of 939nM <Reference id=24656/>.",
      "notes": "",
      "amount": 308
    },
    {
      "id": 1071,
      "name": "eliglustat",
      "appliances": "Eliglustat inhibits the production of glucosylceramide in Madin-Darby canine kidney (MDCK) cells with an IC<sub>50</sub> of 13.7nM <Reference id=24660/>.",
      "notes": "",
      "amount": 716
    },
    {
      "id": 1072,
      "name": "brodalumab",
      "appliances": "BLAST searches using the peptide sequences of the heavy and light chains of brodalumab link to patent US7767206 <Reference id=27108/>, and monoclonal antibody clone AM<sub>H</sub>14/AM<sub>L</sub>14.",
      "notes": "",
      "amount": 677
    },
    {
      "id": 1073,
      "name": "ixekizumab",
      "appliances": "",
      "notes": "",
      "amount": 608
    },
    {
      "id": 1074,
      "name": "olodaterol",
      "appliances": "",
      "notes": "",
      "amount": 849
    },
    {
      "id": 1075,
      "name": "pixantrone",
      "appliances": "",
      "notes": "",
      "amount": 175
    },
    {
      "id": 1076,
      "name": "citalopram",
      "appliances": "",
      "notes": "",
      "amount": 172
    },
    {
      "id": 1077,
      "name": "dosulepin",
      "appliances": "",
      "notes": "",
      "amount": 351
    },
    {
      "id": 1078,
      "name": "estazolam",
      "appliances": "As we are unable to substantiate the MMOA of this drug we have not tagged a primary drug target.",
      "notes": "",
      "amount": 805
    },
    {
      "id": 1079,
      "name": "lofepramine",
      "appliances": "",
      "notes": "",
      "amount": 368
    },
    {
      "id": 1080,
      "name": "lormetazepam",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular target, so we have not mapped a primary drug target in this instance.",
      "notes": "",
      "amount": 457
    },
    {
      "id": 1081,
      "name": "dexmethylphenidate",
      "appliances": "",
      "notes": "",
      "amount": 248
    },
    {
      "id": 1082,
      "name": "modafinil",
      "appliances": "There appears to be no publicly available bioactivity data for this drug at its human molecular target. We have not mapped a primary drug target in this instance.",
      "notes": "",
      "amount": 955
    },
    {
      "id": 1083,
      "name": "perospirone",
      "appliances": "",
      "notes": "",
      "amount": 675
    },
    {
      "id": 1084,
      "name": "pipotiazine",
      "appliances": "",
      "notes": "",
      "amount": 247
    },
    {
      "id": 1085,
      "name": "gabapentin enacarbil",
      "appliances": "As a prodrug it is likely that gabapentin enacarbil has little target affinity. Biological activity will be associated with the active form, gabapentin.",
      "notes": "",
      "amount": 577
    },
    {
      "id": 1086,
      "name": "alglucosidase alfa",
      "appliances": "The molecular target of ths drug is glycogen.",
      "notes": "",
      "amount": 242
    },
    {
      "id": 1087,
      "name": "prasugrel",
      "appliances": "As this is a prodrug its intrinsic effect is likely to be insignificant. We do not map a primary drug target in this instance. Mechanistic activity is related to the active metabolite <Ligand id=1771/>.",
      "notes": "",
      "amount": 231
    },
    {
      "id": 1088,
      "name": "methylnaltrexone",
      "appliances": "",
      "notes": "",
      "amount": 392
    },
    {
      "id": 1089,
      "name": "amfenac",
      "appliances": "We have been unable to find publicly available bioactivity data for this drug at its proposed human molecular targets to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 860
    },
    {
      "id": 1090,
      "name": "insulin glargine",
      "appliances": "",
      "notes": "",
      "amount": 245
    },
    {
      "id": 1091,
      "name": "omaveloxolone",
      "appliances": "",
      "notes": "",
      "amount": 165
    },
    {
      "id": 1092,
      "name": "dupilumab",
      "appliances": "Affinity data in the table below is taken from patent US7608693 <Reference id=27150/>, using antibody clone H4H098P as a representative example of the embodiment of the patent. The clone becoming dupilumab is not reported.",
      "notes": "",
      "amount": 151
    },
    {
      "id": 1093,
      "name": "edoxaban",
      "appliances": "",
      "notes": "",
      "amount": 575
    },
    {
      "id": 1094,
      "name": "alcaftadine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 301
    },
    {
      "id": 1095,
      "name": "dexbrompheniramine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 973
    },
    {
      "id": 1096,
      "name": "ceruletide",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 417
    },
    {
      "id": 1097,
      "name": "etonogestrel",
      "appliances": "Although this drug is a known progesterone receptor agonist we have been unable to find publicly available bioactivity data to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 124
    },
    {
      "id": 1098,
      "name": "butorphanol",
      "appliances": "",
      "notes": "",
      "amount": 612
    },
    {
      "id": 1099,
      "name": "difenoxin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 925
    },
    {
      "id": 1100,
      "name": "dextropropoxyphene",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 468
    },
    {
      "id": 1101,
      "name": "dihydrocodeine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 593
    },
    {
      "id": 1102,
      "name": "levorphanol",
      "appliances": "",
      "notes": "",
      "amount": 932
    },
    {
      "id": 1103,
      "name": "pralidoxime",
      "appliances": "",
      "notes": "",
      "amount": 267
    },
    {
      "id": 1104,
      "name": "acitretin",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 318
    },
    {
      "id": 1105,
      "name": "etretinate",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 655
    },
    {
      "id": 1106,
      "name": "isotretinoin",
      "appliances": "Biological data supports its action <Reference id=30131/>, but we have been unable to find publicly available affinity data for this compound at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 519
    },
    {
      "id": 1107,
      "name": "benzatropine",
      "appliances": "",
      "notes": "",
      "amount": 302
    },
    {
      "id": 1108,
      "name": "ropivacaine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 287
    },
    {
      "id": 1109,
      "name": "prednicarbate",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 880
    },
    {
      "id": 1110,
      "name": "fludroxycortide",
      "appliances": "The only available affinity data for this drug at the glucocorticoid receptor is contained in the DRUGMATRIX <i>in vitro</i> pharmacology data <Reference id=24341/>, which reports a K<sub>i</sub> of 2.02nM. We do not map a primary drug target in this case.",
      "notes": "",
      "amount": 556
    },
    {
      "id": 1111,
      "name": "nedocromil",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 695
    },
    {
      "id": 1112,
      "name": "cromoglicic acid",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 270
    },
    {
      "id": 1113,
      "name": "metaxalone",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 248
    },
    {
      "id": 1114,
      "name": "carisoprodol",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 215
    },
    {
      "id": 1115,
      "name": "benzonatate",
      "appliances": "As the precise molecular nature of the protein target for this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 187
    },
    {
      "id": 1116,
      "name": "trimetrexate",
      "appliances": "",
      "notes": "",
      "amount": 163
    },
    {
      "id": 1117,
      "name": "trimethobenzamide",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 992
    },
    {
      "id": 1118,
      "name": "secobarbital",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its precise molecular target to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 512
    },
    {
      "id": 1119,
      "name": "guaifenesin",
      "appliances": "As the precise MMOA of this drug has not been fully resolved, we have not tagged a primary drug target in this case.",
      "notes": "",
      "amount": 461
    },
    {
      "id": 1120,
      "name": "betanidine",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.",
      "notes": "",
      "amount": 689
    },
    {
      "id": 1121,
      "name": "melphalan",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 729
    },
    {
      "id": 1122,
      "name": "uramustine",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 585
    },
    {
      "id": 1123,
      "name": "thiotepa",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 328
    },
    {
      "id": 1124,
      "name": "fosaprepitant",
      "appliances": "",
      "notes": "",
      "amount": 316
    },
    {
      "id": 1125,
      "name": "carboplatin",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 965
    },
    {
      "id": 1126,
      "name": "cobimetinib",
      "appliances": "",
      "notes": "",
      "amount": 444
    },
    {
      "id": 1127,
      "name": "conestat alfa",
      "appliances": "",
      "notes": "",
      "amount": 263
    },
    {
      "id": 1128,
      "name": "testosterone phenylpropionate",
      "appliances": "",
      "notes": "",
      "amount": 657
    },
    {
      "id": 1129,
      "name": "testosterone isocaproate",
      "appliances": "",
      "notes": "",
      "amount": 990
    },
    {
      "id": 1130,
      "name": "testosterone decanoate",
      "appliances": "",
      "notes": "",
      "amount": 834
    },
    {
      "id": 1131,
      "name": "peginterferon beta-1a",
      "appliances": "",
      "notes": "",
      "amount": 843
    },
    {
      "id": 1132,
      "name": "dulaglutide",
      "appliances": "",
      "notes": "",
      "amount": 225
    },
    {
      "id": 1133,
      "name": "simotinib",
      "appliances": "",
      "notes": "",
      "amount": 303
    },
    {
      "id": 1134,
      "name": "icotinib",
      "appliances": "",
      "notes": "",
      "amount": 516
    },
    {
      "id": 1135,
      "name": "rivoceranib",
      "appliances": "",
      "notes": "",
      "amount": 536
    },
    {
      "id": 1136,
      "name": "dienogest",
      "appliances": "",
      "notes": "",
      "amount": 554
    },
    {
      "id": 1137,
      "name": "estradiol valerate",
      "appliances": "",
      "notes": "",
      "amount": 184
    },
    {
      "id": 1138,
      "name": "blonanserin",
      "appliances": "",
      "notes": "",
      "amount": 120
    },
    {
      "id": 1139,
      "name": "cariprazine",
      "appliances": "",
      "notes": "",
      "amount": 469
    },
    {
      "id": 1140,
      "name": "brexpiprazole",
      "appliances": "",
      "notes": "",
      "amount": 966
    },
    {
      "id": 1141,
      "name": "lesinurad",
      "appliances": "",
      "notes": "",
      "amount": 902
    },
    {
      "id": 1142,
      "name": "benralizumab",
      "appliances": "",
      "notes": "",
      "amount": 776
    },
    {
      "id": 1143,
      "name": "moxetumomab pasudotox",
      "appliances": "",
      "notes": "",
      "amount": 113
    },
    {
      "id": 1144,
      "name": "mepolizumab",
      "appliances": "In monkey studies mepolizumab decreased eosinophil count with an IC<sub>50</sub> of 1.43 &mu;g/ml, and exhibited a half-life of ~14.5 days <Reference id=37821/>.",
      "notes": "",
      "amount": 298
    },
    {
      "id": 1145,
      "name": "eluxadoline",
      "appliances": "",
      "notes": "",
      "amount": 610
    },
    {
      "id": 1146,
      "name": "capivasertib",
      "appliances": "",
      "notes": "",
      "amount": 995
    },
    {
      "id": 1147,
      "name": "alectinib",
      "appliances": "Alecitinib has potent anti-tumour effects in crizotinib resistant cells, in <i>in vivo</i> xenograft models <Reference id=25507/>.",
      "notes": "",
      "amount": 160
    },
    {
      "id": 1148,
      "name": "nirogacestat",
      "appliances": "In a whole cell assay PF-3084014 inhibits &gamma;-secretase activity with an IC50 of 1.2nM <Reference id=25537/>, measured as a reduction of A&beta; formation. The compound also reduced A&beta; in guinea pig brain.",
      "notes": "",
      "amount": 947
    },
    {
      "id": 1149,
      "name": "cilnidipine",
      "appliances": "",
      "notes": "",
      "amount": 400
    },
    {
      "id": 1150,
      "name": "florbetaben",
      "appliances": "",
      "notes": "",
      "amount": 170
    },
    {
      "id": 1151,
      "name": "momelotinib",
      "appliances": "",
      "notes": "",
      "amount": 555
    },
    {
      "id": 1152,
      "name": "pacritinib",
      "appliances": "",
      "notes": "",
      "amount": 165
    },
    {
      "id": 1153,
      "name": "fostamatinib",
      "appliances": "As fostamatinib is a prodrug it is unlikely to have intrinsic inhibitory activity. Bioactivity will be associated with its active form, <a href=\"LigandDisplayForward?tab=biology&ligandId=5706\">tamatinib</a>.",
      "notes": "",
      "amount": 173
    },
    {
      "id": 1154,
      "name": "sacubitril",
      "appliances": "",
      "notes": "",
      "amount": 206
    },
    {
      "id": 1155,
      "name": "gabexate",
      "appliances": "A range of  inhibition values for human serine proteases have been reported but potency seems to be highest against tryptase",
      "notes": "",
      "amount": 140
    },
    {
      "id": 1156,
      "name": "boceprevir",
      "appliances": "Boceprevir inhibits a number of coronavirus proteases <i>in vitro</i> <Reference id=39404/>. IC<sub>50</sub> values for Mpro (3CL proteases) are; SARS-CoV 2.5 &mu;M, MERS-CoV 3.8 &mu;M.",
      "notes": "",
      "amount": 183
    },
    {
      "id": 1157,
      "name": "infigratinib",
      "appliances": "",
      "notes": "",
      "amount": 102
    },
    {
      "id": 1158,
      "name": "xipamide",
      "appliances": "We have been unable to find any publicly available bioactivity data supporting NCC as this drug's molecular target.",
      "notes": "",
      "amount": 279
    },
    {
      "id": 1159,
      "name": "dapoxetine",
      "appliances": "",
      "notes": "",
      "amount": 830
    },
    {
      "id": 1160,
      "name": "sargramostim",
      "appliances": "We have been unable to find publicly available affinity data for this ligand at its primary molecular target.",
      "notes": "",
      "amount": 879
    },
    {
      "id": 1161,
      "name": "encorafenib",
      "appliances": "Encorafenib inhibits the BRAF<sup>V600E</sup> kinase with an IC<sub>50</sub> of 4 nM <Reference id=26177/>.",
      "notes": "",
      "amount": 846
    },
    {
      "id": 1162,
      "name": "filgotinib",
      "appliances": "",
      "notes": "",
      "amount": 232
    },
    {
      "id": 1163,
      "name": "binimetinib",
      "appliances": "",
      "notes": "",
      "amount": 959
    },
    {
      "id": 1164,
      "name": "alpelisib",
      "appliances": "Alpelisib inhibits proliferation of mouse MLg2908 lung fibroblasts (IC<sub>50</sub> 3500 nM) <Reference id=38117/>.",
      "notes": "",
      "amount": 596
    },
    {
      "id": 1165,
      "name": "edrecolomab",
      "appliances": "We have been unable to find publicly available affinity data for this antibody's binding to its molecular target.",
      "notes": "",
      "amount": 568
    },
    {
      "id": 1166,
      "name": "durvalumab",
      "appliances": "The affinity value in the table below is that reported in patent WO2011066389.",
      "notes": "",
      "amount": 486
    },
    {
      "id": 1167,
      "name": "nimotuzumab",
      "appliances": "Patent US6506883 <Reference id=27169/> does not include an affinity value for the interaction between nimotuzumab and the EGFR.",
      "notes": "",
      "amount": 552
    },
    {
      "id": 1168,
      "name": "sarilumab",
      "appliances": "",
      "notes": "",
      "amount": 645
    },
    {
      "id": 1169,
      "name": "tralokinumab",
      "appliances": "",
      "notes": "",
      "amount": 625
    },
    {
      "id": 1170,
      "name": "lonafarnib",
      "appliances": "Data in the table shows the ability of lonafarnib to inhibit farnesyltransferase-mediated farnesylation of human RAS proteins.",
      "notes": "",
      "amount": 863
    },
    {
      "id": 1171,
      "name": "levobetaxolol",
      "appliances": "",
      "notes": "",
      "amount": 259
    },
    {
      "id": 1172,
      "name": "secukinumab",
      "appliances": "",
      "notes": "",
      "amount": 202
    },
    {
      "id": 1173,
      "name": "necitumumab",
      "appliances": "",
      "notes": "",
      "amount": 671
    },
    {
      "id": 1174,
      "name": "reslizumab",
      "appliances": "",
      "notes": "",
      "amount": 559
    },
    {
      "id": 1175,
      "name": "romosozumab",
      "appliances": "",
      "notes": "",
      "amount": 952
    },
    {
      "id": 1176,
      "name": "tildrakizumab",
      "appliances": "",
      "notes": "",
      "amount": 407
    },
    {
      "id": 1177,
      "name": "flibanserin",
      "appliances": "",
      "notes": "",
      "amount": 636
    },
    {
      "id": 1178,
      "name": "sonidegib",
      "appliances": "",
      "notes": "",
      "amount": 550
    },
    {
      "id": 1179,
      "name": "glasdegib",
      "appliances": "",
      "notes": "",
      "amount": 429
    },
    {
      "id": 1180,
      "name": "anifrolumab",
      "appliances": "Anifrolumab inhibits the antiproliferative effect of IFN&omega; on Daudi cells with an EC<sub>50</sub> value of 0.3nM <Reference id=27251/>.",
      "notes": "",
      "amount": 420
    },
    {
      "id": 1181,
      "name": "inotuzumab ozogamicin",
      "appliances": "",
      "notes": "",
      "amount": 308
    },
    {
      "id": 1182,
      "name": "mifamurtide",
      "appliances": "We have been unable to find publicly available affinity data for this drug at its proposed molecular target.",
      "notes": "",
      "amount": 249
    },
    {
      "id": 1183,
      "name": "niraparib",
      "appliances": "",
      "notes": "",
      "amount": 161
    },
    {
      "id": 1184,
      "name": "treosulfan",
      "appliances": "",
      "notes": "",
      "amount": 506
    },
    {
      "id": 1185,
      "name": "unoprostone isopropyl",
      "appliances": "",
      "notes": "",
      "amount": 443
    },
    {
      "id": 1186,
      "name": "tramadol",
      "appliances": "",
      "notes": "",
      "amount": 475
    },
    {
      "id": 1187,
      "name": "safinamide",
      "appliances": "Safinamide is &gt;800-fold selective for MAOB over MAOA <Reference id=27410/>.",
      "notes": "",
      "amount": 666
    },
    {
      "id": 1188,
      "name": "idarucizumab",
      "appliances": "",
      "notes": "",
      "amount": 522
    },
    {
      "id": 1189,
      "name": "abaloparatide",
      "appliances": "As this is an analogue of an endogenous peptide we have tagged its primary target as the PTH1 receptor, although we have been unable to find affinity data for the peptide-receptor interaction.",
      "notes": "",
      "amount": 833
    },
    {
      "id": 1190,
      "name": "osilodrostat",
      "appliances": "",
      "notes": "",
      "amount": 439
    },
    {
      "id": 1191,
      "name": "fadrozole",
      "appliances": "We have tagged CYP19A1 (aromatase) as the primary target of this drug, based on the fact that its clinical use utilises this interaction. However, we also include reported data for interactions with other CYP P450 enzymes.",
      "notes": "",
      "amount": 691
    },
    {
      "id": 1192,
      "name": "sotagliflozin",
      "appliances": "",
      "notes": "",
      "amount": 316
    },
    {
      "id": 1193,
      "name": "polmacoxib",
      "appliances": "We have not tagged a primary molecular target for this compound as we have been unable to identify peer reviewed data confirming its MMOA.",
      "notes": "",
      "amount": 778
    },
    {
      "id": 1194,
      "name": "venetoclax",
      "appliances": "Venetoclax is reported to be &gt;4800-fold more selective for Bcl-2 compared to other protein family members Bcl-xL and Bcl-w <Reference id=27496/>.",
      "notes": "",
      "amount": 157
    },
    {
      "id": 1195,
      "name": "bempedoic acid",
      "appliances": "We have been unable to find any data that quantifies bempedoic acid's inhibitory effect on ACLY in the published, peer-reviewed literature. Given that it is essentially a prodrug this most likely explains the absence of interaction data.",
      "notes": "",
      "amount": 265
    },
    {
      "id": 1196,
      "name": "aducanumab",
      "appliances": "",
      "notes": "",
      "amount": 630
    },
    {
      "id": 1201,
      "name": "elotuzumab",
      "appliances": "The biological activity of elotuzumab has been well characterised <Reference id=27692/><Reference id=27693/>. We have tagged the primary molecular target, providing data from patent US7709610 <Reference id=27698/>.",
      "notes": "",
      "amount": 237
    },
    {
      "id": 1202,
      "name": "elagolix",
      "appliances": "Note that some bioactivity data may be generated using the elagolix sodium salt.",
      "notes": "",
      "amount": 204
    },
    {
      "id": 1203,
      "name": "etelcalcetide",
      "appliances": "",
      "notes": "",
      "amount": 170
    },
    {
      "id": 1204,
      "name": "ertugliflozin",
      "appliances": "Ertugliflozin is &gt;2200 fold selective for SGLT2 compared to SGLT1 <Reference id=27760/>.",
      "notes": "",
      "amount": 134
    },
    {
      "id": 1205,
      "name": "mithramycin",
      "appliances": "SETDB1-amplified lung cancer cell lines (NCI-H1437 and NCI-H1395) are more sensitive to the growth inhibitory effect of mithramycin than cells without SETDB1 amplification <Reference id=27812/>.",
      "notes": "",
      "amount": 693
    },
    {
      "id": 1206,
      "name": "polatuzumab vedotin",
      "appliances": "Patent US8088378 identifies clone huMA79b.v28, as the lead, but does not provide an affinity value for this monoclonal's binding to CD79b. The primary target is tagged based on biological evidence provided in the patent.",
      "notes": "",
      "amount": 858
    },
    {
      "id": 1207,
      "name": "pimavanserin",
      "appliances": "Pimavanserin is approximately 40-fold selective for 5-HT<sub>2A</sub> receptors compared to 5-HT<sub>2B</sub> receptors <Reference id=27943/>.",
      "notes": "",
      "amount": 667
    },
    {
      "id": 1208,
      "name": "remimazolam",
      "appliances": "",
      "notes": "",
      "amount": 648
    },
    {
      "id": 1209,
      "name": "sparsentan",
      "appliances": "",
      "notes": "",
      "amount": 984
    },
    {
      "id": 1210,
      "name": "tenapanor",
      "appliances": "",
      "notes": "",
      "amount": 835
    },
    {
      "id": 1211,
      "name": "roxadustat",
      "appliances": "We have been unable to find an ihibitory constant for roxadustat's inhibition of HIF-PHs (EGLN1-3). Associated patents examine stabilisation of HIF-1&alpha; or increased erythropoietin levels as markers of HIF-PH inhibition.",
      "notes": "",
      "amount": 605
    },
    {
      "id": 1212,
      "name": "daprodustat",
      "appliances": "We have been unable to find an ihibitory constant for daprodustat's inhibition of HIF-PHs (EGLN1-3). Associated patents examine stabilisation of HIF-1&alpha; or increased erythropoietin levels as markers of HIF-PH inhibition.",
      "notes": "",
      "amount": 294
    },
    {
      "id": 1213,
      "name": "phenylbutyrate",
      "appliances": "",
      "notes": "",
      "amount": 756
    },
    {
      "id": 1214,
      "name": "niclosamide",
      "appliances": "",
      "notes": "",
      "amount": 616
    },
    {
      "id": 1215,
      "name": "finerenone",
      "appliances": "",
      "notes": "",
      "amount": 731
    },
    {
      "id": 1216,
      "name": "volanesorsen",
      "appliances": "",
      "notes": "",
      "amount": 826
    },
    {
      "id": 1217,
      "name": "margetuximab",
      "appliances": "",
      "notes": "",
      "amount": 504
    },
    {
      "id": 1218,
      "name": "valbenazine",
      "appliances": "",
      "notes": "",
      "amount": 737
    },
    {
      "id": 1219,
      "name": "tipiracil",
      "appliances": "",
      "notes": "",
      "amount": 186
    },
    {
      "id": 1220,
      "name": "trifluridine",
      "appliances": "",
      "notes": "",
      "amount": 989
    },
    {
      "id": 1221,
      "name": "ozanimod",
      "appliances": "Ozanimod is metabolized to <Ligand id=9889/>, a compound which retains an activity profile indistinguishable from its parent <Reference id=34722/>.",
      "notes": "",
      "amount": 692
    },
    {
      "id": 1222,
      "name": "pexidartinib",
      "appliances": "The associated patent provides a blanket IC<sub>50</sub> value for all exemplary compounds inhibiting either KIT or CSF1R with an inhibitory value of &lt;1&micro;M <Reference id=29384/>.",
      "notes": "",
      "amount": 924
    },
    {
      "id": 1223,
      "name": "brolucizumab",
      "appliances": "Given the research code assigned, it is likely that brolucizumab is the derivative designated 578minmaxT84N_V89L (protein1008) in patent US8349322 B2 <Reference id=29388/>. Data for 578min_max (protein1008) is provided in the interaction table below.",
      "notes": "",
      "amount": 254
    },
    {
      "id": 1224,
      "name": "evinacumab",
      "appliances": "The affinity value in the table below represents antibody binding to full length human ANGPTL3. The corresponding Kd value for binding to the N-terminal coiled-coil domain of ANGPTL3 is reported as 0.66nM <Reference id=29392/>.",
      "notes": "",
      "amount": 277
    },
    {
      "id": 1225,
      "name": "isatuximab",
      "appliances": "The affinity values in the table below represents the K<sub>d</sub>s provided in US20110262454 A1 <Reference id=29401/> for a range of tested CD38-binding antibodies. The K<sub>d</sub> for  hu38SB19 is 0.23 nM <Reference id=29401/>.",
      "notes": "",
      "amount": 628
    },
    {
      "id": 1226,
      "name": "nemolizumab",
      "appliances": "",
      "notes": "",
      "amount": 353
    },
    {
      "id": 1227,
      "name": "ajmalicine",
      "appliances": "",
      "notes": "",
      "amount": 727
    },
    {
      "id": 1228,
      "name": "tolfenamic acid",
      "appliances": "",
      "notes": "",
      "amount": 273
    },
    {
      "id": 1229,
      "name": "enoxacin",
      "appliances": "",
      "notes": "",
      "amount": 679
    },
    {
      "id": 1230,
      "name": "larotrectinib",
      "appliances": "",
      "notes": "",
      "amount": 887
    },
    {
      "id": 1231,
      "name": "ublituximab",
      "appliances": "Ublituximab (LFB-R603) mediates 100 times greater antibody-dependent cell-mediated cytotoxicity by natural killer cells from CLL patients and healthy donors than <Ligand id=6780/> <Reference id=30187/>.",
      "notes": "",
      "amount": 516
    },
    {
      "id": 1232,
      "name": "risankizumab",
      "appliances": "",
      "notes": "",
      "amount": 794
    },
    {
      "id": 1233,
      "name": "pitolisant",
      "appliances": "",
      "notes": "",
      "amount": 283
    },
    {
      "id": 1234,
      "name": "tezepelumab",
      "appliances": "",
      "notes": "",
      "amount": 738
    },
    {
      "id": 1235,
      "name": "galcanezumab",
      "appliances": "A Fab fragment of the antibody binds human &alpha;CGRP with a K<sub>d</sub> of 2.09nM and the &beta; isoform with a K<sub>d</sub> of 1.22nM <Reference id=30392/>.",
      "notes": "",
      "amount": 503
    },
    {
      "id": 1236,
      "name": "neostigmine",
      "appliances": "",
      "notes": "",
      "amount": 388
    },
    {
      "id": 1237,
      "name": "pyridostigmine",
      "appliances": "",
      "notes": "",
      "amount": 828
    },
    {
      "id": 1238,
      "name": "mebeverine",
      "appliances": "We have been unable to find peer reviewed affinity data to corroborate this drug's molecular mechanism of action.",
      "notes": "",
      "amount": 722
    },
    {
      "id": 1239,
      "name": "acenocoumarol",
      "appliances": "",
      "notes": "",
      "amount": 334
    },
    {
      "id": 1240,
      "name": "mometasone",
      "appliances": "",
      "notes": "",
      "amount": 178
    },
    {
      "id": 1241,
      "name": "erdafitinib",
      "appliances": "",
      "notes": "",
      "amount": 517
    },
    {
      "id": 1242,
      "name": "brivaracetam",
      "appliances": "",
      "notes": "",
      "amount": 768
    },
    {
      "id": 1243,
      "name": "apalutamide",
      "appliances": "",
      "notes": "",
      "amount": 206
    },
    {
      "id": 1244,
      "name": "difelikefalin",
      "appliances": "Difelikefalin is &gt;1000-fold selective for the &kappa; receptor compared to the &mu; receptor <Reference id=30644/>.",
      "notes": "",
      "amount": 667
    },
    {
      "id": 1245,
      "name": "enoximone",
      "appliances": "",
      "notes": "",
      "amount": 595
    },
    {
      "id": 1246,
      "name": "celiprolol",
      "appliances": "We have been unable to find peer reviewed affinity data for the interaction of celiprolol at &beta; adrenoceptors, so have not tagged a primary molecular target for this drug.",
      "notes": "",
      "amount": 166
    },
    {
      "id": 1247,
      "name": "vosoritide",
      "appliances": "Due to its extended half-life vosoritide is suitable for once-daily administration.<br>Vosoritide has an EC<sub>50</sub> for cGMP accumulation of 4.9nM <i>vs</i>. the NPR-B receptor endogenously expressed in mouse NIH3T3 fibroblasts <Reference id=30715/>.",
      "notes": "",
      "amount": 210
    },
    {
      "id": 1248,
      "name": "plecanatide",
      "appliances": "We been uable to find affinity data for the interaction of plecanatide with GC-C in peer reviewed literature or the originating patent <Reference id=30718/>.",
      "notes": "",
      "amount": 342
    },
    {
      "id": 1249,
      "name": "nabilone",
      "appliances": "Nabilone is in effect non-selective, exhibiting less than 2-fold selectivity for CB<sub>1</sub> over CB<sub>2</sub> <Reference id=30723/>.",
      "notes": "",
      "amount": 944
    },
    {
      "id": 1250,
      "name": "cinnarizine",
      "appliances": "",
      "notes": "",
      "amount": 588
    },
    {
      "id": 1251,
      "name": "edrophonium",
      "appliances": "",
      "notes": "",
      "amount": 153
    },
    {
      "id": 1252,
      "name": "echothiophate",
      "appliances": "",
      "notes": "",
      "amount": 285
    },
    {
      "id": 1253,
      "name": "dacarbazine",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 137
    },
    {
      "id": 1254,
      "name": "estramustine",
      "appliances": "Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.",
      "notes": "",
      "amount": 118
    },
    {
      "id": 1255,
      "name": "dipipanone",
      "appliances": "",
      "notes": "",
      "amount": 667
    },
    {
      "id": 1256,
      "name": "meptazinol",
      "appliances": "",
      "notes": "",
      "amount": 365
    },
    {
      "id": 1257,
      "name": "pholcodine",
      "appliances": "",
      "notes": "",
      "amount": 765
    },
    {
      "id": 1258,
      "name": "defibrotide",
      "appliances": "Defibrotide's anticoagulant action is much milder compared to the action of heparin and warfarin.  It has a pleiotropic mechanisms of action with possibly  multiple molecular targets  so  we have no affinity values <Reference id=31964/> .",
      "notes": "",
      "amount": 106
    },
    {
      "id": 1259,
      "name": "clobetasone",
      "appliances": "",
      "notes": "",
      "amount": 229
    },
    {
      "id": 1260,
      "name": "satralizumab",
      "appliances": "",
      "notes": "",
      "amount": 722
    },
    {
      "id": 1261,
      "name": "lumateperone",
      "appliances": "",
      "notes": "",
      "amount": 961
    },
    {
      "id": 1262,
      "name": "megestrol",
      "appliances": "The only bioactivity data available appears to be DRUGMATRIX radioligand binding (on ChEMBL) for megestrol acetate <i>vs.</i> the bovine progesterone receptor, which gives an IC<sub>50</sub> of 11nM.",
      "notes": "",
      "amount": 340
    },
    {
      "id": 1263,
      "name": "naldemedine",
      "appliances": "In <i>in vivo</i> models, naldemedine antagonises both the emetic effect and constipation effect at 0.03 mg/kg (po) <Reference id=37556/>.",
      "notes": "",
      "amount": 240
    },
    {
      "id": 1264,
      "name": "crisaborole",
      "appliances": "Inhibits partially purified human PDE4 with an IC50 of 490nM, and inhibits cytokine release <i>in vitro</i> and <i>in vivo</i> <Reference id=30942/>.",
      "notes": "",
      "amount": 857
    },
    {
      "id": 1265,
      "name": "esketamine",
      "appliances": "Displacement assay results for several species reported but nothing specifically for binding to human NMDA nor its subunits.",
      "notes": "",
      "amount": 896
    },
    {
      "id": 1266,
      "name": "olaratumab",
      "appliances": "Patent US8128929 reports preclinical experimental results of the <i>in vitro</i> and <i>in vivo</i> effects of olaratumab <Reference id=30985/>.",
      "notes": "",
      "amount": 212
    },
    {
      "id": 1267,
      "name": "fremanezumab",
      "appliances": "A single injection of TEV-48125 produces a durable anti-vasodilatory effect in animal models in proof-of-concept testing <Reference id=31055/>.",
      "notes": "",
      "amount": 596
    },
    {
      "id": 1268,
      "name": "benperidol",
      "appliances": "",
      "notes": "",
      "amount": 354
    },
    {
      "id": 1269,
      "name": "periciazine",
      "appliances": "We have been unable to source peer-reveiwed data to map a primary molecular target for this drug.",
      "notes": "",
      "amount": 677
    },
    {
      "id": 1270,
      "name": "ivosidenib",
      "appliances": "Ivosidenib inhibits both R132H and R132C IDH1 mutants with IC50s &lt; 100nM <Reference id=31205/>.",
      "notes": "",
      "amount": 320
    },
    {
      "id": 1271,
      "name": "upadacitinib",
      "appliances": "In a kinase screening panel, only two other kinases, Rock1 and Rock2 have IC<sub>50</sub>s below 1000nM <Reference id=31310/>.",
      "notes": "",
      "amount": 355
    },
    {
      "id": 1272,
      "name": "tirabrutinib",
      "appliances": "The inhibitory IC<sub>50</sub> presented here relates to the compound without specified stereochemistry as presented in patent WO2011152351 <Reference id=31370/>. WO2011152351 claims example 8 (14) is selective for BTK over Lck, Fyn and Lyn.",
      "notes": "",
      "amount": 481
    },
    {
      "id": 1273,
      "name": "setmelanotide",
      "appliances": "EC<sub>50</sub> values for cAMP production <i>in vitro</i> <i>vs</i>. human melanocortin receptors are MC4R (0.27mM), MC3R (5.3nM), MC1R (5.8nM), and rat MC4R (0.28nM) <Reference id=31400/>.",
      "notes": "",
      "amount": 200
    },
    {
      "id": 1274,
      "name": "abiraterone acetate",
      "appliances": "",
      "notes": "",
      "amount": 645
    },
    {
      "id": 1275,
      "name": "siponimod",
      "appliances": "Siponimod (BAF312) inhibits hERG by less than 10% at 25&mu;M <Reference id=31524/>. Screening against a panel of receptors, ion channels, transporters, and kinases suggests little potential for off-target effects.",
      "notes": "",
      "amount": 458
    },
    {
      "id": 1276,
      "name": "emapalumab",
      "appliances": "IFN&gamma; binding and neutralisation by NI-0501 and results of biological function studies are provided in patent WO2006109191 <Reference id=31553/>.",
      "notes": "",
      "amount": 149
    },
    {
      "id": 1277,
      "name": "lemborexant",
      "appliances": "Lemborexant (E2006) is equipotent at the OX<sub>1</sub> and OX<sub>2</sub> receptors <Reference id=31585/>.",
      "notes": "",
      "amount": 994
    },
    {
      "id": 1278,
      "name": "ponesimod",
      "appliances": "Ponesimod (ACT-128800) is nominally selective for S1P<sub>1</sub> and S1P<sub>5</sub> receptors compared to other S1P family receptor subtypes <Reference id=31714/>.",
      "notes": "",
      "amount": 385
    },
    {
      "id": 1279,
      "name": "ipragliflozin",
      "appliances": "",
      "notes": "",
      "amount": 662
    },
    {
      "id": 1280,
      "name": "tofogliflozin",
      "appliances": "Tofogliflozin enhances renal glucose excretion and lowers blood glucose in diabetic db/db mice <Reference id=31851/>, consistent with efficacy as an agent providing glucose control in type 2 diabetes.",
      "notes": "",
      "amount": 806
    },
    {
      "id": 1281,
      "name": "bimekizumab",
      "appliances": "Binds to human recombinant IL-17A/F heterodimer with a Kd of 0.116nM, and monkey (cynomolgus) IL-17F with Kd of ~1nM <Reference id=31888/>.",
      "notes": "",
      "amount": 863
    },
    {
      "id": 1282,
      "name": "esflurbiprofen",
      "appliances": "Esflurbiprofen ((S)-flurbiprofen) inhibits prostaglandin biosynthesis <i>in vitro</i> at therapeutic concentrations <Reference id=31934/>. COX-1 is inhibited with an IC50 of ~30nM and COX-2 with an IC50 of ~900nM <Reference id=31934/>.",
      "notes": "",
      "amount": 537
    },
    {
      "id": 1283,
      "name": "itolizumab",
      "appliances": "",
      "notes": "",
      "amount": 898
    },
    {
      "id": 1284,
      "name": "leniolisib",
      "appliances": "Data are presented for Example 67 in patent WO2012004299 <Reference id=31951/>.",
      "notes": "",
      "amount": 296
    },
    {
      "id": 1285,
      "name": "avacopan",
      "appliances": "",
      "notes": "",
      "amount": 175
    },
    {
      "id": 1286,
      "name": "deflazacort",
      "appliances": "<i>In vitro</i> binding to rat kidney, thymus and liver glucocorticoid receptors is reported in <Reference id=32434/>.",
      "notes": "",
      "amount": 546
    },
    {
      "id": 1287,
      "name": "adomeglivant",
      "appliances": "",
      "notes": "",
      "amount": 438
    },
    {
      "id": 1288,
      "name": "L-cycloserine",
      "appliances": "",
      "notes": "",
      "amount": 559
    },
    {
      "id": 1289,
      "name": "D-cycloserine",
      "appliances": "",
      "notes": "",
      "amount": 443
    },
    {
      "id": 1290,
      "name": "telotristat ethyl",
      "appliances": "",
      "notes": "",
      "amount": 732
    },
    {
      "id": 1291,
      "name": "SNP",
      "appliances": "",
      "notes": "",
      "amount": 234
    },
    {
      "id": 1292,
      "name": "relatlimab",
      "appliances": "",
      "notes": "",
      "amount": 500
    },
    {
      "id": 1293,
      "name": "gefapixant",
      "appliances": "",
      "notes": "",
      "amount": 179
    },
    {
      "id": 1294,
      "name": "belumosudil",
      "appliances": "",
      "notes": "",
      "amount": 726
    },
    {
      "id": 1295,
      "name": "tislelizumab",
      "appliances": "",
      "notes": "",
      "amount": 891
    },
    {
      "id": 1296,
      "name": "betrixaban",
      "appliances": "Betrixaban has limited hERG liability (K<sub>i</sub> 1.8 &mu;M) <Reference id=33261/>.",
      "notes": "",
      "amount": 589
    },
    {
      "id": 1297,
      "name": "clodronic acid",
      "appliances": "",
      "notes": "",
      "amount": 162
    },
    {
      "id": 1298,
      "name": "cevimeline",
      "appliances": "Bioactivity may be associated with the administered form, cevimeline hydrochloride, and with enantiomers with specified stereochemistry.",
      "notes": "",
      "amount": 378
    },
    {
      "id": 1299,
      "name": "proguanil",
      "appliances": "",
      "notes": "",
      "amount": 879
    },
    {
      "id": 1300,
      "name": "tapinarof",
      "appliances": "Tapinarof inhibits proinflammatory cytokine expression <i>in vitro</i> and exhibits anti-inflammatory effects <i>in vivo</i> <Reference id=33691/>.",
      "notes": "",
      "amount": 343
    },
    {
      "id": 1301,
      "name": "tibolone",
      "appliances": "",
      "notes": "",
      "amount": 670
    },
    {
      "id": 1302,
      "name": "atogepant",
      "appliances": "",
      "notes": "",
      "amount": 285
    },
    {
      "id": 1303,
      "name": "emicizumab",
      "appliances": "Binds activated factor IX (IXa) with an affinity constant (K<sub>D</sub>) of 1.52 &mu;M, and activated factor X (Xa) with a K<sub>D</sub> of 0.98 &mu;M <Reference id=33974/>.",
      "notes": "",
      "amount": 535
    },
    {
      "id": 1304,
      "name": "macimorelin",
      "appliances": "In human subjects macimorelin stimulates rapid GH release after <i>i.v.</i> injection.<Reference id=33980/>. The acetate salt is orally active.",
      "notes": "",
      "amount": 467
    },
    {
      "id": 1305,
      "name": "camrelizumab",
      "appliances": "",
      "notes": "",
      "amount": 138
    },
    {
      "id": 1306,
      "name": "pemigatinib",
      "appliances": "",
      "notes": "",
      "amount": 395
    },
    {
      "id": 1307,
      "name": "surufatinib",
      "appliances": "This compound inhbits the hERG channel with an IC<sub>50</sub>of 6.8 &mu;M <Reference id=34087/>.",
      "notes": "",
      "amount": 162
    },
    {
      "id": 1308,
      "name": "difamilast",
      "appliances": "OPA-15406 exhibits high selectivity for the PDE4B isoform <Reference id=34113/>.",
      "notes": "",
      "amount": 207
    },
    {
      "id": 1309,
      "name": "efgartigimod alfa",
      "appliances": "",
      "notes": "",
      "amount": 651
    },
    {
      "id": 1310,
      "name": "pecazine",
      "appliances": "",
      "notes": "",
      "amount": 696
    },
    {
      "id": 1311,
      "name": "futibatinib",
      "appliances": "TAS-120 inhibits proliferation of FGFR overexpressing human gastric cancer OCUM-2MD3 cells with a GI<sub>50</sub> of &lt;4.6nM <Reference id=34165/>.",
      "notes": "",
      "amount": 249
    },
    {
      "id": 1312,
      "name": "rozanolixizumab",
      "appliances": "",
      "notes": "",
      "amount": 249
    },
    {
      "id": 1313,
      "name": "levosalbutamol",
      "appliances": "Note that clinically administered formulations can contain the tartrate, sulphate or hydrochloride salts of levosalbutamol.",
      "notes": "",
      "amount": 671
    },
    {
      "id": 1314,
      "name": "zanubrutinib",
      "appliances": "In a cellular assay, zanubrutinib inhibits BTK with an IC<sub>50</sub> of 20nM <Reference id=34572/>.",
      "notes": "",
      "amount": 182
    },
    {
      "id": 1315,
      "name": "ozagrel",
      "appliances": "",
      "notes": "",
      "amount": 872
    },
    {
      "id": 1316,
      "name": "lofexidine",
      "appliances": "",
      "notes": "",
      "amount": 276
    },
    {
      "id": 1317,
      "name": "esaxerenone",
      "appliances": "",
      "notes": "",
      "amount": 168
    },
    {
      "id": 1318,
      "name": "teneligliptin",
      "appliances": "",
      "notes": "",
      "amount": 916
    },
    {
      "id": 1319,
      "name": "primaquine",
      "appliances": "",
      "notes": "",
      "amount": 469
    },
    {
      "id": 1320,
      "name": "artemether",
      "appliances": "The interaction table below provides data from an evaluation of the antimalarial (asexual blood stage) activity of artemether, using a panel of <i>P. falciparum</i> strains.",
      "notes": "",
      "amount": 708
    },
    {
      "id": 1321,
      "name": "artesunate",
      "appliances": "The interaction table below provides data from an evaluation of the antimalarial (asexual blood stage) activity of artesunate, using a panel of<i> P. falciparum</i> strains.",
      "notes": "",
      "amount": 563
    },
    {
      "id": 1322,
      "name": "artenimol",
      "appliances": "The interaction table below provides data from an evaluation of the antimalarial (asexual blood stage) activity of artenimol, using a panel of <i>P. falciparum</i> strains.",
      "notes": "",
      "amount": 500
    },
    {
      "id": 1323,
      "name": "trifarotene",
      "appliances": "The high metabolic instability of trifarotene (CD5789) suggests that it will exhibit limited systemic exposure when used as a topical agent.",
      "notes": "",
      "amount": 408
    },
    {
      "id": 1324,
      "name": "lumefantrine",
      "appliances": "The interaction table below provides data from an evaluation of the antimalarial (asexual blood stage) activity of lumefantrine, using a panel of <i>P. falciparum</i> strains.",
      "notes": "",
      "amount": 272
    },
    {
      "id": 1325,
      "name": "abrocitinib",
      "appliances": "",
      "notes": "",
      "amount": 861
    },
    {
      "id": 1326,
      "name": "elobixibat",
      "appliances": "",
      "notes": "",
      "amount": 911
    },
    {
      "id": 1327,
      "name": "vericiguat",
      "appliances": "",
      "notes": "",
      "amount": 313
    },
    {
      "id": 1328,
      "name": "piperaquine",
      "appliances": "The interaction table below provides data from an evaluation of the antimalarial (asexual blood stage) activity of piperaquine, using a panel of <i>P. falciparum</i> strains.",
      "notes": "",
      "amount": 855
    },
    {
      "id": 1329,
      "name": "selinexor",
      "appliances": "The inhibitory activity of selinexor on XPO1 has principally been determined by assessing inhibition of nucleus &gt; cytoplasm export of XPO1 cargo proteins. We have been unable to find a value for the binding affinity of selinexor to XPO1.",
      "notes": "",
      "amount": 206
    },
    {
      "id": 1330,
      "name": "aprocitentan",
      "appliances": "",
      "notes": "",
      "amount": 747
    },
    {
      "id": 1331,
      "name": "cemiplimab",
      "appliances": "Cemiplimab does not bind mouse PD-1 <i>in vitro</i> or <i>in vivo</i>, or rat PD-1 <i>in vitro</i> <Reference id=36190/>. The antibody blocks human PD-1/PD-L1 interaction with an IC<sub>50</sub> &lt;1nM in an ELISA <Reference id=36190/>.",
      "notes": "",
      "amount": 907
    },
    {
      "id": 1332,
      "name": "vibegron",
      "appliances": "Vibegron is inactive at the &beta;<sub>1</sub> and &beta;<sub>2</sub> adrenoceptors <Reference id=36239/>. It does not inhbit the hERG channel or the drug-metabolising CYP450 isozymes 2C9, 2D6 and 3A4.",
      "notes": "",
      "amount": 284
    },
    {
      "id": 1333,
      "name": "dimetindene",
      "appliances": "Note that some bioactivity data may map to the active (<i>S</i>)-enantiomer (<Ligand id=10104/>), or to the maleate salt.",
      "notes": "",
      "amount": 172
    },
    {
      "id": 1334,
      "name": "mizolastine",
      "appliances": "",
      "notes": "",
      "amount": 176
    },
    {
      "id": 1335,
      "name": "rupatadine",
      "appliances": "Rupatadine competitively inhibits PAF-induced platelet aggregation in human platelet-rich plasma with an IC<sub>50</sub> of 680 nM <Reference id=36247/>.",
      "notes": "",
      "amount": 909
    },
    {
      "id": 1336,
      "name": "revefenacin",
      "appliances": "<i>In vivo</i>, revefenacin (TD-4208) exhibits low systemic exposure, and is highly lung-selective in its action <Reference id=36351/>.",
      "notes": "",
      "amount": 706
    },
    {
      "id": 1337,
      "name": "benidipine",
      "appliances": "",
      "notes": "",
      "amount": 279
    },
    {
      "id": 1338,
      "name": "ravulizumab",
      "appliances": "",
      "notes": "",
      "amount": 471
    },
    {
      "id": 1339,
      "name": "sulfadoxine",
      "appliances": "",
      "notes": "",
      "amount": 424
    },
    {
      "id": 1340,
      "name": "ubrogepant",
      "appliances": "",
      "notes": "",
      "amount": 583
    },
    {
      "id": 1341,
      "name": "tezacaftor",
      "appliances": "",
      "notes": "",
      "amount": 291
    },
    {
      "id": 1342,
      "name": "migalastat",
      "appliances": "",
      "notes": "",
      "amount": 200
    },
    {
      "id": 1343,
      "name": "ibalizumab",
      "appliances": "Burkly <i>et al.</i>'s original analysis of ibalizumab (therein named 5A8) binding to CD4 expressed on CHO cells gives an EC<sub>50</sub> of ~1&mu;g/ml <Reference id=36815/>.",
      "notes": "",
      "amount": 614
    },
    {
      "id": 1344,
      "name": "troleandomycin",
      "appliances": "",
      "notes": "",
      "amount": 152
    },
    {
      "id": 1345,
      "name": "omidenepag",
      "appliances": "Topically administered omidenepag reduces intraocular pressure in rodent models <Reference id=37378/>. In these experiments the drug was applied as omidenepag isopropyl which is hydrolysed to omidenepag, which is the EP<sub>2</sub> agonist.",
      "notes": "",
      "amount": 819
    },
    {
      "id": 1346,
      "name": "olutasidenib",
      "appliances": "",
      "notes": "",
      "amount": 482
    },
    {
      "id": 1350,
      "name": "avapritinib",
      "appliances": "BLU-285 is more potent at mutant KIT and PDGFRA proteins than at their wild type counterparts: IC<sub>50</sub>s for KITdel557-558, KIT<sup>D816V</sup> and PDGFRA<sup>D842V</sup> are 0.6, 0.27 and 0.24 nM respectively <Reference id=37673/>.",
      "notes": "",
      "amount": 720
    },
    {
      "id": 1351,
      "name": "stanozolol",
      "appliances": "",
      "notes": "",
      "amount": 895
    },
    {
      "id": 1352,
      "name": "zilucoplan",
      "appliances": "",
      "notes": "",
      "amount": 395
    },
    {
      "id": 1353,
      "name": "bremelanotide",
      "appliances": "",
      "notes": "",
      "amount": 617
    },
    {
      "id": 1354,
      "name": "ripasudil",
      "appliances": "",
      "notes": "",
      "amount": 929
    },
    {
      "id": 1355,
      "name": "mobocertinib",
      "appliances": "",
      "notes": "",
      "amount": 751
    },
    {
      "id": 1356,
      "name": "mepenzolic acid",
      "appliances": "",
      "notes": "",
      "amount": 634
    },
    {
      "id": 1357,
      "name": "mitapivat",
      "appliances": "",
      "notes": "",
      "amount": 188
    },
    {
      "id": 1358,
      "name": "envafolimab",
      "appliances": "KN035 does not bind to human PD-L2 or to mouse PD-L1 <i>in vitro</i> <Reference id=38284/>.",
      "notes": "",
      "amount": 603
    },
    {
      "id": 1359,
      "name": "amivantamab",
      "appliances": "",
      "notes": "",
      "amount": 453
    },
    {
      "id": 1360,
      "name": "carotegrast methyl",
      "appliances": "Carotegrast methyl (AJM300) has limited pharmacological action prior to hydrolytic activation in the liver. The active metabolite is <Ligand id=10511/> (HCA2969).",
      "notes": "",
      "amount": 990
    },
    {
      "id": 1361,
      "name": "ilaprazole",
      "appliances": "Ilaprazole inhibits parietal cell secretion of H<sup>+</sup> ions (<i>i.e.</i> gastric acid) more potently than <Ligand id=4279/> <Reference id=38354/>.",
      "notes": "",
      "amount": 911
    },
    {
      "id": 1362,
      "name": "diroximel fumarate",
      "appliances": "As this compound is a prodrug it may have little or no measurable bioactivity at the molecular target of its active counterpart. Therefore, we have not tagged a primary drug target.",
      "notes": "",
      "amount": 160
    },
    {
      "id": 1363,
      "name": "crizanlizumab",
      "appliances": "",
      "notes": "",
      "amount": 230
    },
    {
      "id": 1364,
      "name": "elexacaftor",
      "appliances": "Elevation of CFTR protein on the surface of patient-derived bronchial epithelial cells (with either the F508del-MF genotype, or the F508del-F508del genotype) in the presence of elexacaftor was determined using immuno-staining <Reference id=38476/>.",
      "notes": "",
      "amount": 729
    },
    {
      "id": 1365,
      "name": "teprotumumab",
      "appliances": "",
      "notes": "",
      "amount": 846
    },
    {
      "id": 1366,
      "name": "samidorphan",
      "appliances": "",
      "notes": "",
      "amount": 296
    },
    {
      "id": 1367,
      "name": "sotorasib",
      "appliances": "AMG510-mediated disruption of KRAS<sup>G12C</sup> signalling inhibits downstream ERK1/2 phosphorylation in a cell-based assay with an IC<sub>50</sub> of 68 nM <Reference id=38817/>.",
      "notes": "",
      "amount": 492
    },
    {
      "id": 1368,
      "name": "motixafortide",
      "appliances": "Motixafortide potently inhibits the entry of T cell line-tropic strains of HIV-1 into T cells <Reference id=38819/>, and it exhibits CXCR4-dependent cytotoxicity towards malignant hematopoietic cells (AML and MM cells and xenografts) <Reference id=38818/>.",
      "notes": "",
      "amount": 649
    },
    {
      "id": 1369,
      "name": "lurbinectedin",
      "appliances": "In a DNA melting assay, the ligand concentration that produced half the maximal change in melting temperature (C<sub>50</sub>) of synthetic oligodeoxynucleotides was ~6.7 &mu;M <Reference id=38826/>.",
      "notes": "",
      "amount": 451
    },
    {
      "id": 1370,
      "name": "iptacopan",
      "appliances": "In blood samples derived from patients with PNH, LNP023 prevents complement-mediated erythrocyte lysis with an IC<sub>50</sub> value of 0.4 &mu;M <Reference id=38917/>.",
      "notes": "",
      "amount": 941
    },
    {
      "id": 1371,
      "name": "enfortumab vedotin",
      "appliances": "",
      "notes": "",
      "amount": 182
    },
    {
      "id": 1372,
      "name": "avibactam",
      "appliances": "Avibactam inhibits TEM-1 beta-lactamase <i>in vitro</i> with an K<sub>i</sub> of 260 nM <Reference id=39143/>.",
      "notes": "",
      "amount": 146
    },
    {
      "id": 1373,
      "name": "ceftazidime",
      "appliances": "Ceftazidime has broad-spectrum activity against both Gram-positive bacteria and Gram-negative bacteria, including <i>Pseudomonas aeruginosa</i> (MIC<sub>90</sub> of 2 &mu;g/ml) <Reference id=44136/>.",
      "notes": "",
      "amount": 583
    },
    {
      "id": 1374,
      "name": "aztreonam",
      "appliances": "Aztreonam is specifically active against aerobic gram-negative bacilli.",
      "notes": "",
      "amount": 665
    },
    {
      "id": 1375,
      "name": "carbenicillin",
      "appliances": "",
      "notes": "",
      "amount": 244
    },
    {
      "id": 1376,
      "name": "sulbactam",
      "appliances": "",
      "notes": "",
      "amount": 720
    },
    {
      "id": 1377,
      "name": "cefepime",
      "appliances": "",
      "notes": "",
      "amount": 701
    },
    {
      "id": 1378,
      "name": "cenobamate",
      "appliances": "Cenobamate inhibits the persistent component of the Na<sup>+</sup> current (I<sub>NaP</sub>) with an IC<sub>50</sub>  value of  53100 nM, in mechanically isolated rat hippocamal neurons in patch-clamp experiments <Reference id=39160/>.",
      "notes": "",
      "amount": 840
    },
    {
      "id": 1379,
      "name": "cefiderocol",
      "appliances": "<i>In vitro</i>, the most potent antimicrobial activity was against KPC-2 producing <i>Klebsiella pneumoniae</i> (ATCC BAA-1705) <Reference id=39166/>. The MIC for this strain was 0.063 &mu;g/ml.",
      "notes": "",
      "amount": 865
    },
    {
      "id": 1380,
      "name": "cefpodoxime",
      "appliances": "MIC<sub>50</sub> against penicillin-susceptible <i>Streptococcus pneumoniae</i> is 0.03 &mu;g/ml <Reference id=39176/>.",
      "notes": "",
      "amount": 712
    },
    {
      "id": 1381,
      "name": "ceftobiprole",
      "appliances": "",
      "notes": "",
      "amount": 875
    },
    {
      "id": 1382,
      "name": "ceftolozane",
      "appliances": "",
      "notes": "",
      "amount": 982
    },
    {
      "id": 1383,
      "name": "colistin",
      "appliances": "",
      "notes": "",
      "amount": 608
    },
    {
      "id": 1384,
      "name": "contezolid",
      "appliances": "",
      "notes": "",
      "amount": 792
    },
    {
      "id": 1385,
      "name": "dalfopristin",
      "appliances": "",
      "notes": "",
      "amount": 381
    },
    {
      "id": 1386,
      "name": "quinupristin",
      "appliances": "The MIC for antibacterial activity against  <i>Staphylococcus aureus</i> RN4220 is 4 &mu;g/ml <Reference id=39212/>.",
      "notes": "",
      "amount": 607
    },
    {
      "id": 1387,
      "name": "delafloxacin",
      "appliances": "",
      "notes": "",
      "amount": 378
    },
    {
      "id": 1388,
      "name": "diacerein",
      "appliances": "",
      "notes": "",
      "amount": 358
    },
    {
      "id": 1389,
      "name": "eravacycline",
      "appliances": "The MIC value for antibacterial activity against tetracycline-resistant <i>Enterococcus faecalis</i> 159 is 15.6 ng/ml <Reference id=39221/>.",
      "notes": "",
      "amount": 212
    },
    {
      "id": 1390,
      "name": "fosfomycin",
      "appliances": "",
      "notes": "",
      "amount": 786
    },
    {
      "id": 1391,
      "name": "fusidic acid",
      "appliances": "",
      "notes": "",
      "amount": 508
    },
    {
      "id": 1392,
      "name": "gatifloxacin",
      "appliances": "",
      "notes": "",
      "amount": 543
    },
    {
      "id": 1393,
      "name": "grepafloxacin",
      "appliances": "",
      "notes": "",
      "amount": 648
    },
    {
      "id": 1394,
      "name": "imipenem",
      "appliances": "The MIC for antibacterial activity against vancomycin-susceptible <i>Staphylococcus aureus</i> Mu50omega is 0.38 ng/ml <Reference id=39188/>, and for against drug-resistant <i>Streptococcus pneumoniae</i> (isolate 1635) it is 2 ng/ml <Reference id=39260/>.",
      "notes": "",
      "amount": 410
    },
    {
      "id": 1395,
      "name": "lefamulin",
      "appliances": "The MIC for antibacterial activity against methicillin-sensitive <i>Staphylococcus aureus</i> ATCC 19636 is 31 ng/ml <Reference id=39267/>.",
      "notes": "",
      "amount": 308
    },
    {
      "id": 1396,
      "name": "linezolid",
      "appliances": "",
      "notes": "",
      "amount": 886
    },
    {
      "id": 1397,
      "name": "meropenem",
      "appliances": "The MIC for antibacterial activity against <i>Haemophilus influenzae</i>, <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i> is 0.06 ng/ml <Reference id=39277/>.",
      "notes": "",
      "amount": 265
    },
    {
      "id": 1398,
      "name": "nemonoxacin",
      "appliances": "<i>In vitro</i> antibacterial activity against various pathogens was reported by Lauderdale <i>et al.</i> in 2010 <Reference id=39295/>.",
      "notes": "",
      "amount": 497
    },
    {
      "id": 1399,
      "name": "omadacycline",
      "appliances": "<i>In vitro</i> antibacterial activity against a panel of Gram-positive and Gram-negative bacteria is reported in <Reference id=39301/>.",
      "notes": "",
      "amount": 286
    },
    {
      "id": 1400,
      "name": "oxantel",
      "appliances": "",
      "notes": "",
      "amount": 339
    },
    {
      "id": 1401,
      "name": "ozenoxacin",
      "appliances": "",
      "notes": "",
      "amount": 992
    },
    {
      "id": 1402,
      "name": "plazomicin",
      "appliances": "Plazomicin displays potent <i>in vitro</i> activity against Enterobacteriaceae, including isolates producing aminoglycoside-modifying enzymes and carbapenem-resistant isolates (reviewed in <Reference id=44095/>).",
      "notes": "",
      "amount": 280
    },
    {
      "id": 1403,
      "name": "relebactam",
      "appliances": "Relebactam inhibits &beta;-lactamase KPC-2 in <i>Klebsiella pneumoniae</i> (measuring hydrolysis of nitrocefin in vitro) with an IC<sub>50</sub> of 210 nM <Reference id=39320/>.",
      "notes": "",
      "amount": 640
    },
    {
      "id": 1404,
      "name": "sarafloxacin",
      "appliances": "Sarafloxacin inhibited 90% of <i>Enterobacteriaceae</i> at &le;1 &mu;g/ml, <i>Staphylococcus aureus</i> 0.25 &mu;g/ml, hemolytic streptococci 2 &mu;g/ml, and <i>Pseudomonas aeruginosa</i> 2 &mu;g/ml <Reference id=39338/>.",
      "notes": "",
      "amount": 358
    },
    {
      "id": 1405,
      "name": "sisomicin",
      "appliances": "Anaerobic organisms are not sensitive to sisomicin <Reference id=39339/>.",
      "notes": "",
      "amount": 347
    },
    {
      "id": 1406,
      "name": "sparfloxacin",
      "appliances": "The MIC for sparfloxacin <i>in vitro</i> antimicrobial activity against quinolone-susceptible <i>Bordetella pertussis</i> BP106 is 4 ng/ml <Reference id=39345/>, and against <i>Staphylococcus aureus</i> UC76 it is 13 ng/ml <Reference id=39346/>.",
      "notes": "",
      "amount": 997
    },
    {
      "id": 1407,
      "name": "tebipenem pivoxil",
      "appliances": "",
      "notes": "",
      "amount": 450
    },
    {
      "id": 1408,
      "name": "tedizolid",
      "appliances": "The MIC for antimicrobial activity against vancomycin-nonsusceptible <i>Staphylococcus aureus</i> is 0.12 &mu;g/ml <Reference id=39357/>.",
      "notes": "",
      "amount": 419
    },
    {
      "id": 1409,
      "name": "temafloxacin",
      "appliances": "The MIC for antibacterial activity against <i>Escherichia coli</i> SS is 5 ng/ml <Reference id=39358/>.",
      "notes": "",
      "amount": 966
    },
    {
      "id": 1410,
      "name": "vaborbactam",
      "appliances": "Inhibits <i>Escherichia coli</i> recombinant SHV-12 &beta;-lactamase with a K<sub>i</sub> of 29 nM <i>in vitro</i> <Reference id=39374/>.",
      "notes": "",
      "amount": 973
    },
    {
      "id": 1411,
      "name": "dalbavancin",
      "appliances": "",
      "notes": "",
      "amount": 528
    },
    {
      "id": 1412,
      "name": "oritavancin",
      "appliances": "The MIC for antimicrobial activity against <i>Streptococcus</i> Group F clinical isolates is 0.5 ng/ml <Reference id=39385/>.",
      "notes": "",
      "amount": 627
    },
    {
      "id": 1413,
      "name": "telithromycin",
      "appliances": "Telithromycin has been reported to inhibit growth <i>Plasmodium falciparum in vitro</i> <Reference id=39386/>.",
      "notes": "",
      "amount": 708
    },
    {
      "id": 1414,
      "name": "adagrasib",
      "appliances": "",
      "notes": "",
      "amount": 915
    },
    {
      "id": 1415,
      "name": "aviptadil",
      "appliances": "",
      "notes": "",
      "amount": 529
    },
    {
      "id": 1416,
      "name": "fluticasone furoate",
      "appliances": "Glucocorticoid receptor agonist.",
      "notes": "",
      "amount": 611
    },
    {
      "id": 1417,
      "name": "cefotaxime",
      "appliances": "The MIC<sub>90</sub> <i>vs</i>. beta-lactamase negative and beta-lactamase positive <i>Haemophilus influenzae</i> is 15 ng/ml <i>in vitro</i> <Reference id=39357/>.",
      "notes": "",
      "amount": 815
    },
    {
      "id": 1418,
      "name": "amikacin",
      "appliances": "The MIC<sub>90</sub> for amikacin's antibacterial activity  against non-gentamicin-resistant <i>Escherichia coli</i> clinical isolate is 2 &mu;g/ml <i>in vitro</i> <Reference id=39444/>.",
      "notes": "",
      "amount": 973
    },
    {
      "id": 1419,
      "name": "amoxicillin",
      "appliances": "The MIC<sub>90</sub> for antibacterial activity against clinical Isolates of <i>Streptococcus pyogenes</i> A and <i>S. pneumoniae</i> is 15 ng/ml <i>in vitro</i> <Reference id=39330/>.",
      "notes": "",
      "amount": 241
    },
    {
      "id": 1420,
      "name": "ampicillin",
      "appliances": "The MIC<sub>90</sub> for antimicrobial activity against clinical isolates of <i>Streptococcus pyogenes</i> is &le;15 ng/ml <i>in vitro</i> <Reference id=39445/>.",
      "notes": "",
      "amount": 181
    },
    {
      "id": 1421,
      "name": "cefaclor",
      "appliances": "The MIC90 for antibacterial activity against &beta;-lactamase negative and &beta;-lactamase positive <i>Haemophilus influenzae</i> isolates is 2 &mu;g/ml <Reference id=39446/>.",
      "notes": "",
      "amount": 944
    },
    {
      "id": 1422,
      "name": "cefixime",
      "appliances": "The MIC90 for antibacterial activity against &beta;-lactamase positive, ampicillin resistant <i>Haemophilus influenzae</i> isolate is 60 ng/ml <Reference id=39447/>.",
      "notes": "",
      "amount": 416
    },
    {
      "id": 1423,
      "name": "ceftaroline fosamil",
      "appliances": "MIC90 for antibacterial activity against erythromycin-susceptible <i>Streptococcus pyogenes</i> and <i>Streptococcus pneumoniae</i> serotype 3 is &le;8 ng/ml <i>in vitro</i> <Reference id=39448/><Reference id=39449/>.",
      "notes": "",
      "amount": 864
    },
    {
      "id": 1424,
      "name": "cefuroxime",
      "appliances": "MIC90 for antimicrobial activity against macrolide-resistant <i>Streptococcus sp</i>. 'group A' is 30 ng/ml <Reference id=39451/>.",
      "notes": "",
      "amount": 724
    },
    {
      "id": 1425,
      "name": "chloramphenicol",
      "appliances": "MIC90 for antimicrobial activity against &beta;-lactamase-negative, ampicillin-resistant <i>Haemophilus influenzae</i> is 1 &mu;g/ml <i>in vitro</i> <Reference id=39452/>.",
      "notes": "",
      "amount": 964
    },
    {
      "id": 1426,
      "name": "ciprofloxacin",
      "appliances": "The MIC90 for antibacterial activity against ciprofloxacin-susceptible <i>Haemophilus influenzae</i> is 8 ng/ml <i>in vitro</i> <Reference id=39454/>.",
      "notes": "",
      "amount": 726
    },
    {
      "id": 1427,
      "name": "clarithromycin",
      "appliances": "The MIC90 for antibacterial activity against macrolide-susceptible <i>Streptococcus pneumoniae</i> is 0.06 &mu;g/ml <i>in vitro</i> <Reference id=39455/>.",
      "notes": "",
      "amount": 415
    },
    {
      "id": 1428,
      "name": "daptomycin",
      "appliances": "MIC90 for antibacterial activity against erythromycin-nonsusceptible <i>Streptococcus pyogenes</i> is &le;30 ng/ml <i>in vitro</i> <Reference id=39448/>.",
      "notes": "",
      "amount": 829
    },
    {
      "id": 1429,
      "name": "ertapenem",
      "appliances": "MIC90 for antibacterial activity against carbapenemase-producing <i>Klebsiella pneumoniae</i> is &le;30 ng/ml <i>in vitro</i> <Reference id=39462/>.",
      "notes": "",
      "amount": 572
    },
    {
      "id": 1430,
      "name": "fidaxomicin",
      "appliances": "MIC90 for antibacterial activity against <i>Clostridium difficile</i> ranges from 0.01-0.5 &mu;g/ml <i>in vitro</i> <Reference id=39466/><Reference id=39467/>.",
      "notes": "",
      "amount": 868
    },
    {
      "id": 1431,
      "name": "flucloxacillin",
      "appliances": "We have been unable to identify quantitative data for the antibacterial activity of flucloxacillin.",
      "notes": "",
      "amount": 902
    },
    {
      "id": 1432,
      "name": "levofloxacin",
      "appliances": "MIC90 for antibacterial activity against <i>Pseudomonas aeruginosa</i> strains ranges from 1-128 &mu;g/ml i<i>n vitro</i> <Reference id=39126/><Reference id=39470/><Reference id=39454/>.",
      "notes": "",
      "amount": 601
    },
    {
      "id": 1433,
      "name": "lymecycline",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 537
    },
    {
      "id": 1434,
      "name": "metronidazole",
      "appliances": "Antibacterial activity against anaerobic bacteria is reported in <Reference id=39474/>.",
      "notes": "",
      "amount": 689
    },
    {
      "id": 1435,
      "name": "moxifloxacin",
      "appliances": "MIC90 for antibacterial activity against ciprofloxacin and methicillin resistant <i>Staphylococcus aureus</i> is 4 &mu;g/ml <i>in vitro</i> <Reference id=39295/>.",
      "notes": "",
      "amount": 361
    },
    {
      "id": 1436,
      "name": "mupirocin",
      "appliances": "MIC90 for antimicrobial activity against methicillin-resistant <i>Staphylococcus aureus</i> is approximately 3 &mu;g/ml <i>in vitro</i> <Reference id=39475/>.",
      "notes": "",
      "amount": 159
    },
    {
      "id": 1437,
      "name": "ofloxacin",
      "appliances": "MIC for antibacterial activity against <i>Klebsiella pneumoniae</i> is 0.05 &mu;g/ml <i>in vitro</i> <Reference id=39477/>.",
      "notes": "",
      "amount": 222
    },
    {
      "id": 1438,
      "name": "oxytetracycline",
      "appliances": "MIC for antibacterial activity against multidrug-resistant <i>Proteus vulgaris</i> MTCC 1771 is 12.5 &mu;g/ml <i>in vitro</i> <Reference id=39478/>.",
      "notes": "",
      "amount": 884
    },
    {
      "id": 1439,
      "name": "phenoxymethylpenicillin",
      "appliances": "MIC90 for antimicrobial activity against multiple drug-resistant <i>Streptococcus pneumoniae</i> serotype 19F is 4 &mu;g/ml <i>in vitro </i> <Reference id=39449/>.",
      "notes": "",
      "amount": 460
    },
    {
      "id": 1440,
      "name": "piperacillin",
      "appliances": "MIC90 for antibacterial activity against <i>Campylobacter jejuni</i> is &gt;512 &mu;g/ml <i>in vitro</i> <Reference id=39479/>.",
      "notes": "",
      "amount": 662
    },
    {
      "id": 1441,
      "name": "pivmecillinam",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 456
    },
    {
      "id": 1442,
      "name": "streptomycin",
      "appliances": "MIC90 for antimycobacterial activity against rifampin-resistant <i>Mycobacterium tuberculosis</i> ATCC 35838 is 0.47 &mu;g/ml <i>in vitro</i> <Reference id=39484/>.",
      "notes": "",
      "amount": 281
    },
    {
      "id": 1443,
      "name": "teicoplanin",
      "appliances": "MIC for antibacterial activity against <i>Clostridium difficile</i> ranges from 0.25- 0.5 &mu;g/ml <i>in vitro</i> <Reference id=39486/><Reference id=39487/>.",
      "notes": "",
      "amount": 505
    },
    {
      "id": 1444,
      "name": "telavancin",
      "appliances": "Data for <i>in vitro</i> antibacterial activity is available in these references: <Reference id=39489/><Reference id=39490/><Reference id=39491/><Reference id=39492/>",
      "notes": "",
      "amount": 300
    },
    {
      "id": 1445,
      "name": "temocillin",
      "appliances": "MIC for antimicrobial activity against <i>Escherichia coli</i> clinical isolates expressing &beta;-lactamase KPC is 8 &mu;g/ml <i>in vitro </i><Reference id=39493/>.",
      "notes": "",
      "amount": 967
    },
    {
      "id": 1446,
      "name": "tetracycline",
      "appliances": "Potent antibacterial activity against <i>Mycoplasma genitalium</i> strains is reported in <Reference id=39281/>.",
      "notes": "",
      "amount": 647
    },
    {
      "id": 1447,
      "name": "ticarcillin",
      "appliances": "MIC for antibacterial activity against <i>Pseudomonas aeruginosa</i> KG2505 is 0.25 &mu;g/ml <i>in vitro</i> <Reference id=39494/>.",
      "notes": "",
      "amount": 964
    },
    {
      "id": 1448,
      "name": "tobramycin",
      "appliances": "MIC for antibacterial activity against Lancefield <i>Streptococcus</i> sp. groups C, F and G is 8 ng/ml <i>in vitro</i> <Reference id=39454/>.",
      "notes": "",
      "amount": 780
    },
    {
      "id": 1449,
      "name": "trimethoprim",
      "appliances": "MIC for antibacterial activity against methicillin-resistant <i>Staphylococcus aureus</i> is 8 ng/ml <i>in vitro</i> <Reference id=39497/>.",
      "notes": "",
      "amount": 827
    },
    {
      "id": 1612,
      "name": "chiglitazar",
      "appliances": "Preclinically chiglitazar improved impaired insulin and glucose tolerance in monosodium L-glutamate obese rats <Reference id=44439/>.",
      "notes": "",
      "amount": 363
    },
    {
      "id": 1450,
      "name": "vancomycin",
      "appliances": "MIC for antibacterial activity against <i>Clostridium difficile</i> strains is approximately 1 &mu;g/ml <i>in vitro</i> <Reference id=39498/><Reference id=39499/><Reference id=39466/>.",
      "notes": "",
      "amount": 604
    },
    {
      "id": 1451,
      "name": "sulfamethoxazole",
      "appliances": "MIC for antibacterial activity against &beta;-lactamase-producing bacterial strains is reported in <Reference id=39500/>.",
      "notes": "",
      "amount": 114
    },
    {
      "id": 1452,
      "name": "dapsone",
      "appliances": "Inhibits dihydrofolate reductase activity in <i>Pneumocystis carinii</i> with an IC<sub>50</sub> of 1.5 &mu;M <i>in vitro</i> <Reference id=39501/>.",
      "notes": "",
      "amount": 990
    },
    {
      "id": 1453,
      "name": "cefotetan",
      "appliances": "MIC for antibacterial activity across a range of <i>Bacteroides</i> spp. range from 4-128 &mu;g/ml <i>in vitro</i> <Reference id=39503/><Reference id=39504/>.",
      "notes": "",
      "amount": 891
    },
    {
      "id": 1454,
      "name": "cefoxitin",
      "appliances": "MIC for antibacterial activity against <i>Staphylococcus aureus</i> ATCC 29213 is 2 &mu;g/ml <i>in vitro</i> <Reference id=39505/>.",
      "notes": "",
      "amount": 613
    },
    {
      "id": 1455,
      "name": "lincomycin",
      "appliances": "MIC concentrations for antibacterial activity against <i>Streptococcus pneumoniae</i> lie in the 0.05-0.4 &mu;g/ml range, and for <i>Streptococcus pyogenes</i> the range is 0.04-0.8 &mu;g/ml <Reference id=39511/>.",
      "notes": "",
      "amount": 299
    },
    {
      "id": 1456,
      "name": "nafcillin",
      "appliances": "MIC data for antibacterial activity across stapylococcal species, and references back to primary data sources are available from antibacterials.toku-e.com <Reference id=39512/>.",
      "notes": "",
      "amount": 676
    },
    {
      "id": 1457,
      "name": "oxacillin",
      "appliances": "MIC data for antibacterial activity across a wide rang of bacterial species, and references back to primary data sources are available from antibacterials.toku-e.com <Reference id=39513/>.",
      "notes": "",
      "amount": 155
    },
    {
      "id": 1458,
      "name": "acetylcysteine",
      "appliances": "",
      "notes": "",
      "amount": 656
    },
    {
      "id": 1459,
      "name": "tenofovir",
      "appliances": "OAT1 and OAT3 in the basal membrane actively transport 20-30% of tenofovir into proximal tubule cells <Reference id=39703/>. ABCC2 (MRP2) and ABCC4 (MRP4) at the apical surface secrete tenofovir into the tubular lumen <Reference id=39749/>.",
      "notes": "",
      "amount": 938
    },
    {
      "id": 1460,
      "name": "retapamulin",
      "appliances": "MIC for antibacterial activity against a range of <i>Streptococcus</i> species is 0.016 &mu;g/ml <i>in vitro</i> <Reference id=39679/>.",
      "notes": "",
      "amount": 704
    },
    {
      "id": 1461,
      "name": "sitafloxacin",
      "appliances": "MIC for <i>in vitro</i> activity against penicillin-resistant <i>Streptococcus pneumoniae</i> 217 is 0.12 &mu;g/ml <Reference id=39690/>.",
      "notes": "",
      "amount": 429
    },
    {
      "id": 1462,
      "name": "cefteram",
      "appliances": "<i>In vitro</i> activity is reported in <Reference id=39717/>, <Reference id=39716/> and <Reference id=39718/>.",
      "notes": "",
      "amount": 622
    },
    {
      "id": 1463,
      "name": "fostemsavir",
      "appliances": "The active moiety, temsavir, exhibits anti-HIV-1 activity with an EC<sub>50</sub> of 153 nM in a pseudotyped virus assay <Reference id=39853/>.",
      "notes": "",
      "amount": 131
    },
    {
      "id": 1464,
      "name": "cedazuridine",
      "appliances": "",
      "notes": "",
      "amount": 162
    },
    {
      "id": 1465,
      "name": "belantamab mafodotin",
      "appliances": "",
      "notes": "",
      "amount": 259
    },
    {
      "id": 1466,
      "name": "spectinomycin",
      "appliances": "The MIC for antibacterial activity against penicillin-,ofloxacin- and tetracyclin-resistant <i>Neisseria gonorrhoeae</i> is 8 &mu;g/ml <i>in vitro</i> <Reference id=39933/>.",
      "notes": "",
      "amount": 362
    },
    {
      "id": 1467,
      "name": "clavulanic acid",
      "appliances": "",
      "notes": "",
      "amount": 133
    },
    {
      "id": 1468,
      "name": "almonertinib",
      "appliances": "HS-10296 inhibits EGFR<sup>T790M</sup> enzyme activity in a TR-FRET assay with an IC<sub>50</sub> of 0.49 nM (compared to an IC<sub>50</sub> of 1.89 nM for wild type enzyme) <Reference id=39963/>.",
      "notes": "",
      "amount": 782
    },
    {
      "id": 1469,
      "name": "atazanavir",
      "appliances": "",
      "notes": "",
      "amount": 505
    },
    {
      "id": 1470,
      "name": "favipiravir",
      "appliances": "Favipiravir does not inhibit human DNA polymerases or RNA transcriptase <Reference id=39995/>.",
      "notes": "",
      "amount": 588
    },
    {
      "id": 1471,
      "name": "metopimazine",
      "appliances": "",
      "notes": "",
      "amount": 998
    },
    {
      "id": 1472,
      "name": "alizapride",
      "appliances": "",
      "notes": "",
      "amount": 821
    },
    {
      "id": 1473,
      "name": "abacavir",
      "appliances": "Abacavir has <i>in vitro</i> activity against both laboratory HIV-1 strains (IC<sub>50</sub> of 3.7 &mu;M for strain IIIB) and clinical isolates (IC<sub>50</sub> of 0.26 &mu;M) <Reference id=40024/>.",
      "notes": "",
      "amount": 808
    },
    {
      "id": 1474,
      "name": "carbetocin",
      "appliances": "",
      "notes": "",
      "amount": 974
    },
    {
      "id": 1475,
      "name": "risdiplam",
      "appliances": "Oral administration of risdiplam increases full-length <i>SMN2</i> mRNA expression in healthy subjects and increases SMN2 protein level in patients with spinal muscular atrophy <Reference id=40130/>.",
      "notes": "",
      "amount": 905
    },
    {
      "id": 1476,
      "name": "bedaquiline",
      "appliances": "The MIC for antimycobacterial activity against drug-resistant <i>Mycobacterium tuberculosis</i> is 2-3 nM <i>in vitro</i> <Reference id=40137/><Reference id=40136/>.",
      "notes": "",
      "amount": 273
    },
    {
      "id": 1477,
      "name": "pretomanid",
      "appliances": "<i>In vitro</i> antimycobacterial activity and efficacy in preclinical models was first reported 2000 <Reference id=40140/>.",
      "notes": "",
      "amount": 612
    },
    {
      "id": 1478,
      "name": "concizumab",
      "appliances": "<i>In vitro</i>, concizumab demonstrates binding to cell surface TFPI on EA.hy926 cells and neutralises TFPI inhibition of Factor X activation <Reference id=40193/>. It cross-reacts with rabbit TFPI, but not with rat TFPI.",
      "notes": "",
      "amount": 199
    },
    {
      "id": 1479,
      "name": "dalpiciclib",
      "appliances": "",
      "notes": "",
      "amount": 792
    },
    {
      "id": 1480,
      "name": "odevixibat",
      "appliances": "",
      "notes": "",
      "amount": 315
    },
    {
      "id": 1481,
      "name": "clascoterone",
      "appliances": "",
      "notes": "",
      "amount": 757
    },
    {
      "id": 1482,
      "name": "bromhexine",
      "appliances": "",
      "notes": "",
      "amount": 536
    },
    {
      "id": 1483,
      "name": "terlipressin",
      "appliances": "",
      "notes": "",
      "amount": 117
    },
    {
      "id": 1484,
      "name": "darunavir",
      "appliances": "Darunavir has potent <i>in vitro</i> activity against laboratory HIV-1 strains (an IC<sub>50</sub> value of 0.003 &mu;M for HIV-1<sub>LAI</sub>) and against multi-PI-resistant clinical isolates <Reference id=40424/>.",
      "notes": "",
      "amount": 313
    },
    {
      "id": 1485,
      "name": "emtricitabine",
      "appliances": "Emtricitabine has potent <i>in vitro</i> activity against laboratory HIV-1 strains. The (-)-enantiomer is the most potent with an IC<sub>50</sub> of 0.008 &mu;M against HIV-1 (strain LAV) <Reference id=40436/>.",
      "notes": "",
      "amount": 677
    },
    {
      "id": 1486,
      "name": "nomegestrol",
      "appliances": "Nomegestrol is a progesterone receptor agonist, but we have been unable to find activity data.",
      "notes": "",
      "amount": 188
    },
    {
      "id": 1487,
      "name": "belzutifan",
      "appliances": "",
      "notes": "",
      "amount": 676
    },
    {
      "id": 1488,
      "name": "mavacamten",
      "appliances": "In experiments using mouse cardiac myofibrils mavacamten (MYK-461) dose-dependently reduces ATPase activity, with an IC<sub>50</sub> of 300 nM <Reference id=40621/>.",
      "notes": "",
      "amount": 172
    },
    {
      "id": 1489,
      "name": "daclatasvir",
      "appliances": "Daclatasvir exhibits picomolar EC<sub>50</sub>s towards replicons expressing a broad range of HCV genotypes <Reference id=40624/>.",
      "notes": "",
      "amount": 898
    },
    {
      "id": 1490,
      "name": "glecaprevir",
      "appliances": "Potent antiviral activity against major HCV genotypes <i>in vitro</i> and <i>in vivo</i> <Reference id=40625/>.",
      "notes": "",
      "amount": 182
    },
    {
      "id": 1491,
      "name": "pibrentasvir",
      "appliances": "Potent antiviral activity against major HCV genotypes <i>in vitro</i> and <i>in vivo</i> <Reference id=40625/>.",
      "notes": "",
      "amount": 738
    },
    {
      "id": 1492,
      "name": "velpatasvir",
      "appliances": "Has activity against HCV genotypes 1-6 <Reference id=40626/>.",
      "notes": "",
      "amount": 952
    },
    {
      "id": 1493,
      "name": "dasabuvir",
      "appliances": "",
      "notes": "",
      "amount": 935
    },
    {
      "id": 1494,
      "name": "ledipasvir",
      "appliances": "Low dose GS-5885 monotherapy, delivered for 3 days, demonstrated significant antiviral activity in genotype 1a and 1b HCV-infected patients in an early Phase 1 study <Reference id=40630/>.",
      "notes": "",
      "amount": 244
    },
    {
      "id": 1495,
      "name": "ombitasvir",
      "appliances": "ABT-267 exhibits pan-genotypic anti-HCV activity, with an EC<sub>50</sub> range of 1.7-19.3 pM against GT1a, -1b, -2a, -2b, -3a, -4a, and -5a and 366 pM against GT6a <Reference id=40629/>.",
      "notes": "",
      "amount": 790
    },
    {
      "id": 1496,
      "name": "paritaprevir",
      "appliances": "",
      "notes": "",
      "amount": 780
    },
    {
      "id": 1497,
      "name": "casirivimab",
      "appliances": "",
      "notes": "",
      "amount": 308
    },
    {
      "id": 1498,
      "name": "imdevimab",
      "appliances": "",
      "notes": "",
      "amount": 996
    },
    {
      "id": 1499,
      "name": "cilgavimab",
      "appliances": "Binds to the trimeric S2P<sub>ecto</sub> synthetic spike protein mimic with an EC<sub>50</sub> of 1.5 ng/ml <Reference id=40995/>.",
      "notes": "",
      "amount": 481
    },
    {
      "id": 1500,
      "name": "tixagevimab",
      "appliances": "Binds to the trimeric S2P<sub>ecto</sub> synthetic spike protein mimic with an EC<sub>50</sub> of 10.2 ng/ml <Reference id=40995/>.",
      "notes": "",
      "amount": 541
    },
    {
      "id": 1501,
      "name": "regdanvimab",
      "appliances": "",
      "notes": "",
      "amount": 569
    },
    {
      "id": 1502,
      "name": "sotrovimab",
      "appliances": "<i>In vitro</i>, sotrovimab induces both antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) <Reference id=43256/>.",
      "notes": "",
      "amount": 886
    },
    {
      "id": 1503,
      "name": "naxitamab",
      "appliances": "Naxitamab (hu3F8V1) binds to GD2 <i>in vitro</i> (Biacore SPR assay) with a K<sub>D</sub> of 3 nM <Reference id=41059/>.",
      "notes": "",
      "amount": 998
    },
    {
      "id": 1504,
      "name": "berotralstat",
      "appliances": "",
      "notes": "",
      "amount": 489
    },
    {
      "id": 1505,
      "name": "ciclopirox",
      "appliances": "",
      "notes": "",
      "amount": 538
    },
    {
      "id": 1506,
      "name": "miltefosine",
      "appliances": "",
      "notes": "",
      "amount": 283
    },
    {
      "id": 1507,
      "name": "epalrestat",
      "appliances": "",
      "notes": "",
      "amount": 975
    },
    {
      "id": 1508,
      "name": "cabotegravir",
      "appliances": "Inhibits HIV-1 integrase strand transfer activity using (using [<sup>3</sup>H]-DNA as substrate ) with an IC<sub>50</sub> of 3 nM <i>in vitro</i> <Reference id=41324/>.",
      "notes": "",
      "amount": 636
    },
    {
      "id": 1509,
      "name": "rilpivirine",
      "appliances": "Inhibits HIV K103N/Y181C mutant reverse transcriptase in cell based assay with an EC<sub>50</sub> of 0.8 nM <Reference id=41325/>.",
      "notes": "",
      "amount": 694
    },
    {
      "id": 1510,
      "name": "voclosporin",
      "appliances": "Voclosporin binds cyclophilin A (a.k.a. peptidylprolyl isomerase A) <Reference id=41333/>.",
      "notes": "",
      "amount": 273
    },
    {
      "id": 1511,
      "name": "dotinurad",
      "appliances": "",
      "notes": "",
      "amount": 921
    },
    {
      "id": 1512,
      "name": "plitidepsin",
      "appliances": "Plitidepsin inhibits replication of SARS-CoV-2 <i>in vitro</i> with an IC<sub>90</sub> of 88 nM <Reference id=41358/>.",
      "notes": "",
      "amount": 501
    },
    {
      "id": 1513,
      "name": "faricimab",
      "appliances": "",
      "notes": "",
      "amount": 146
    },
    {
      "id": 1514,
      "name": "itraconazole",
      "appliances": "A repurposing screen found that itraconazole inhibited the activity of SARS-CoV-2 3CL-Pro by ~12% <i>in vitro</i>.",
      "notes": "",
      "amount": 667
    },
    {
      "id": 1515,
      "name": "posaconazole",
      "appliances": "",
      "notes": "",
      "amount": 184
    },
    {
      "id": 1516,
      "name": "tirzepatide",
      "appliances": "",
      "notes": "",
      "amount": 326
    },
    {
      "id": 1517,
      "name": "viltolarsen",
      "appliances": "",
      "notes": "",
      "amount": 829
    },
    {
      "id": 1518,
      "name": "triheptanoin",
      "appliances": "",
      "notes": "",
      "amount": 598
    },
    {
      "id": 1519,
      "name": "cetilistat",
      "appliances": "",
      "notes": "",
      "amount": 236
    },
    {
      "id": 1520,
      "name": "epcoritamab",
      "appliances": "",
      "notes": "",
      "amount": 295
    },
    {
      "id": 1521,
      "name": "casimersen",
      "appliances": "",
      "notes": "",
      "amount": 150
    },
    {
      "id": 1522,
      "name": "viloxazine",
      "appliances": "Binds to NET with a K<sub>d</sub> of 115 nM <Reference id=41944/>. Binding affinity for SERT is >17 &mu;M.",
      "notes": "",
      "amount": 218
    },
    {
      "id": 1523,
      "name": "nirmatrelvir",
      "appliances": "PF-07321332 inhibits Mpro from SARS-CoV-2 and related coronaviruses <i>in vitro</i> <Reference id=43276/>.",
      "notes": "",
      "amount": 468
    },
    {
      "id": 1524,
      "name": "lopinavir",
      "appliances": "Inhibits HIV1 protease with K<sub>i</sub> 0.0013 nM <i>in vitro</i> <Reference id=41950/>.",
      "notes": "",
      "amount": 463
    },
    {
      "id": 1525,
      "name": "zavegepant",
      "appliances": "",
      "notes": "",
      "amount": 454
    },
    {
      "id": 1526,
      "name": "dostarlimab",
      "appliances": "A meeting abstract indicates that dostarlimab has high affinity for both human and cynomolgus monkey PD-1, but does not cross-react with the mouse orthologue, and that it inhibits the interaction of both PD-L1 and PD-L2 with PD-1.",
      "notes": "",
      "amount": 331
    },
    {
      "id": 1527,
      "name": "loncastuximab tesirine",
      "appliances": "",
      "notes": "",
      "amount": 835
    },
    {
      "id": 1528,
      "name": "vonoprazan",
      "appliances": "",
      "notes": "",
      "amount": 634
    },
    {
      "id": 1529,
      "name": "brincidofovir",
      "appliances": "Antiviral activity against infection by human cytomegalovirus (human herpesvirus 5) AD169 (in HFF cells) EC<sub>50</sub> 0.9 nM <Reference id=42170/>.",
      "notes": "",
      "amount": 270
    },
    {
      "id": 1530,
      "name": "balsalazide",
      "appliances": "Biological activity resides with <Ligand id=2700/> (a.k.a. 5-aminosalicylic acid or 5-ASA) which reduces inflammation by disrupting the production of arachidonic acid metabolites in the colon mucosa.",
      "notes": "",
      "amount": 809
    },
    {
      "id": 1531,
      "name": "vaniprevir",
      "appliances": "Vaniprevir (MK-7009) inhibits genotype 1 and genotype 2 NS3/4a protease enzymes <Reference id=42369/>. The K<sub>i</sub> for inhibition of genotype 1b NS3/4a protease is 0.05 nM, and for genotype 2a NS3/4a protease it is 0.9 nM.",
      "notes": "",
      "amount": 938
    },
    {
      "id": 1532,
      "name": "raltegravir",
      "appliances": "Raltegravir (MK-0518) inhibits wild type HIV integrase with an IC<sub>50</sub> of 40 nM <Reference id=42370/>.",
      "notes": "",
      "amount": 346
    },
    {
      "id": 1533,
      "name": "narlaprevir",
      "appliances": "The inhibition constant (K<sub>i</sub>) <i>vs</i>. HCV NS3 protease is 7 nM <i>in vitro</i> <Reference id=42373/>.",
      "notes": "",
      "amount": 523
    },
    {
      "id": 1534,
      "name": "grazoprevir",
      "appliances": "MK-5172 is active against HCV genotype 1-3 NS3/4a and clinically relevant mutant enzymes. K<sub>i</sub> <i>vs</i>. wild type genotype 1b and 3a NS3/4a's are 0.02 and 0.7 nM respectively <Reference id=42377/>.",
      "notes": "",
      "amount": 704
    },
    {
      "id": 1535,
      "name": "elvitegravir",
      "appliances": "Elvitegravir (GS-9137) inhibits HIV integrase-mediated strand transfer with an IC<sub>50</sub> of 7.2 nM <Reference id=42378/>. Its antiviral EC<sub>50</sub> is is 0.9 nM.",
      "notes": "",
      "amount": 361
    },
    {
      "id": 1536,
      "name": "bictegravir",
      "appliances": "Inhibits HIV integrase strand transfer activity with an IC<sub>50</sub> of 7.5 nM <Reference id=42379/>.",
      "notes": "",
      "amount": 578
    },
    {
      "id": 1537,
      "name": "zucapsaicin",
      "appliances": "",
      "notes": "",
      "amount": 810
    },
    {
      "id": 1538,
      "name": "udenafil",
      "appliances": "",
      "notes": "",
      "amount": 498
    },
    {
      "id": 1539,
      "name": "olsalazine",
      "appliances": "See the ligand page for <Ligand id=2700/> for bioactivity data.",
      "notes": "",
      "amount": 566
    },
    {
      "id": 1540,
      "name": "bilastine",
      "appliances": "Bilastine displaces [<sup>3</sup>H]-pyrilamine from H<sub>1</sub> receptors expressed in guinea-pig cerebellum and human embryonic kidney (HEK) cell lines <Reference id=42388/>.",
      "notes": "",
      "amount": 366
    },
    {
      "id": 1541,
      "name": "anagliptin",
      "appliances": "Bioactivity may have been determined using the hydrochloride salt.",
      "notes": "",
      "amount": 450
    },
    {
      "id": 1542,
      "name": "retifanlimab",
      "appliances": "",
      "notes": "",
      "amount": 923
    },
    {
      "id": 1543,
      "name": "melphalan flufenamide",
      "appliances": "Melphalan flufenamide's anti-tumour activity is identical to that of melphalan, but is it more selective for tumour cells that overexpress aminopeptidases that the parent drug <Reference id=42473/>.",
      "notes": "",
      "amount": 739
    },
    {
      "id": 1544,
      "name": "pirtobrutinib",
      "appliances": "In call assays pirtobrutinib inhibits wild-type and mutant forms of BTK (e.g., BTK<sup>C481S</sup> and BTK <sup>C481R</sup> that are resistant to previous irreversible BTK inhibitors) at nanomolar concentrations <Reference id=42539/><Reference id=44563/>.",
      "notes": "",
      "amount": 945
    },
    {
      "id": 1545,
      "name": "famciclovir",
      "appliances": "Biological activity resides in the active metabolite, penciclovir triphosphate.",
      "notes": "",
      "amount": 518
    },
    {
      "id": 1546,
      "name": "daridorexant",
      "appliances": "",
      "notes": "",
      "amount": 799
    },
    {
      "id": 1547,
      "name": "racecadotril",
      "appliances": "The active metabolite of racecadotril, <Ligand id=5278/> is the main contributor towards its enkephalinase inhibitory action <Reference id=42610/>.",
      "notes": "",
      "amount": 674
    },
    {
      "id": 1548,
      "name": "sunvozertinib",
      "appliances": "",
      "notes": "",
      "amount": 493
    },
    {
      "id": 1549,
      "name": "maralixibat",
      "appliances": "",
      "notes": "",
      "amount": 319
    },
    {
      "id": 1550,
      "name": "tisotumab vedotin",
      "appliances": "",
      "notes": "",
      "amount": 422
    },
    {
      "id": 1551,
      "name": "temocapril",
      "appliances": "Biological activity is associated with the active metabolite (CS-622 diacid; temocaprilat), which was reported to be slightly more potent than <Ligand id=6332/> in inhibiting ACE isolated from rabbit lung <Reference id=43007/>.",
      "notes": "",
      "amount": 718
    },
    {
      "id": 1552,
      "name": "mirodenafil",
      "appliances": "We have been unable to find a quantitative value for mirodenafil's inhibition of PDE5 activity.",
      "notes": "",
      "amount": 422
    },
    {
      "id": 1553,
      "name": "bifemelane",
      "appliances": "",
      "notes": "",
      "amount": 675
    },
    {
      "id": 1554,
      "name": "aranidipine",
      "appliances": "Aranidipine inhibits CaCl<sub>2</sub>-induced contractions in rabbit aorta with IC<sub>50</sub> ~5.4 nM <Reference id=43019/>. For (<i>S</i>)-aranidipine the IC<sub>50</sub> is 3.3 nM.",
      "notes": "",
      "amount": 385
    },
    {
      "id": 1555,
      "name": "baloxavir marboxil",
      "appliances": "Bioactivity is associated with the active metabolite baloxavir (S-033447). Baloxavir inhibits Influenza A-induced death of MDCK cells <i>in vitro</i> with an EC<sub>50</sub> of 0.9 nM <Reference id=43047/>.",
      "notes": "",
      "amount": 986
    },
    {
      "id": 1556,
      "name": "pabinafusp alfa",
      "appliances": "",
      "notes": "",
      "amount": 668
    },
    {
      "id": 1557,
      "name": "telitacicept",
      "appliances": "",
      "notes": "",
      "amount": 190
    },
    {
      "id": 1558,
      "name": "enarodustat",
      "appliances": "",
      "notes": "",
      "amount": 909
    },
    {
      "id": 1559,
      "name": "levoketoconazole",
      "appliances": "",
      "notes": "",
      "amount": 296
    },
    {
      "id": 1560,
      "name": "vadadustat",
      "appliances": "",
      "notes": "",
      "amount": 986
    },
    {
      "id": 1561,
      "name": "tetrandrine",
      "appliances": "",
      "notes": "",
      "amount": 559
    },
    {
      "id": 1562,
      "name": "ensitrelvir",
      "appliances": "S-217622 is active (<i>in vitro</i>) against SARS-CoV-2 variants that were in circulation during the period of its development, and it has antiviral activity against other coronavirus strains (MERS-CoV, SARS-CoV, HCoV-229E and HCoV-OC43).",
      "notes": "",
      "amount": 712
    },
    {
      "id": 1563,
      "name": "iruplinalkib",
      "appliances": "Retains activity against ALK with mutations L1196M and C1156Y <Reference id=43336/>. IC<sub>50</sub> for inhibition of EGFR<sup>T790M/L858R</sup> is <100 nM. Reduces human lung cancer cell-derived xenograft tumour volume <i>in vivo</i>.",
      "notes": "",
      "amount": 473
    },
    {
      "id": 1564,
      "name": "betahistine",
      "appliances": "K<sub>i</sub> at rat H<sub>3</sub> receptor is ~2 &mu;M <Reference id=30246/><Reference id=43520/>.",
      "notes": "",
      "amount": 224
    },
    {
      "id": 1565,
      "name": "ganaxolone",
      "appliances": "",
      "notes": "",
      "amount": 938
    },
    {
      "id": 1566,
      "name": "chlorprothixene",
      "appliances": "",
      "notes": "",
      "amount": 774
    },
    {
      "id": 1567,
      "name": "VV116",
      "appliances": "116-NTP inhibits SARS-CoV-2 RdRp with an IC<sub>50</sub> of 670 nM in a biochemical enzyme activity assay <Reference id=43656/>. The prodrug V116 inhibits SARS-CoV-2 replication with an EC<sub>50</sub> of 350 nM in a Vero E6 cell infection assay.",
      "notes": "",
      "amount": 319
    },
    {
      "id": 1568,
      "name": "revaprazan",
      "appliances": "",
      "notes": "",
      "amount": 862
    },
    {
      "id": 1569,
      "name": "tegoprazan",
      "appliances": "",
      "notes": "",
      "amount": 289
    },
    {
      "id": 1570,
      "name": "rifaximin",
      "appliances": "Rifaximin has a similar antimicrobial activity spectrum to <Ligand id=2765/> <Reference id=43757/>. MIC<sub>90</sub> for a range of enteric pathogens is in the range of 4-64 &mu;g/ml <Reference id=43776/>.",
      "notes": "",
      "amount": 474
    },
    {
      "id": 1571,
      "name": "somatrogon",
      "appliances": "",
      "notes": "",
      "amount": 915
    },
    {
      "id": 1572,
      "name": "rifapentine",
      "appliances": "The MIC for <i>Mycobacterium tuberculosis</i> (laboratory and clinical isolates) is in the range 0.02-0.2 &mu;g/ml, demonstrating improved antitubercular <i>in vitro</i> activity over <Ligand id=2765/> <Reference id=43777/>.",
      "notes": "",
      "amount": 759
    },
    {
      "id": 1573,
      "name": "novobiocin",
      "appliances": "MIC<sub>90</sub> for antibacterial activity against strains of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is 0.25 &mu;g/ml <i>in vitro</i> <Reference id=43746/>.",
      "notes": "",
      "amount": 998
    },
    {
      "id": 1574,
      "name": "cefoperazone",
      "appliances": "Cefoperazone has broad-spectrum activity against Gram-positive and Gram-negative bacteria. <i>In vitro</i> activity is reported in <Reference id=43755/>.",
      "notes": "",
      "amount": 609
    },
    {
      "id": 1575,
      "name": "resmetirom",
      "appliances": "",
      "notes": "",
      "amount": 574
    },
    {
      "id": 1576,
      "name": "cefpiramide",
      "appliances": "It has broad-spectrum activity against Gram-positive and Gram-negative bacteria and has antipseudomonal activity <Reference id=43760/><Reference id=43761/>.",
      "notes": "",
      "amount": 484
    },
    {
      "id": 1577,
      "name": "cefditoren",
      "appliances": "MIC<sub>90</sub> values have been determined for a range of clinical isolates including, <i>Neisseria gonorrhoeae</i> (MIC<sub>90</sub> &le;  15 ng/ml) and <i>Haemophilus influenzae</i> (MIC<sub>90</sub> of 60 ng/ml) <Reference id=43786/>.",
      "notes": "",
      "amount": 339
    },
    {
      "id": 1578,
      "name": "latamoxef",
      "appliances": "Latamoxef has broad-spectrum activity against a range of Gram-negative and Gram-positive bacteria and is &beta;-lactamase-resistant (reviewed in <Reference id=43768/>).",
      "notes": "",
      "amount": 548
    },
    {
      "id": 1579,
      "name": "cefoselis",
      "appliances": "<i>In vitro</i> activity is reported in <Reference id=43781/><Reference id=43782/>.",
      "notes": "",
      "amount": 974
    },
    {
      "id": 1580,
      "name": "maribavir",
      "appliances": "IC<sub>50</sub> <i>vs</i>. CMV pUL97 kinase is 3 nM <Reference id=43842/>.",
      "notes": "",
      "amount": 264
    },
    {
      "id": 1581,
      "name": "dorzagliatin",
      "appliances": "",
      "notes": "",
      "amount": 360
    },
    {
      "id": 1582,
      "name": "isepamicin",
      "appliances": "Several studies report that isepamicin has a comparable spectrum of antibacterial acivity to that of <Ligand id=10894/> <Reference id=44019/><Reference id=44240/>.",
      "notes": "",
      "amount": 519
    },
    {
      "id": 1583,
      "name": "netilmicin",
      "appliances": "Netilmicin demonstrates activity against most Gram-negative and some Gram-positive bacteria, including many gentamicin-resistant strains (reviewed in <Reference id=44242/>).",
      "notes": "",
      "amount": 545
    },
    {
      "id": 1584,
      "name": "paromomycin",
      "appliances": "Paromomycin demonstates activity against most Gram-negative and many Gram-positive bacteria as well a number of clinically important species of protozoa and cestodes (reviewed in <Reference id=44243/>).",
      "notes": "",
      "amount": 840
    },
    {
      "id": 1585,
      "name": "micronomicin",
      "appliances": "Micronomicin has a broad-spectrum of antibacterial activity against both Gram-positive and Gram-negative bacteria <Reference id=44062/><Reference id=44063/>.",
      "notes": "",
      "amount": 702
    },
    {
      "id": 1586,
      "name": "spesolimab",
      "appliances": "",
      "notes": "",
      "amount": 491
    },
    {
      "id": 1587,
      "name": "eflapegrastim",
      "appliances": "",
      "notes": "",
      "amount": 159
    },
    {
      "id": 1588,
      "name": "bekanamycin",
      "appliances": "Bekanamycin has activity against Gram-positive and Gram-negative bacteria but lacks antipseudomonal activity and is modified by many inactivating enzymes (reviewed in <Reference id=44251/>).",
      "notes": "",
      "amount": 262
    },
    {
      "id": 1589,
      "name": "doripenem",
      "appliances": "Doripenem has potent activity against a range of Gram-positive and Gram-negative bacteria including <i>Pseudomonas aeruginosa</i> (MIC of 0.02 &mu;g/ml) <Reference id=44117/>.",
      "notes": "",
      "amount": 242
    },
    {
      "id": 1590,
      "name": "enmetazobactam",
      "appliances": "Enmetazobactam has potent inhibitory activity against class A &beta;-lactamases, with a mechanism that differs from tazobactam <Reference id=44137/>.",
      "notes": "",
      "amount": 815
    },
    {
      "id": 1591,
      "name": "cefapirin",
      "appliances": "Cefapirin demonstrates good efficacy against Gram-positive and Gram-negative bacteria and is reported to have a similar spectrum of antibacterial activity to that of <Ligand id=8798/> <Reference id=44151/>.",
      "notes": "",
      "amount": 285
    },
    {
      "id": 1592,
      "name": "cefaloglycin",
      "appliances": "Cefaloglycin demonstrates broad-spectrum antibacterial activity that is comparable <i>in vitro</i> to that of <Ligand id=8798/> <Reference id=44153/>.",
      "notes": "",
      "amount": 671
    },
    {
      "id": 1593,
      "name": "lecanemab",
      "appliances": "",
      "notes": "",
      "amount": 301
    },
    {
      "id": 1594,
      "name": "cefamandole",
      "appliances": "Cefamandole has broad-spectrum antibacterial activity <Reference id=44205/>.",
      "notes": "",
      "amount": 794
    },
    {
      "id": 1595,
      "name": "cefmetazole",
      "appliances": "Cefmetazole has broad-spectrum antibacterial activity, including Gram-positive, Gram-negative and anaerobic bacteria <Reference id=44259/>.",
      "notes": "",
      "amount": 952
    },
    {
      "id": 1596,
      "name": "cefonicid",
      "appliances": "Cefonicid has broad-spectrum antibacterial activity <Reference id=44260/>.",
      "notes": "",
      "amount": 369
    },
    {
      "id": 1597,
      "name": "ceforanide",
      "appliances": "Ceforanide has broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria, including many Enterobacteriaceae <Reference id=44261/><Reference id=44262/>.",
      "notes": "",
      "amount": 945
    },
    {
      "id": 1598,
      "name": "cefprozil",
      "appliances": "Cefprozil has broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria, including many Enterobacteriaceae <Reference id=44265/>.",
      "notes": "",
      "amount": 822
    },
    {
      "id": 1599,
      "name": "upacicalcet",
      "appliances": "",
      "notes": "",
      "amount": 500
    },
    {
      "id": 1600,
      "name": "talquetamab",
      "appliances": "Talquetamab (JNJ-64407564) activates T cell-mediated cytotoxicity against GPRC5D-positive cells with EC<sub>50</sub> of &lt;1 nM <i>in vitro</i> <Reference id=44318/>.",
      "notes": "",
      "amount": 778
    },
    {
      "id": 1601,
      "name": "loracarbef",
      "appliances": "Loracarbef has broad-spectrum activity against Gram-positive and Gram-negative bacteria <Reference id=44453/>.",
      "notes": "",
      "amount": 700
    },
    {
      "id": 1602,
      "name": "mirvetuximab soravtansine",
      "appliances": "The antibody component (known as M9346A) of mirvetuximab soravtansine binds to FOLR1 with a Kd of 0.08 nM <i>in vitro</i> <Reference id=44339/>.",
      "notes": "",
      "amount": 993
    },
    {
      "id": 1603,
      "name": "teplizumab",
      "appliances": "Teplizumab's CD3e binding affinity will be similar to that of its parent antibody <Ligand id=6889/>.",
      "notes": "",
      "amount": 886
    },
    {
      "id": 1604,
      "name": "azlocillin",
      "appliances": "",
      "notes": "",
      "amount": 293
    },
    {
      "id": 1605,
      "name": "dicloxacillin",
      "appliances": "Antimicrobial activity against <i>Staphylococcus aureus</i> ATCC 25923; MIC 0.03 &mu;g/ml <Reference id=44442/>.",
      "notes": "",
      "amount": 769
    },
    {
      "id": 1606,
      "name": "hetacillin",
      "appliances": "Antibacterial activity against <i>Streptococcus pneumoniae</i> 9585; MIC 0.004 &mu;g/ml <Reference id=44443/>.",
      "notes": "",
      "amount": 959
    },
    {
      "id": 1607,
      "name": "methicillin",
      "appliances": "MIC<sub>50</sub> against methicillin-resistant <i>Staphylococcus aureus</i> is 128 &mu;g/ml <i>in vitro</i> <Reference id=44444/>.",
      "notes": "",
      "amount": 636
    },
    {
      "id": 1608,
      "name": "mezlocillin",
      "appliances": "Antibacterial activity against <i>Staphylococcus aureus</i> 4978 Israel; MIC 3.12 &mu;g/ml <Reference id=44445/>. FDA marketing authorisation has been discontinued.",
      "notes": "",
      "amount": 445
    },
    {
      "id": 1609,
      "name": "pheneticillin",
      "appliances": "The MIC against <i>Staphylococcus aureus</i> 421 is 0.031 &mu;g/ml <Reference id=44503/>.",
      "notes": "",
      "amount": 261
    },
    {
      "id": 1610,
      "name": "linzagolix",
      "appliances": "",
      "notes": "",
      "amount": 762
    },
    {
      "id": 1611,
      "name": "clazosentan",
      "appliances": "",
      "notes": "",
      "amount": 494
    },
    {
      "id": 1613,
      "name": "carfecillin",
      "appliances": "Carfecillin is reported to show a similar spectrum of antibacterial activity to that of <Ligand id=10768/> <i>in vitro</i> <Reference id=44505/>. It has activity against Gram-positive and some Gram-negative bacteria including <i>Pseudomonas aeruginosa</i>.",
      "notes": "",
      "amount": 195
    },
    {
      "id": 1614,
      "name": "talampicillin",
      "appliances": "This compound has no intrinsic antibacterial activity but is well absorbed from the intestine and hydrolysed on absorption to release <Ligand id=10896/> <Reference id=44506/>.",
      "notes": "",
      "amount": 529
    },
    {
      "id": 1615,
      "name": "sultamicillin",
      "appliances": "The <i>in vitro</i> antibacterial activity of sultamicillin is primarily due to the <Ligand id=10896/> component.",
      "notes": "",
      "amount": 533
    },
    {
      "id": 1616,
      "name": "bacampicillin",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 833
    },
    {
      "id": 1617,
      "name": "mosunetuzumab",
      "appliances": "Mosunetuzumab effectively kills patient-derived CLL B cells <i>in vitro</i> and <i>in vivo</i> <Reference id=44465/>.",
      "notes": "",
      "amount": 220
    },
    {
      "id": 1618,
      "name": "moxisylyte",
      "appliances": "Several studies indicate that moxisylyte/thymoxamine is an &alpha;-adrenoceptor antagonist <Reference id=44480/><Reference id=44479/>, but none provide quantitative data for the drug's activity at the receptor level.",
      "notes": "",
      "amount": 346
    },
    {
      "id": 1619,
      "name": "zanamivir",
      "appliances": "Zanamivir inhibits influenza A and B neuraminidase with K<sub>i</sub> values &lt;1 nM <Reference id=44482/><Reference id=44483/>. It is a low potency inhibitor of human neuraminidase isoenzymes NEU1-4 <i>in vitro</i> <Reference id=44481/>.",
      "notes": "",
      "amount": 293
    },
    {
      "id": 1620,
      "name": "bexagliflozin",
      "appliances": "Bexagliflozin is ~2400-fold selective for SGLT2 compared to SGLT1 <i>in vitro</i> <Reference id=44551/>.",
      "notes": "",
      "amount": 853
    },
    {
      "id": 1621,
      "name": "elacestrant",
      "appliances": "Elacestrant inhibits estrogen-induced activation of ER&alpha;-mediated gene transcription <i>in vitro</i> and <i>in vivo</i> (SERM action), and downregulates <i>ESR1</i> expression in MCF-7 cells (SERD action) <Reference id=44566/>",
      "notes": "",
      "amount": 571
    },
    {
      "id": 1622,
      "name": "tinidazole",
      "appliances": "The MIC for activity against anaerobic Gram-negative bacteria (<i>Bacteroides fragilis</i> and <i>Fusobacterium</i> spp.) is 0.28 &mu;g/ml <i>in vitro</i> <Reference id=44639/>.",
      "notes": "",
      "amount": 136
    },
    {
      "id": 1623,
      "name": "sugemalimab",
      "appliances": "",
      "notes": "",
      "amount": 577
    },
    {
      "id": 1624,
      "name": "furazolidone",
      "appliances": "MIC<sub>90</sub> for antibacterial activity against <i>Helicobacter pylori</i> is 0.5 &mu;g/ml <Reference id=44641/>.<br>In man, the metabolites of furazolidone are known to inhibit monoamine oxidase (MAO) <Reference id=44650/>.",
      "notes": "",
      "amount": 669
    },
    {
      "id": 1625,
      "name": "pamiparib",
      "appliances": "",
      "notes": "",
      "amount": 899
    },
    {
      "id": 1626,
      "name": "nifurtoinol",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 856
    },
    {
      "id": 1627,
      "name": "penpulimab",
      "appliances": "",
      "notes": "",
      "amount": 695
    },
    {
      "id": 1628,
      "name": "nifuratel",
      "appliances": "The MIC for activity against anaerobic Gram-negative bacteria (<i>Bacteroides</i> spp. and<i> Fusobacterium</i> spp.) is 0.25-1.0 &mu;g/ml <i>in vitro</i> <Reference id=44685/>.",
      "notes": "",
      "amount": 356
    },
    {
      "id": 1629,
      "name": "zimberelimab",
      "appliances": "",
      "notes": "",
      "amount": 525
    },
    {
      "id": 1630,
      "name": "nifurtimox",
      "appliances": "Nifurtimox is active against all lifecycle stages of <i>Trypanosoma cruzi</i>, the parasite that causes Chagas disease.<br>The compound demonstrates activity against Gram-positive and Gram-negative bacteria <Reference id=44629/>.",
      "notes": "",
      "amount": 236
    },
    {
      "id": 1631,
      "name": "furagin",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 194
    },
    {
      "id": 1632,
      "name": "azidamfenicol",
      "appliances": "We have been unable to find quantitative data for the antibacterial activity of this drug.",
      "notes": "",
      "amount": 842
    },
    {
      "id": 1633,
      "name": "cinoxacin",
      "appliances": "Cinoxacin has <i>in vitro</i> activity against many Gram-negative bacteria, particularly strains of Enterobacteriaceae <Reference id=44849/>.",
      "notes": "",
      "amount": 188
    },
    {
      "id": 1634,
      "name": "lomefloxacin",
      "appliances": "Lomefloxacin has <i>in vitro</i> activity against both Gram-positive and Gram-negative bacteria spp. including, Staphylococci (MIC<sub>90</sub> 1.56-3.13 &mu;g/ml) and many Enterobacteriaceae (MIC<sub>90</sub> &le; 0.78 &mu;g/ml) <Reference id=44856/>.",
      "notes": "",
      "amount": 518
    },
    {
      "id": 1635,
      "name": "methoxsalen",
      "appliances": "",
      "notes": "",
      "amount": 489
    },
    {
      "id": 1636,
      "name": "rufloxacin",
      "appliances": "Rufloxacin has a broad-spectrum of antibacterial activity <i>in vitro</i>, with an MIC of &lt;0.39 &mu;g/ml for <i>Klebsiella pneumoniae</i> and 0.78 &mu;g/ml for <i>Staphylococcus aureus</i> <Reference id=44831/>.",
      "notes": "",
      "amount": 128
    },
    {
      "id": 1637,
      "name": "piromidic acid",
      "appliances": "The MIC for antibacterial activity against <i>Escherichia coli</i> is 1 &mu;g/ml <i>in vitro</i> <Reference id=44838/>.",
      "notes": "",
      "amount": 558
    },
    {
      "id": 1638,
      "name": "trofinetide",
      "appliances": "Trofinetide displaces [<sup>3</sup>H]glutamate from rat N-methyl-D-aspartate glutamate receptors (in brain synaptic membranes) with a Ki of ~8 &mu;M <Reference id=44808/>.",
      "notes": "",
      "amount": 796
    },
    {
      "id": 1639,
      "name": "flunarizine",
      "appliances": "",
      "notes": "",
      "amount": 203
    },
    {
      "id": 1640,
      "name": "tafolecimab",
      "appliances": "",
      "notes": "",
      "amount": 532
    },
    {
      "id": 1641,
      "name": "efonidipine",
      "appliances": "",
      "notes": "",
      "amount": 538
    },
    {
      "id": 1642,
      "name": "moxonidine",
      "appliances": "",
      "notes": "",
      "amount": 429
    },
    {
      "id": 1643,
      "name": "sulfanilamide",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic. Sulfanilamide demonstrates <i>in vivo</i> activity against <i>Streptococcus</i> spp. <Reference id=45468/><Reference id=45467/>.",
      "notes": "",
      "amount": 389
    },
    {
      "id": 1644,
      "name": "sulfadiazine",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 583
    },
    {
      "id": 1645,
      "name": "sulfamerazine",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 816
    },
    {
      "id": 1646,
      "name": "sulfametoxydiazine",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 197
    },
    {
      "id": 1647,
      "name": "sulfadimidine",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 584
    },
    {
      "id": 1648,
      "name": "keverprazan",
      "appliances": "Keverprazan inhibits the H<sup>+</sup>/K<sup>+</sup>-ATPase activity in rabbit gastric mucosa microsomes with an IC<sub>50</sub> of <100nM <Reference id=45503/>.",
      "notes": "",
      "amount": 352
    },
    {
      "id": 1649,
      "name": "lamivudine",
      "appliances": "",
      "notes": "",
      "amount": 772
    },
    {
      "id": 1650,
      "name": "delavirdine",
      "appliances": "",
      "notes": "",
      "amount": 536
    },
    {
      "id": 1651,
      "name": "etravirine",
      "appliances": "",
      "notes": "",
      "amount": 239
    },
    {
      "id": 1652,
      "name": "nevirapine",
      "appliances": "",
      "notes": "",
      "amount": 350
    },
    {
      "id": 1653,
      "name": "stavudine",
      "appliances": "",
      "notes": "",
      "amount": 163
    },
    {
      "id": 1654,
      "name": "doravirine",
      "appliances": "",
      "notes": "",
      "amount": 650
    },
    {
      "id": 1655,
      "name": "amprenavir",
      "appliances": "",
      "notes": "",
      "amount": 991
    },
    {
      "id": 1656,
      "name": "fosamprenavir",
      "appliances": "",
      "notes": "",
      "amount": 813
    },
    {
      "id": 1657,
      "name": "sulfamethizole",
      "appliances": "A study of clinical isolates found a high incidence of resistance to sulfamethizole (47%), in nosocomial-acquired urinary tract infections caused by <i>Escherichia coli</i> <Reference id=45643/>.",
      "notes": "",
      "amount": 483
    },
    {
      "id": 1658,
      "name": "indinavir",
      "appliances": "",
      "notes": "",
      "amount": 746
    },
    {
      "id": 1659,
      "name": "tipranavir",
      "appliances": "",
      "notes": "",
      "amount": 261
    },
    {
      "id": 1660,
      "name": "durlobactam",
      "appliances": "Durlobactam has potent <i>in vitro</i> activity against clinically relevant class A, C and D serine beta-lactamases (IC<sub>50</sub> = 4-190 nM) <Reference id=45597/>.",
      "notes": "",
      "amount": 698
    },
    {
      "id": 1661,
      "name": "sulfisoxazole",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 363
    },
    {
      "id": 1662,
      "name": "sulfametrole",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>). <Reference id=45668/>",
      "notes": "",
      "amount": 151
    },
    {
      "id": 1663,
      "name": "sulfamoxole",
      "appliances": "The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in <Reference id=45471/>).",
      "notes": "",
      "amount": 631
    },
    {
      "id": 1664,
      "name": "glofitamab",
      "appliances": "",
      "notes": "",
      "amount": 367
    },
    {
      "id": 1665,
      "name": "toludesvenlafaxine",
      "appliances": "",
      "notes": "",
      "amount": 279
    },
    {
      "id": 1666,
      "name": "nalidixic acid",
      "appliances": "The MIC<sub>90</sub> for antibacterial activity against <i>Escherichia coli</i> is 8 &mu;g/ml <i>in vitro</i> <Reference id=45742/>.",
      "notes": "",
      "amount": 330
    },
    {
      "id": 1667,
      "name": "pipemidic acid",
      "appliances": "The MIC for  <i>in vitro</i> antibacterial activity is 1-3 &mu;g/ml against <i>Escherichia coli</i> and 10-25 &mu;g/ml against <i>Pseudomonas aeruginosa</i> <Reference id=45743/><Reference id=45744/>.",
      "notes": "",
      "amount": 437
    },
    {
      "id": 1668,
      "name": "bulevirtide",
      "appliances": "",
      "notes": "",
      "amount": 118
    },
    {
      "id": 1669,
      "name": "rezvilutamide",
      "appliances": "Rezvilutamide inhibits testosterone-induced PSA secretion by LnCAP cells with an IC<sub>50</sub> of 22nM <i>in vitro</i>, and inhibits LnCAP proliferation (IC<sub>50</sub> 33 nM) <Reference id=45816/>.",
      "notes": "",
      "amount": 196
    },
    {
      "id": 1670,
      "name": "penamecillin",
      "appliances": "Orally administered penamecillin provides prolonged serum levels of penicillin G <Reference id=45913/>.",
      "notes": "",
      "amount": 184
    },
    {
      "id": 1671,
      "name": "mecillinam",
      "appliances": "Mecillinam has antibacterial activity against Gram-negative species and in particular Enterobacteriaceae, with an IC<sub>50</sub> for <i>Escherichia coli</i> in the range of of 0.016-0.1 &mu;g/ml <Reference id=45920/><Reference id=45924/>.",
      "notes": "",
      "amount": 257
    },
    {
      "id": 1672,
      "name": "avacincaptad pegol",
      "appliances": "",
      "notes": "",
      "amount": 767
    },
    {
      "id": 1673,
      "name": "zuranolone",
      "appliances": "&alpha;1&beta;2&gamma;2 EC<sub>50</sub> is 375 nM by automated patch clamp electrophysiology <Reference id=45933/>. &alpha;4&beta;3&delta; EC<sub>50</sub> is 299 nM by manual patch clamp electrophysiology <Reference id=45933/>.",
      "notes": "",
      "amount": 216
    },
    {
      "id": 1674,
      "name": "beinaglutide",
      "appliances": "",
      "notes": "",
      "amount": 968
    },
    {
      "id": 1675,
      "name": "delamanid",
      "appliances": "The MIC for activity against drug-susceptible and drug-resistant strains of <i>Mycobacterium tuberculosis</i> H37Rv is 0.006 &mu;g/ml <Reference id=45957/>.",
      "notes": "",
      "amount": 122
    },
    {
      "id": 1676,
      "name": "elranatamab",
      "appliances": "",
      "notes": "",
      "amount": 968
    },
    {
      "id": 1677,
      "name": "pozelimab",
      "appliances": "",
      "notes": "",
      "amount": 800
    },
    {
      "id": 1678,
      "name": "nadifloxacin",
      "appliances": "Nadifloxacin has potent <i>in vitro</i> antibacterial activity against Gram-positive bacteria, including <i>Cutibacterium acnes</i> <Reference id=46080/><Reference id=46079/>.",
      "notes": "",
      "amount": 569
    },
    {
      "id": 1679,
      "name": "josamycin",
      "appliances": "Josamycin is effective <i>in vitro</i> against Gram-positive cocci <Reference id=46090/>.",
      "notes": "",
      "amount": 486
    },
    {
      "id": 1680,
      "name": "clofoctol",
      "appliances": "",
      "notes": "",
      "amount": 938
    },
    {
      "id": 1681,
      "name": "dirithromycin",
      "appliances": "",
      "notes": "",
      "amount": 779
    },
    {
      "id": 1682,
      "name": "pristinamycin IIA",
      "appliances": "The two components of pristinamycin demonstrate synergistic antibacterial activty against Gram-positive bacteria <Reference id=46185/>.",
      "notes": "",
      "amount": 626
    },
    {
      "id": 1683,
      "name": "pristinamycin IA",
      "appliances": "The two components of pristinamycin demonstrate synergistic antibacterial activty against Gram-positive bacteria <Reference id=46185/>.",
      "notes": "",
      "amount": 864
    },
    {
      "id": 1684,
      "name": "befotertinib",
      "appliances": "Befotertinib inhibits proliferation of NSCLC cells with IC<sub>50</sub> values of 543 nM (WT EGFR) and 15.7 (EGFR with double mutant L858R/T790M) <Reference id=46164/>.",
      "notes": "",
      "amount": 355
    },
    {
      "id": 1685,
      "name": "ethionamide",
      "appliances": "The MIC for <i>in vitro</i> antimycobacterial activity is 0.25 &mu;g/ml against <i>Mycobacterium tuberculosis</i> H37Rv and 0.25-4.0 &mu;g/ml against a panel of drug-sensitive and drug-resistant <i>M. tuberculosis</i> isolates <Reference id=46314/>.",
      "notes": "",
      "amount": 485
    },
    {
      "id": 1686,
      "name": "simnotrelvir",
      "appliances": "",
      "notes": "",
      "amount": 174
    },
    {
      "id": 1687,
      "name": "cadonilimab",
      "appliances": "Cadonilimab does not bind to Fc receptors so exhibits minimal effector functions, and has no effect on interleukin-6 (IL-6)/IL-8 release.",
      "notes": "",
      "amount": 258
    },
    {
      "id": 1688,
      "name": "toripalimab",
      "appliances": "JS001 blocks binding of PD-1 to its ligands PD-L1 and PD-L2 with similar potencies (IC<sub>50</sub> ~3.0 nM) <Reference id=46260/>. It does not bind to PD-1 antigens on rodent peripheral blood mononuclear cells.",
      "notes": "",
      "amount": 142
    },
    {
      "id": 1689,
      "name": "sintilimab",
      "appliances": "Sintilimab binds weakly to rabbit PD-1 and does not bind to mouse or rat PD-1 <Reference id=46264/>. It inhibits binding of PD-L1 to PD-1 on CHO cells with an IC<sub>50</sub> of ~4&mu;g/ml.",
      "notes": "",
      "amount": 791
    },
    {
      "id": 1690,
      "name": "ethambutol",
      "appliances": "Ethambutol has speceific antibacterial activity against actively growing species of Mycobacterium, including <i>M. tuberculosis</i>, <i>M. kansasii</i> and a number of strains of the <i>Mycobacterium avium</i> complex (MAC).",
      "notes": "",
      "amount": 947
    },
    {
      "id": 1691,
      "name": "oxolinic acid",
      "appliances": "The MIC for antibacterial activity against <i>Proteus vulgaris</i> WLRI 240 is 0.4 &mu;g/ml <i>in vitro</i> <Reference id=46283/>.",
      "notes": "",
      "amount": 832
    },
    {
      "id": 1692,
      "name": "taurolidine",
      "appliances": "",
      "notes": "",
      "amount": 122
    },
    {
      "id": 1693,
      "name": "narlumosbart",
      "appliances": "",
      "notes": "",
      "amount": 692
    },
    {
      "id": 1694,
      "name": "adebrelimab",
      "appliances": "The killing effect of SHR-1316 on breast cancer cells has been demonstated <i>in vitro</i> <Reference id=46559/>.",
      "notes": "",
      "amount": 596
    },
    {
      "id": 1695,
      "name": "efanesoctocog alfa",
      "appliances": "Efanesoctocog alfa pharmacokinetics were reported in late 2023 <Reference id=46560/>.",
      "notes": "",
      "amount": 670
    },
    {
      "id": 1696,
      "name": "divozilimab",
      "appliances": "",
      "notes": "",
      "amount": 332
    },
    {
      "id": 1697,
      "name": "papaverine",
      "appliances": "Papaverine acts as a smooth muscle relaxant in blood vessels (peripheral vasodilator). Its pharmacodynamic actions appear to be a result of inhibition of phophodiesterases (PDEs).",
      "notes": "",
      "amount": 392
    },
    {
      "id": 1698,
      "name": "foslevodopa",
      "appliances": "Foslevodopa is converted to levodopa which is used physiologically as a precursor to increase dopamine levels.",
      "notes": "",
      "amount": 379
    },
    {
      "id": 1699,
      "name": "landiolol",
      "appliances": "Landiolol is ~250 fold selective for &beta;<sub>1</sub>-ARs compared to &beta;<sub>2</sub>-ARs.",
      "notes": "",
      "amount": 214
    },
    {
      "id": 1700,
      "name": "viomycin",
      "appliances": "The MIC for activity against <i>Mycobacterium tuberculosis</i> H37Rv is 5 &mu;g/ml <Reference id=47188/>.",
      "notes": "",
      "amount": 386
    },
    {
      "id": 1701,
      "name": "capreomycin IB",
      "appliances": "",
      "notes": "",
      "amount": 441
    },
    {
      "id": 1702,
      "name": "enviomycin",
      "appliances": "The MIC for antibacterial activity against <i>Mycobacterium tuberculosis</i> H37Rv is 4 &mu;g/ml <Reference id=47274/>.",
      "notes": "",
      "amount": 204
    },
    {
      "id": 1703,
      "name": "oleandomycin",
      "appliances": "The <i>in vitro</i> antibacterial activity of oleandomycin is less potent than that of <Ligand id=1456/> <Reference id=47297/> <Reference id=47298/>.",
      "notes": "",
      "amount": 224
    }
  ],
  "equipments": [
    {
      "id": 1,
      "room_id": 1,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 2,
      "room_id": 1,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 3,
      "room_id": 1,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 4,
      "room_id": 1,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 5,
      "room_id": 1,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 6,
      "room_id": 2,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 7,
      "room_id": 2,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 8,
      "room_id": 2,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 9,
      "room_id": 2,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 10,
      "room_id": 2,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 11,
      "room_id": 3,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 12,
      "room_id": 3,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 13,
      "room_id": 3,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 14,
      "room_id": 3,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 15,
      "room_id": 4,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 16,
      "room_id": 4,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 17,
      "room_id": 4,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 18,
      "room_id": 4,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 19,
      "room_id": 4,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 20,
      "room_id": 5,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 21,
      "room_id": 5,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 22,
      "room_id": 5,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 23,
      "room_id": 6,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 24,
      "room_id": 6,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 25,
      "room_id": 6,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 26,
      "room_id": 6,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 27,
      "room_id": 7,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 28,
      "room_id": 7,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 29,
      "room_id": 7,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 30,
      "room_id": 8,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 31,
      "room_id": 8,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 32,
      "room_id": 8,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 33,
      "room_id": 8,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 34,
      "room_id": 8,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 35,
      "room_id": 9,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 36,
      "room_id": 9,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 37,
      "room_id": 9,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 38,
      "room_id": 10,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 39,
      "room_id": 10,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 40,
      "room_id": 10,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 41,
      "room_id": 10,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 42,
      "room_id": 10,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 43,
      "room_id": 11,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 44,
      "room_id": 11,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 45,
      "room_id": 11,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 46,
      "room_id": 11,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 47,
      "room_id": 12,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 48,
      "room_id": 12,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 49,
      "room_id": 12,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 50,
      "room_id": 13,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 51,
      "room_id": 13,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 52,
      "room_id": 13,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 53,
      "room_id": 13,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 54,
      "room_id": 13,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 55,
      "room_id": 14,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 56,
      "room_id": 14,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 57,
      "room_id": 14,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 58,
      "room_id": 14,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 59,
      "room_id": 15,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 60,
      "room_id": 15,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 61,
      "room_id": 15,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 62,
      "room_id": 15,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 63,
      "room_id": 16,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 64,
      "room_id": 16,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 65,
      "room_id": 16,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 66,
      "room_id": 16,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 67,
      "room_id": 17,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 68,
      "room_id": 17,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 69,
      "room_id": 17,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 70,
      "room_id": 17,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 71,
      "room_id": 18,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 72,
      "room_id": 18,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 73,
      "room_id": 18,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 74,
      "room_id": 19,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 75,
      "room_id": 19,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 76,
      "room_id": 19,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 77,
      "room_id": 20,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 78,
      "room_id": 20,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 79,
      "room_id": 20,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 80,
      "room_id": 20,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 81,
      "room_id": 20,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 82,
      "room_id": 21,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 83,
      "room_id": 21,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 84,
      "room_id": 21,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 85,
      "room_id": 21,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 86,
      "room_id": 21,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 87,
      "room_id": 22,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 88,
      "room_id": 22,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 89,
      "room_id": 22,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 90,
      "room_id": 22,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 91,
      "room_id": 22,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 92,
      "room_id": 23,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 93,
      "room_id": 23,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 94,
      "room_id": 23,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 95,
      "room_id": 23,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 96,
      "room_id": 23,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 97,
      "room_id": 24,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 98,
      "room_id": 24,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 99,
      "room_id": 24,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 100,
      "room_id": 24,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 101,
      "room_id": 25,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 102,
      "room_id": 25,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 103,
      "room_id": 25,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 104,
      "room_id": 26,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 105,
      "room_id": 26,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 106,
      "room_id": 26,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 107,
      "room_id": 26,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 108,
      "room_id": 26,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 109,
      "room_id": 27,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 110,
      "room_id": 27,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 111,
      "room_id": 27,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 112,
      "room_id": 27,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 113,
      "room_id": 27,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 114,
      "room_id": 28,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 115,
      "room_id": 28,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 116,
      "room_id": 28,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 117,
      "room_id": 28,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 118,
      "room_id": 29,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 119,
      "room_id": 29,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 120,
      "room_id": 29,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 121,
      "room_id": 30,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 122,
      "room_id": 30,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 123,
      "room_id": 30,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 124,
      "room_id": 31,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 125,
      "room_id": 31,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 126,
      "room_id": 31,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 127,
      "room_id": 31,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 128,
      "room_id": 32,
      "name": "Oxygen Tank",
      "notes": ""
    },
    {
      "id": 129,
      "room_id": 32,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 130,
      "room_id": 32,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 131,
      "room_id": 33,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 132,
      "room_id": 33,
      "name": "Defibrillator",
      "notes": ""
    },
    {
      "id": 133,
      "room_id": 33,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 134,
      "room_id": 33,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 135,
      "room_id": 34,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 136,
      "room_id": 34,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 137,
      "room_id": 34,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 138,
      "room_id": 34,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 139,
      "room_id": 35,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 140,
      "room_id": 35,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 141,
      "room_id": 35,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 142,
      "room_id": 36,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 143,
      "room_id": 36,
      "name": "Bedside Table",
      "notes": ""
    },
    {
      "id": 144,
      "room_id": 36,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 145,
      "room_id": 36,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 146,
      "room_id": 36,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 147,
      "room_id": 37,
      "name": "Wheelchair",
      "notes": ""
    },
    {
      "id": 148,
      "room_id": 37,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 149,
      "room_id": 37,
      "name": "Patient Monitor",
      "notes": ""
    },
    {
      "id": 150,
      "room_id": 37,
      "name": "IV Pole",
      "notes": ""
    },
    {
      "id": 151,
      "room_id": 38,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 152,
      "room_id": 38,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 153,
      "room_id": 38,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 154,
      "room_id": 39,
      "name": "Ventilator",
      "notes": ""
    },
    {
      "id": 155,
      "room_id": 39,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 156,
      "room_id": 39,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 157,
      "room_id": 40,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 158,
      "room_id": 40,
      "name": "Blood Pressure",
      "notes": ""
    },
    {
      "id": 159,
      "room_id": 40,
      "name": "Surgical Lights",
      "notes": ""
    },
    {
      "id": 160,
      "room_id": 40,
      "name": "Hospital Bed",
      "notes": ""
    },
    {
      "id": 161,
      "room_id": 40,
      "name": "Crutches ",
      "notes": ""
    },
    {
      "id": 162,
      "room_id": 41,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 163,
      "room_id": 41,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 164,
      "room_id": 41,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 166,
      "room_id": 42,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 167,
      "room_id": 42,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 168,
      "room_id": 43,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 169,
      "room_id": 43,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 170,
      "room_id": 43,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 171,
      "room_id": 43,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 172,
      "room_id": 44,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 173,
      "room_id": 44,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 174,
      "room_id": 44,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 175,
      "room_id": 45,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 176,
      "room_id": 45,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 177,
      "room_id": 45,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 178,
      "room_id": 45,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 179,
      "room_id": 45,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 180,
      "room_id": 46,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 181,
      "room_id": 46,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 182,
      "room_id": 46,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 183,
      "room_id": 46,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 184,
      "room_id": 47,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 185,
      "room_id": 47,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 186,
      "room_id": 47,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 187,
      "room_id": 48,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 188,
      "room_id": 48,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 189,
      "room_id": 48,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 190,
      "room_id": 48,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 191,
      "room_id": 49,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 192,
      "room_id": 49,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 193,
      "room_id": 49,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 194,
      "room_id": 49,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 195,
      "room_id": 49,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 196,
      "room_id": 50,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 197,
      "room_id": 50,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 198,
      "room_id": 50,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 199,
      "room_id": 51,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 200,
      "room_id": 51,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 201,
      "room_id": 51,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 202,
      "room_id": 51,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 203,
      "room_id": 51,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 204,
      "room_id": 52,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 205,
      "room_id": 52,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 206,
      "room_id": 52,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 207,
      "room_id": 52,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 208,
      "room_id": 52,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 209,
      "room_id": 53,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 210,
      "room_id": 53,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 211,
      "room_id": 53,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 212,
      "room_id": 54,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 213,
      "room_id": 54,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 214,
      "room_id": 54,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 215,
      "room_id": 54,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 216,
      "room_id": 55,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 217,
      "room_id": 55,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 218,
      "room_id": 55,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 219,
      "room_id": 56,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 220,
      "room_id": 56,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 221,
      "room_id": 56,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 222,
      "room_id": 57,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 223,
      "room_id": 57,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 224,
      "room_id": 57,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 225,
      "room_id": 58,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 226,
      "room_id": 58,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 227,
      "room_id": 58,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 228,
      "room_id": 58,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 229,
      "room_id": 59,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 230,
      "room_id": 59,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 231,
      "room_id": 59,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 232,
      "room_id": 59,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 233,
      "room_id": 60,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 234,
      "room_id": 60,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 235,
      "room_id": 60,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 236,
      "room_id": 61,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 237,
      "room_id": 61,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 238,
      "room_id": 61,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 239,
      "room_id": 61,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 240,
      "room_id": 62,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 241,
      "room_id": 62,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 242,
      "room_id": 62,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 243,
      "room_id": 62,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 244,
      "room_id": 63,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 245,
      "room_id": 63,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 246,
      "room_id": 63,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 247,
      "room_id": 63,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 248,
      "room_id": 64,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 249,
      "room_id": 64,
      "name": "Laboratory Equipment",
      "notes": ""
    },
    {
      "id": 250,
      "room_id": 64,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 251,
      "room_id": 64,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 252,
      "room_id": 65,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 253,
      "room_id": 65,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 254,
      "room_id": 65,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 255,
      "room_id": 66,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 256,
      "room_id": 66,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 257,
      "room_id": 66,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 258,
      "room_id": 66,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 259,
      "room_id": 67,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 260,
      "room_id": 67,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 261,
      "room_id": 67,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 262,
      "room_id": 68,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 263,
      "room_id": 68,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 264,
      "room_id": 68,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 265,
      "room_id": 68,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 266,
      "room_id": 68,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 267,
      "room_id": 69,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 268,
      "room_id": 69,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 269,
      "room_id": 69,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 270,
      "room_id": 69,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 271,
      "room_id": 69,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 272,
      "room_id": 70,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 273,
      "room_id": 70,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 274,
      "room_id": 70,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 275,
      "room_id": 70,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 276,
      "room_id": 67,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 277,
      "room_id": 67,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 278,
      "room_id": 68,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 279,
      "room_id": 68,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 280,
      "room_id": 68,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 281,
      "room_id": 68,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 282,
      "room_id": 68,
      "name": "Anesthesia Machine",
      "notes": ""
    },
    {
      "id": 283,
      "room_id": 69,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 284,
      "room_id": 69,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 285,
      "room_id": 69,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 286,
      "room_id": 70,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 287,
      "room_id": 70,
      "name": "Sphygmomanometer",
      "notes": ""
    },
    {
      "id": 288,
      "room_id": 70,
      "name": "Ultrasound Machine",
      "notes": ""
    },
    {
      "id": 289,
      "room_id": 69,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 290,
      "room_id": 69,
      "name": "Electrocardiogram Machine",
      "notes": ""
    },
    {
      "id": 291,
      "room_id": 70,
      "name": "Stethoscope",
      "notes": ""
    },
    {
      "id": 292,
      "room_id": 70,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 293,
      "room_id": 70,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 294,
      "room_id": 70,
      "name": "Microscope",
      "notes": ""
    },
    {
      "id": 295,
      "room_id": 70,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 165,
      "room_id": 42,
      "name": "X-ray Machine",
      "notes": ""
    },
    {
      "id": 297,
      "room_id": 45,
      "name": "Some room equipment",
      "notes": "Used for some purposes"
    }
  ]
}